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Background and Objectives: Gravity Relief Mobilisation is a novel manual therapy 
treatment for persistent musculoskeletal pain. It involves the facilitation of a non-
volitional movement response. In the massage practice of the researcher, GRM appeared 
to have short–term benefit for musculoskeletal pain after transient increases of pain but 
its lasting effects were unknown. 
Aim: To evaluate if GRM is an effective component of a massage therapy intervention for 
chronic low back pain (CLBP). 
Method: Five individuals with CLBP were recruited into a concurrent series of Single Case 
Experiments (SCEs). Participants were randomized to a baseline (control) phase of 3-7 
weeks then crossed into a 13–14 week intervention phase with 10–13 treatments.  
Ecological Momentary Assessments (EMA) were completed by the participants using an 
on line tool called the PainQuILT identifying low back pain (LBP) locations, pain intensity 
of LBP locations, and pain interference. EMAs were completed at a similar time of day up 
to three times per week. The 12 week follow up phase involved each participant 
completing three EMAs during weeks 4, 8, and 12.  
Results: Four participants completed the intervention and follow-up phases. One 
participant withdrew during the intervention due to transient pain increases. EMA 
compliance rates were high and sufficient data were collected for the final analysis. 
Participant-1 did not improve. Participant-2 and -5 had reduced LBP intensity and pain 
interference, with large effect sizes (phi values of >1). Participant-4 experienced small to 
moderate reduction in LBP intensity and pain interference (phi values of 0.24 (0.16 to 
0.58), p=0.2; and 0.7 (0.36 to 0.93), p<0.001).  
Conclusions: GRM shows potential as an effective component of a massage therapy 
intervention for CLBP, with favourable effect on mean pain intensity of LBP locations, and 
pain interference, but may not be tolerated by all individuals. SCE design with data 
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energy work: Types of massage or body work therapy where the principle goal is to 
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non-volitional movement: Movement occurring from neural processes that are not 
accompanied by conscious initiation or direction of movement (Hallett, 2007). Excluded 
from this definition are spinal reflexes, movement under hypnosis, and para-normal 
phenomena. 
pandiculation: The drive to self–stretch by isotonic and isometric muscle contractions, 
followed by sudden relaxation, for example the stretch–yawn reflex.  
rehabilitation  taxonomy: Classification system used to characterise rehabilitation 
interventions, including categories of treatments and their ingredients. Treatment targets 
are linked to treatment mechanisms. 
therapeutic pulse:  A ‘pulsing’ detected by the practitioner with palpation and gentle 
holding of tissues. Its strength increases and then subsides as the palpable tension 




Chapter 1 Introduction 
This thesis describes a series of single case experiments designed to explore the effects of 
a massage therapy-based intervention in people with chronic low back pain (CLBP). The 
intervention features a novel manual therapy technique called Gravity Relief Mobilisation 
(GRM). It is combined with components that are non-unique features of usual massage 
therapy practice. Gravity Relief Mobilisation targets a non-volitional movement 
phenomenon observed to occur in response to some manual therapy techniques. Non-
volitional movement can be defined as movement occurring from neural processes that 
are not accompanied by conscious initiation or direction of movement (Hallett, 2007). 
The topic of the research is GRM and CLBP was selected as the condition on which to 
explore its effects. The researcher is a massage therapist, whose massage techniques have 
developed over 15 years of clinical practice with increasing proportions of clients who 
experience persistent musculoskeletal pain. Gravity Relief Mobilisation is now her 
predominant manual therapy technique used, which is a departure from her original 
professional training. The purpose of this research project is to investigate whether GRM 
is an effective ingredient of a massage therapy intervention for persistent musculoskeletal 
pain. 
This research is being done from a pragmatic perspective and psychological factors are 
recognised as being important. The phenomenological complexity of the CLBP condition 
encompasses psychological risk factors that are influenced by the comfort, caring and 
behaviours of the practitioner. 
1.1  The Intervention 
The planned intervention consists of 4–12 sessions, of 1–1 1/2 hours duration, over 12 
weeks, provided by the researcher at her practice in urban Rotorua.  The massage 
sessions are mainly GRM but also incorporate conventional manual massage.  
The intervention is described using terminology of a rehabilitation treatment taxonomy 
and a massage treatment taxonomy.  Both of these were developed to characterise 
interventions for research and clinical applications (Sherman, Dixon, Thompson, & 
Cherkin, 2006; Whyte, Dijkers, Hart, Zanca, Packel, Ferraro, & Tsaousides., 2014). The 
rehabilitation treatment taxonomy proposes interventions can be defined by: component 




that produce change in the target, and articulation of the theoretical or known 
mechanisms that link ingredients to the targets (Hoffmann et al., 2014). Combinations of 
treatments make up an intervention (Dijkers, Hart, Whyte, Zanca, Packel, & Tsauosides, 
2014). The massage taxonomy categorises massage techniques (called treatment 
ingredients in this intervention) under four principle goals of treatment. These are: 
clinical massage, relaxation massage, energy work, and movement education (Sherman et 
al., 2006). 
The four component treatments of the GRM CLBP Intervention are: 1) GRM, 2) Relaxation 
massage, 3) Breathing education, and 4) Posture and movement education. Each treatment 
session combines some or all the component treatments. The intervention is based on a 
biopsychosocial model of pain; it is delivered by and within the scope of a sole massage 
practitioner. Apart from GRM, the other treatments are usual features of massage practice 
(Sherman et al., 2006) contributing wellness components to the treatment sessions (Fritz, 
2000d). Wellness components of massage therapy is the practitioners’ provision of basic 
information about health and lifestyle. For example, nutrition, sleep, breathing, and 
movement (Fritz, 2000d). It also includes empathic listening and building of a therapeutic 
alliance (Smith,J., Sullivan, & Baxter, 2009, 2010; Smith,M., Russell, & Hodges, 2006).   
Wellness components are non-essential to the theoretical mechanism of the intervention 
but were thought to enhance the client experience and consolidate potential clinical gains 
in functionally meaningful ways. Additionally, it is the therapist’s duty of care to provide 
usual massage therapy treatment session components to meet the expectations of clients 
seeking treatment. Therefore, the intervention is massage therapy based, and its unique 
essential ingredient GRM is incorporated into usual practice.  
 GRM 
GRM is essential to the GRM CLBP Intervention, it is made up of treatment ingredients 
that are discussed in more detail in the Background and Method chapters. GRM has 
become the primary treatment used by the researcher to address chronic musculoskeletal 
pain gradually replacing the direct pressure massage techniques (ingredients) of her 
training.  A personal accounting of the discovery of the non-volitional movement response 
to manual therapy that led to the GRM concept can be found in the preface of the 
Appendix Gravity Relief Mobilisation Intervention for Chronic Low Back Pain: Treatment 
Manual (p. iii). The GRM is very different to direct pressure massage. Direct pressure is a 




Swedish massage, and Trigger Point Therapy (McPartland & Simons, 2006; Sherman et al., 
2006). Client feedback indicated that GRM was better tolerated than direct pressure 
massage. The practitioner subjectively observed improved clinical outcomes of reduced 
pain and increased joint ranges of motion when she applied GRM compared to techniques 
learnt in her original clinical training as a massage therapist. 
 The other treatments 
The other component treatments of the GRM CLBP Intervention are also made up of 
ingredients that may be essential or non-essential to the treatments’ theoretical 
mechanism. The following sections are brief introduction to the Treatments. Treatment 
ingredients are discussed in more detail in the Background and Method chapters.  
1.1.2.1 Relaxation massage 
The aim of the relaxation massage is to familiarise the client to the practitioner’s touch, 
built rapport, and provide opportunity for practitioner to collect palpatory feedback 
(Fritz, 2000b). It is non-essential because some people do not like massage or are 
uncomfortable to undress for massage techniques to be effectively applied. When working 
with these individuals the researcher has used holding techniques instead of gliding and 
kneading and found GRM to be acceptable to these clients. 
1.1.2.2 Breathing education 
Breathing instruction is a standard part of massage practice that aims to further facilitate 
relaxation (Chaitow, 2004; Fritz, 2000d; Wang,S., Li, Xu, Lin, shao, Zhao, & Wang, T., 2010).  
In this intervention chronically stressed accessory breathing muscles (Bartley & Clifton-
Smith, 2006) are targeted with the application of holding techniques whilst breathing is 
verbally directed by the practitioner. It is thought that GRM requires a decrease in 
sympathetic nervous system tone to be effectively applied and breathing is an important 
tool to facilitate this physiological response (Mehling, Hamel, Acree, Byl, & Hecht, 2005; 
Wang et al., 2010). However, each client varies as to whether breathing instruction is 
needed in addition to relaxation massage and so it is a non-essential ingredient.   
1.1.2.3 Posture and movement education 
The practitioner has observed that, at the end of a GRM treatments session, many clients 
ask what they can do to help themselves in their day to day lives between treatment 
sessions. It is common for massage therapists provide instruction on exercises they can 




movement. This is also a non-essential ingredient due to client individual variation in 
posture and movement.  
1.2  Ethical Issues  
In reviewing the literature for similar techniques nothing identical to GRM was found, 
which means GRM has no research evidence base to justify its clinical use. According to 
the declaration of Helsinki, novel interventions that hope to alleviate suffering must be 
evaluated for safety and efficacy (World Medical Association, 2013). Massage New 
Zealand (2018) code of ethics requires its members to apply techniques that are most 
appropriate for the presenting condition according to principles of Evidenced Based 
Practice. Evidenced Based Practice encompasses: addressing client values, practitioner 
clinical expertise, and identification of the best research evidence demonstrating 
therapeutic effects when applying interventions (Sackett, Rosenberg, Gray, Haynes, & 
Richardson, 1996). Therefore, as GRM is a novel technique it is the practitioner’s 
responsibility to determine how appropriate it is for a given condition. 
Even though GRM is non-invasive (does not push against tissue barriers), incidence of 
transient pain or discomfort for a few days following treatment sessions had been 
reported by clients. Therefore, more information on whether these adverse effects were 
attributable to treatment sessions was needed to: determine if outcomes justified the 
techniques use and/or to inform aspects of clinical practice. For example, adjustment of 
treatment session duration and scheduling, to maximise potential benefits whilst 
minimising pain interference with the client’s important responsibilities and activities. 
1.3  Chronic low back pain 
The aim of this research was to explore the effects of a clinical intervention featuring GRM 
for individuals with chronic musculoskeletal pain and to indicate if any effects are 
enduring. To date the researcher has not observed the GRM intervention to be useful in 
acute musculoskeletal pain conditions. As back pain is the most common problem seen by 
massage therapists in North America and New Zealand, (Sherman, Cherkin, Kahn, Erro, 
Hrbek, Deyo, & Eisenburg, 2005; Smith,J., Sullivan, & Baxter, 2011; Sundberg, Cramer, 
Sibbritt, Adams, & Lauche, 2017), low back pain is a relevant and convenient condition on 
which to test the use of GRM.   
Underpinning massage therapy interventions, are various models of MSK 




massage techniques work. In other words, how the problem is framed and how the 
problem is addressed. Examples of models of pain are: biomechanical (McKenzie & May, 
2003), biotensegrity (Levin, 2002; Myers, 2002), and neurophysiological (Puentedura & 
Flynn, 2016). Two examples of different approaches to addressing the problem are: the 
clinical system of massage, or the relaxation system of massage. Other massage therapy 
practice models and systems that may have meta-physical explanations are not discussed.  
This intervention for CLBP targets assume pathologies and dysfunction in the low back 
neuromuscular system. This includes contractile elements (within muscle, tendons, 
fascia), as well as fascia surrounding muscle and low back nervous tissue. The exact 
physical aetiology of pain in CLBP is often unknown. It has been proposed that the cross 
linking of collagen in tissues caused by a reduction of optimal movement patterns (which 
maintains their gliding capabilities) may contribute (Bertolucci, 2011; Tozzi, 2015a). If so, 
the use of GRM may elicit movement to free the pathological adhesions in the tissues. In 
addition, GRM theoretically targets the brains’ body schema and motor cortex which have 
undergone use dependant alterations and movement inhibition (Ziemann, Muellbacher, 
Hallett, & Cohen, 2001). The maintenance of tissue gliding capabilities is hypothesised to 
happen by the reduction of movement inhibition. The rationale and existing evidence 
supporting these assumptions is discussed in the treatment manual Appendix. 
The practitioner–researcher has proposed the following theoretical model for the effects 
of GRM.  Movement is the basic mechanism by which GRM is thought to target symptoms 
of CLBP. The theoretical mechanism of GRM utilises isotonic contractions of muscles. to 
address CLBP sequelae. Muscle and connective tissues are continuous from the back and 
pelvis into the hip region. Therefore, it is logical that the movement of these and the 
paralumbar muscles effect the overall function of the low back system.  
This logic progresses to needing balanced movement of the entire neuromusculoskeletal 
system to obtain ease of movement, and so application of GRM always treats the entire 
body. The hip, knee, foot/ankle, shoulder, elbow, wrist/hand, and the head/neck regions 
are all addressed. Another reason for treating the whole body is that single site chronic 
musculoskeletal pain is rare and site specific treatments may be inappropriate for a large 
number of these patients (Carnes et al., 2007). Additionally poor physical function 
predicted chronicity of back pain in a follow up study, of 2000 adults, four years after the 
original survey (Smith,B., Elliott, Hannaford, Chambers, & Smith., 2004). As non–specific 




moving is the aim of this intervention (Accident Compensation Corporation, 2004; 
Guzmán, Esmail, Karjalainen, Malmivaara, Irvin, & Bombardier., 2001; Van Middelkoop, 
Rubinstein, Kuijpers, Verhagen, Ostelo, Koes, & van Tulder., 2011).  
1.4  Research Objectives 
In clinical practice, the practitioner–researcher had subjectively observed reduced pain, 
after a transient period of increased pain intensity and distribution, following treatment 
sessions for musculoskeletal pain that included GRM. However it was unknown if 
improvements were sustained for a period after completion of a course of treatment 
sessions. Therefore, the primary objective was to evaluate whether the GRM intervention 
would cause a sustained reduction in low back pain and improvement in functional 
outcomes for a follow–up period after the intervention course finished. It was 
hypothesised that the intervention would cause a short-term increase in pain intensity 
and pain distribution after each treatment session. To test these, the following research 
objectives were determined: 
1. Examine the effects of the intervention featuring GRM on low back pain and number of 
pain locations for a period of 12 weeks after intervention exposure finished. 
2. Examine the effects of the intervention featuring GRM on pain interference over 12 
weeks post intervention delivery. 
3. Evaluate if the intervention featuring GRM causes an increase in low back pain levels 
and number of pain locations within 72 hours post treatment session. 
The research strategy required monitoring of the response to the intervention over time, 
and a group randomised controlled trial was thought not to be feasible within the context 
of clinical practice; therefore single case design methodology was used.  To facilitate 
collection of data at multiple time points, data collection was via an electronic data 
collection tool called “Pain QuILT” which is a modified version of the Brief Pain Inventory 
(Lalloo, 2014; Song, Lin, Huang, Wu, Chen, & Hsieh., 2016).   
1.5  Thesis Structure 
The literature review in chapter two provides, background on massage therapy in the 
contemporary New Zealand context. It also examines occurrences of non-volitional 
movement and its utilisation in therapeutic contexts. Manual therapy treatments similar 
to GRM are discussed and efficacy or effectiveness studies are evaluated. In addition, 
current interventions for current CLBP are presented. Chapter three details the research 




considerations, and the data-analysis strategy. The results of the data collection process 
and data–analysis are presented in chapter four, clearly linked to the research objectives. 
Chapter five discusses the implications of the results, the research limitations, and 




Chapter 2 Background 
2.1  Introduction 
The purpose of this research project was to investigate whether GRM is an effective 
component of a massage therapy intervention for persistent musculoskeletal pain. To test 
this the GRM intervention was assessed, using a series of single case experiments, in 
people with chronic low back pain. The intervention was developed and delivered by the 
student–investigator who is the practitioner–researcher in this project.  GRM (described 
in detail in section 3.5.2) has the key feature of non-volitional movement that is facilitated 
by a manual therapy technique.  The proposed mechanism of effect is stimulation of the 
body’s self–correcting response to use-dependent changes in neuro-myofascial tissues 
and the brain.  
To fully understand the particular nature of GRM and its application, this background 
chapter first describes massage therapy, defines its scope of practice, and discusses if the 
novel GRM treatment fits within its scope. This is followed by an explanation of how 
massage therapy treatments can be characterized for research purposes; then the use of 
massage therapy for management of painful persistent musculoskeletal conditions is 
discussed—in particular for management of Chronic Low Back Pain (CLBP). Next, other 
somatic therapies found to have non-volitional movement components, similar to that 
seen in GRM, are outlined.  Their treatment processes and proposed mechanisms are then 
summarized.  No critical evaluation of evidence for their theoretical mechanisms is given 
as this would require a dedicated literature review of basic sciences which is beyond 
scope of this thesis. Instead the non-volitional movement interventions key treatment 
ingredients are compared. Finally, challenges to massage therapy outcomes research and 
the rationale for using single case methodology are discussed.  
2.2  Massage Therapy 
Massage therapy is a manual therapy that manipulates the body’s soft tissues; it is used 
for stress reduction and the treatment of musculoskeletal disorders (Fritz, 2000c). New 
Zealand massage therapy practice first became established in 1913, when the Otago 
Medical School founded the School of Massage evolving into the university’s current 
School of Physiotherapy (University of Otago, n.d.). In New Zealand therapeutic massage 
became re-established legally in 2004 as a specialist Complementary and Alternative 
Medicine practice (Smith,D., Smith, Baxter, & Spronken-Smith, 2012) and now has degree 




Manual therapies are techniques, applied by the hands to the body, with the intention of 
remedying a disorder and can be categorised as massage, manipulations, or mobilisations. 
The American Academy of Orthopaedic Physical Therapists gives a widely accepted 
definition of manual therapy and its targeted effects as: 
"Skilled hand movements intended to produce any or all of the following effects: improve 
tissue extensibility; increase range of motion of the joint complex; mobilize or manipulate 
soft tissues and joints; induce relaxation; change muscle function; modulate pain; and 
reduce soft tissue swelling, inflammation or movement restriction." (American Physical 
Therapy Association, 2014). Massage therapy does not assess or treat acute trauma or 
medical conditions (Fritz, 2000c). Massage therapy assessment includes client history, 
evaluation of posture, joint ranges of motion, some specialist orthopaedic tests and 
condition of tissues under palpation (Smith J., Sullivan, & Baxter, 2011). In New Zealand 
Massage therapy is not regulated however Massage New Zealand code of ethics requires 
its members to adhere to their individual scope of practice (MNZ, 2018). This means 
various health conditions may be dealt with by an appropriately trained massage 
practitioner if under supervision of the referring health professional. 
The Guide to Physical Therapist Practice defines mobilisation as a skilled manual therapy 
technique that passively moves joints and muscles (Wise, 2015). Definitions of passive 
include: inert or inactive; and submission or offering no resistance (The Concise Oxford 
Dictionary, 1986). Mobilisation therefore requires no volitional movement from the client.  
The umbrella term manipulation is stated, by the Practice Affairs Committee of the 
Orthopaedic Section of the American Physical Therapy Association, to include 
mobilisation techniques and these are not specific to any profession (as cited in Wise, 
2015).  
Clinical massage practice, is the ‘systematic’ combination of component techniques that 
directly: stroke, knead, stretch and compress soft tissues (Fritz, 2000b; Sherman et al., 
2006). It is distinguished from other clinical manual therapy practices of osteopathy, 
chiropractic, and physiotherapy by the omission of high velocity thrust manipulations of 
bone (Fritz, 2000b; Mintken, DeRosa, Little, & Smith, 2008; Massage New Zealand, 2018). 
Massage practice may include mobilisation, which is the low velocity application of 
pressure gradients to passively move joints or tissues within normal ranges of movement 




To describe a massage intervention for the purposes of research, the components of the 
therapy (what the therapist does) and the proposed purpose or aim (why the therapist 
does them) must be defined. Contemporary massage practice is a mix of treatment 
systems aiming to achieve a range of outcomes using: techniques applied by the hands, 
massage tools, stretching, exercises, and wellness components (Fritz, 2000b, 2000d; 
Sherman et al., 2006; Smith,J. et al. 2011; Sundberg et al., 2017).  
A massage taxonomy derived for research purposes classifies massage therapy in a three- 
tiered hierarchy. Principal goals are at the top, with divisions of massage styles, and a list 
of 36 component techniques (Figure 2.1) (Sherman et al., 2006). The four principal 
treatment goals [aims] are: Movement re-education that aims to create freedom in 
movement, energy work that aims to free energy blockages, relaxation massage that aims 
to improve wellness and move body fluids (for example lymph), and clinical massage that 
aims to reduce movement restrictions and relieve pain (Sherman et al., 2006). The 
number of massage styles is innumerable, and it could be argued every practitioner has 
their own style, using preferred techniques that over time they develop into their own 
treatment system. What is seen in massage practice is the formalization of some styles as 
proprietary modalities. 
    
Figure 2-1. Massage Therapy Taxonomy 
The massage taxonomy identifies the 36 techniques, by their consistent mechanical 
processes, and they may be uniquely combined in various massage styles to address more 
than one treatment goal (Sherman et al., 2006). The taxonomy has been adopted by 
massage research (Furlan, Brosseau, Imamura, & Irvin, 2002), but evidence of whether 
the treatments achieve their aims is not included. Narrative reviews of evidence for 
manual therapy mechanisms, have reasoned that effects are a combination of mechanisms 
(Bialosky, Bishop, Price, Robinson, & George, 2009; Gracovetsky, 2016; Wellens, 2010).  





















Another division in manual therapy is the distinction of direct and in-direct techniques, 
which is predominantly used when referring to the osteopathic and massage therapy 
treatment called Myofascial Release (MFR).  Use of the term MFR indicates the treatments’ 
theoretical target tissue, and its’ aims to restore gliding and movement capability of the 
tissues (Chaitow, 2017; Ehrenfeuchter, William, Kappler, & Kimberly, 2011). Other 
manual therapy treatments such as Positional Release Technique, Myofascial Unwinding 
and Muscle Repositioning are also considered to be types of myofascial release 
(Bertolucci, 2008; Chaitow, 2016a; Minasny, 2009). 
Fascia is a target of many manual therapy techniques (Ajimsha, Al-Mudahka, & Al-
Madzhar, 2015; Barnes, 1997; Laimi et al., 2018; Myers, 2002). Simply put, fascia is the 
connective tissue that permeates the entire body, it is highly innervated and contains a 
sparse number of muscle cells that can contract (Klingler, Velders, Hoppe, Pedro, Schleip,  
2014; Schleip, 2003a, 2003b; Schleip, Klingler, & Lehmann-Horn, 2005). Although its 
targeting by manual therapists has become more common with increased knowledge 
about the fascial systems characteristics (Schleip, et al., 2005; Wilke, Krause, Vogt, & 
Banzer, 2016), efficacy of manual therapy in affecting fascia’s plasticity characteristics is 
lacking (Schleip, 2003a, 2003b).  
In the literature there are some differences in how direct and in-direct techniques in MFR 
are defined. Some authors use the amount of pressure as the distinctive factor. For 
example, direct techniques apply forces in the order of kilograms and in-direct techniques 
apply forces in the order of grams (Ajimsha, et al., 2015; Laimi, et al.,2018). Other authors 
include some kind of tissue movement description. For example, part of in-direct 
techniques involves moving a limb into its most relaxed position, or guiding it though the 
path of least resistance (Ajimsha et al., 2015; Ehrenfeuchter et al., 2011; Minasny, 2009). 
The definitions being used for this thesis are: MFR direct techniques stretch tissues by 
direct application of forces (against resistance) ranging from grams to kilograms 
(Parravicini & Bergna, 2017); MFR in-direct techniques elicit a movement response to the 
therapists’ touch that can be further facilitated by the specifics of the technique (Chaitow, 
2017; Minasny, 2009; Parravicini & Bergna, 2017).  
Direct MFR techniques apply an external force with the hands or a massage tool intending 
to correct a contraction or adhesion (Ajimsha et al., 2015; Parravicini & Bergna, 2017). In 
other words, compression and/or stretching of the tissues. Direct techniques are used to 




contain adhesions, or are ‘mal-aligned’ soft tissue fibres (Bialosky, Bishop, Price, 
Robinson, & George, 2009; Klingler, Velders, Hoppe, Pedro, & Schleip, 2014). The 
theoretical mechanisms are: deformation of the mechanical properties of the tissues 
(Chaudhry, Schleip, Bukiet, Maney, & Findley, 2008), peripheral mechano-receptor 
responses to the mechanical stimulus (Bialosky et al. 2009; Schleip, 2003a, 2003b), and 
mechanical strain effects on cells (Parravicini & Bergna, 2017). These assume that 
mechano-transduction of forces translates to effects that increase tissue movement 
capability.  
In-direct techniques also apply external forces but aim to elicit a movement response 
assumed to be a self-corrective mechanism (Holey & Dixon, 2014; Minasny, 2009). The 
force is much gentler than some direct techniques.  It is always applied with the hands so 
the practitioner can modulate the pressure and detect any sensation of movement. The 
exact outcome is unknown, because after applying a force stimulus the practitioner acts to 
support or allow a range of potential neurophysiological responses to occur (Bialosky et 
al., 2009). In manual therapy, this may be following the movement response of the tissues 
with the hands, as in myofascial unwinding techniques (Minasny, 2009). The theoretical 
mechanisms are neurobiological and neurophysiological, meaning the complex 
interaction of peripheral and central nervous systems (Bialosky et al., 2009; Chaitow, 
2017; Tozzi, 2015a, 2015b). GRM by this definition can be called a type of indirect MFR. 
However, the term MFR is not being used to describe GRM because it is not known if the 
predominant effects are in the myofasciae. 
Clinical or structural massage using direct mechanical stretch and compression of the 
connective tissues is widely practiced, yet it has not been confirmed that mechanical 
effects persist (Bialosky et al., 2009; Wellens, 2010; Zusman, 2011).  Chaudhry et al 
(2008), used a mathematical model calculating the forces needed to deform fasciae by 
shearing or compression and showed that these forces were well beyond what a manual 
therapist could apply. They concluded the remaining possible mechanisms of tissue 
changes in response to manual therapy, are reflexive neurophysiological changes, or are a 
result of twisting and/or extension forces within the fasciae. With fasciae being 
understood as material within the body that may be affected by stimulus of 
neurophysiological mechanisms and not external compression or shearing forces of 
manual therapy, the use of direct techniques needs revision (Farasyn, Meeusen, & Nijs, 




Evidence for the neurophysiological model of manual therapy mechanisms is strong 
(Bialosky et al., 2009; Wellens, 2010) but the mechanical/structural model persists in 
clinical practice of both massage therapy (Smith, J. et al., 2011) and physiotherapy 
(Darlow, 2016; Gardner Refshauge, Smith, McAuley, Hubsher, & Goodall., 2017; Wellens, 
2010; Zusman, 2011, 2013). It is the practitioner–researcher’s position that even though 
direct techniques may produce short term clinical effects in targeted tissues, any longer-
term effects are a product of in-direct neurophysiological and non-specific psychological 
mechanisms affecting the whole person. 
 Massage Therapy for Chronic Low Back Pain 
Back pain is a significant burden to the world’s population. Worldwide, back pain is the 
most prevalent musculoskeletal pain site (Swain & Johnson, 2014).  Globally 10.8% of 
years lived with disability are attributable to back and neck pain (Institute for Health 
Metrics and Evaluation, 2016). In New Zealand this figure is estimated to be 17.0% 
(Institute for Health Metrics and Evaluation).  A postal survey, sampling the NZ general 
population (n=540), also identified that back pain affected 21-29% of working age adults, 
potentially contributing to disability thus affecting productivity (Taylor, 2005). New 
Zealand Maori are 1.37 times more likely to experience chronic pain than non-Maori (New 
Zealand Ministry of Health, 2017) with back pain a common pain location.  
Low back pain is defined as being experienced in any part of the posterior body from the 
inferior margin of the 12th rib to the gluteal folds (Deyo et al., 2014). Acute low back pain 
is less than three months duration and can be very painful. Its natural history is episodic 
pain with gradual improvement and acute back pain, by definition, does not cause an 
enduring loss of function (Accident Compensation Corporation, 2004). Chronic low back 
pain lasts for at least three months (Deyo et al., 2014) and disrupts normal functions 
(Accident Compensation Corporation, 2004). For research purposes CLBP criteria, 
includes low back pain experienced on at least half of the days of the past six months 
(Deyo et al., 2014). 
The likelihood of recovery from low back pain decreases with chronicity (Balagué, 
Mannion, Pellisé, & Cedraschi, 2012). Developments in the understanding of psychological 
factors determining chronicity of low back pain shows that as duration of low back pain 
increases, people are found to have higher prevalence and levels of life stress, increased 
sensitivity to touch, altered perceptions of where their body is in space, and are more 




2016). CLBP is also affected by complex biopsychosocial factors (Andersson, 1999; 
O'Sullivan., 2011; O'Sullivan, Caneiro, O'Keeffe, & O'Sullivan, 2016; Rabey, Smith, Beales, 
Slater, & O’Sullivan, 2016), with current interventions aiming to reduce disability and 
target unidentified barriers to recovery (Kendall, Linton, & Main, 1997).  
Over 50% of people experiencing back pain in New Zealand accessed ACC funded manual 
therapy during 2012–2013 (National Health Committee, 2015). This might be  
attributable to New Zealand’s ACC model of care, which subsidises treatment of 
musculoskeletal pain after injury when treatment is provided by registered manual 
therapy practitioners in the fields of Physiotherapy, Osteopathy, and Chiropractic. 
Massage therapy is usually entirely privately funded by clients. 
2.2.1.1 Evidence synthesis for massage therapy efficacy  
A Cochrane systematic review of randomised controlled trial (RCTs) evaluating massage 
therapy for non-specific low back pain (Furlan, Giraldo, Baskwill, Irvin, & Imamura, 2015) 
identified 25 trials, which included over three thousand participants (n=3096). The 
authors calculated standardized mean differences (SMD) between outcomes after 
massage intervention and control intervention to compare studies with different 
outcomes. The meta-analysis of the combined sub-acute and CLBP, which include studies 
of participants having back pain for four weeks or longer, included 21 relevant trials.  
Outcomes were categorised as short term if measured up to six months after 
randomisation and long term if measured longer than six months after randomisation. 
Comparisons were made of massage versus active controls (13 trials), and massage 
versus inactive controls (8 trials). Active controls were other types of manual and physical 
therapy (that did not include massage) or relaxation and self-care training. Inactive 
controls were wait-list controls, sham treatments or usual care that was also received by 
the intervention arm.  
For sub-acute and CLBP combined the review found beneficial effects of massage therapy 
compared to active controls on pain for both short (SMD -0.37, 95% CI -0.62 to -0.13) and 
long-term follow-up (SMD -0.40, 95% CI -0.80 to -0.01). However, the results were mixed 
and in individual trials some of the active controls had outcomes superior to massage. 
Massage was not found to be better than active controls for either short- and long-term 
functional outcomes. Compared to inactive controls, in short term follow up, massage for 
sub-acute and CLBP showed reduced pain (SMD -0.75, 95% CI -0.90, -0.60) and improved 




low to very low, this was in large part due to the inherent inability to blind participants 
and practitioners to the interventions.  
It could be interpreted that it is therapeutic attention on the low back pain condition, in 
the form of massage therapy, has small to medium desirable effects on pain outcomes, 
compared to no intervention. Massage appears to provide better pain relief than other 
types of interventions in the short-term but is no better or inferior to other interventions 
for functional outcomes. It is difficult to draw conclusions about all massage therapy from 
the Cochrane review, because the meta-analysis combined a large range of massage styles 
and varying pressures. For example, three massage interventions included reflexology 
massage to the feet only (Eghbali, Safari, Nazari, & Abdoli, 2012; Poole, Glenn, & Murphy, 
2007; Quinn, Baxter, & Hughes, 2005), which is very different to massage to the thoraco-
lumbar region using a wooden tool to apply deep pressure (Farasyn et al., 2006). Overall 
the review included studies of eight types of massage therapy using variable pressures 
ranging from deep tissue to relaxation and these can be separated into three groups. The 
first includes treatments with various combinations of stroking, kneading, stretching and 
compression of the soft tissue (n=17); the second group applies static compression (n=7) 
containing subgroups of reflexology (n=3) and acupressure (n=4); the third group 
contains only one study that uses Muscle Energy Technique that is an in-direct MFR 
technique (Fritz, 2000a). The body regions treated when described also varied: feet only, 
low back only, back and legs, or whole body.  Furthermore 21 of the studies examined 
multi-dose effects and four examined single-dose effects.  This intervention heterogeneity 
may have contributed to the mixed results when massage was compared to active 
controls. None of the interventions included in this Cochrane review involved non-
volitional movement facilitation, like GRM.  
In addition to the limitation of heterogeneity of massage types, the Cochrane review also 
contained varied population samples. Examining the study characteristics for 
heterogeneity in the participants, it appears the main problem is the large range of low 
back pain duration at enrolment (Andersson, 1999; Smith, B., Elliott, Hannaford, 
Chambers, & Smith, 2004). Effects of regression to the mean for low back pain is likely for 
participants experiencing pain for less than three months (Andersson, 1999). For 
example, Preyde’s (2000) study of clinical massage for sub-acute low back pain includes 
pain durations of one week to eight months, while Hsieh, Kuo, Lee, Yen, Chien, and Chen’s 
(2002) trial of Acupressure includes low back pain durations of one month to ten years. 




not indicate that more positive results are possible because it is likely some of the 
participants were recovering over time.  If regression to the mean was controlled for, the 
Cochrane review might show less favourable short-term effects for massage.  
In conclusion, it is sensible that research investigating massage therapy must compare 
well described massage treatments. Furthermore, it is important to include participants 
with appropriate duration of pain, focusing on people with lower back pain for more than 
three months. Furlan et al (2015) reasonably concluded massage therapy when broadly 
defined, had no effect on function compared to other interventions, but does have small to 
moderate effects on short term relief of pain for no longer than three months.   
A useful meta-analysis of 37 randomized trials (n=1802) examined psychological and 
physiological effects of practitioner–applied massage therapy (Moyer, Rounds, & Hannum, 
2004). Treatments that used a massage tool, were self-applied, or included exercise 
therapy were excluded. Both single–dose effects and multiple-dose effects were examined 
and the findings support that massage therapy is effective. The effect sizes were 
calculated from the between group comparison of means divided by the pooled standard 
deviation, as Hedges’s g. Single-dose results showed small reductions of state anxiety 
(g=0.37, 95% CI 0.14 to 0.59, p<0.01), blood pressure (g=0.25, 95% CI 0.03 to 0.48, 
p<0.05) and heart rate (g=0.41, 95% CI 0.19 to 0.62, p<0.01), but no effects on immediate 
pain. Multiple dose effects showed greater reductions, in trait anxiety (g=0.75, 95% CI 
0.27 to 1.22, p<0.01), depression (g=0.62, 95% CI 0.37 to 0.88, p<0.01), and delayed pain 
(g=0.31, 95% CI 0.10 to 0.52, p<0.01). The effect sizes on depression and trait anxiety are 
similar to that of psychotherapy and it could be hypothesized that this effect may be 
largely contributed by the role of the practitioner and their psychological interactions 
with the client. 
Serious adverse events are rare in massage therapy interventions (Furlan et al., 2002) 
provided the treatment is within the scope of accepted massage therapy professional 
practice and does not include bony thrust manipulations (Yin, Gao, Wu, Litscher, & Xu, 
2014). A Cochrane review lists increased pain as the most common adverse events in 
randomised controlled trials of massage therapy (Furlan et al., 2015). In particular in a 
trial of an intensive course of direct Myofascial Release, increased pain was reported by 
25% of participants. The twelve-week study involved three 60 minute sessions per week 




Thus far, it appears that massage is useful for low back pain management, a finding 
endorsed by the 2018 Lancet report on Prevention and Treatment on low back pain 
(Foster et al., 2018). The recommendations, derived from a systematic review of clinical 
trials, are supportive of massage as an adjunctive treatment for CLBP. Even though the 
effects of massage on CLBP are short term, massage provides a non-pharmacological 
treatment with minimal risk of adverse effect.  Massage can be justifiable by its low risk, 
wide availability, and as it may address some of the biopsychosocial risk factors of CLBP 
(Smith, B. et al., 2004) through the massage practitioners’ role of providing comfort and 
caring (Smith, J. et al., 2009, 2010). The Lancet report also identifies the greater 
significance of psychological co-morbidities for chronic low back pain requiring 
management (Foster et al., 2018), which may mean the type of manual manipulations of 
tissues is somewhat irrelevant; more important is the entire massage experience. The 
psychological effects of massage therapy experience appear clear (Moyer, Rounds, & 
Hannum., 2004), and the role of comfort and caring provided by the therapists is well 
acknowledged (Smith, J. et al., 2009, 2010).  
 Other Manual Therapies for CLBP 
There is some evidence that certain manual therapies, for example spinal manipulation 
and myofascial release, show promise for musculoskeletal pain relief when applied to 
clinical sub groups (Ajimsha et al., 2015; Bialosky et al., 2009; Tozzi, Bongiorno, & 
Vitturini, 2011). Some of these therapies include techniques that appear to utilise in-
direct mechanisms to gently restore movement and mobility of the body. One of these, 
MFR includes a mix of direct and indirect techniques. The objectives of MFR are:  to 
address adhesions which are thought to contribute to soft tissues determinants of pain 
(Borg–Stein & Wilkins, 2006; Klingler et al., 2014) and, to cause spontaneous release of 
contractile elements of fascia (Chaitow, 2016a).  MFR as a distinct massage treatment 
group warrants further discussion here because by definition of how GRM is applied, it is 
best described as an MFR technique. 
A systematic review of MFR effectiveness for body pain  identified 19 randomized control 
trials on enrolling people with pain in eight different body regions  (Ajimsha et al., 2015). 
The included RCTs involved human adult participants, specifically targeted the 
myofasciae and used various MFR techniques. Trigger point (direct pressure) therapy 
studies were excluded. The combined trials included 14 different clinical measurement 




Only two of the trial interventions state using in-direct MFR, with the remainder being 
direct MFR. The techniques used are heterogeneous and are contingent on the definition 
of what MFR is. Highlighting one challenge in examining the literature on MFR: the 
definitions of different types of MFR are inconsistent. The authors concluded that MFR 
shows therapeutic promise based on their overall impression of its effectiveness but until 
the mechanism of action of MFR is better understood no reasonable selection of preferred 
technique can be made. 
The conclusions of Ajimsha et al.s’ (2015) systematic review have been challenged by 
another systematic review of MFR. It identified eight RCTS of MFR therapy in adult 
participants (n=457) with four types of chronic non-cancer MSK pain (Laimi et al., 2018). 
In this systematic review Laimi et al. (2018) defined direct MFR as sustained forces 
applied in the order of kilograms, either by a practitioner or self applied with a tool, and 
in-direct MFR as being low load sustained stretch. The self–MFR techniques included 
were applied with tools, such as massage rollers, and are routinely used by athletes for 
conditions such as Achilles tendon pain. In-direct movement responses to MFR are not 
mentioned. Again this is a very heterogeneous mix of MFR definitions with different 
pressures and applications, but all of the trials assessed multi-dose interventions. The risk 
of bias was rated as low for three of the trials and high for the remaining five. 
Heterogeneity of study populations precluded meta-analysis so conclusions were drawn 
from a narrative synthesis of effect sizes. In five of the eight trials these did not reach 
levels of minimal clinically important change. The authors conclude that the evidence 
does not support the use of MFR for the treatment of MSK pain. Even though the authors 
used a narrower search strategy than Ajimsha et al. the chronic pain conditions captured 
were single site problems such as lateral epi-condylitis and heel pain, and multi-site 
problems such as low back pain and fibromyalgia. It seems unreasonable to combine 
studies of techniques that use a large difference in pressure; practitioner hands on 
techniques versus self–applied treatments using a tool; and of single site pain with multi-
site pain. The latter clinical sub-group is likely to have more complex aetiologies. In 
addition, how treatments that include human touch affect recipients, is very likely to be 
different to, self–application of pressure using a massage tool. So even though this is a 
review specific to the massage treatment of MFR for chronic musculoskeletal pain, the 
ambiguous definition of what MFR actually is means that further research exploring 




In summary, to date the evidence synthesis regarding interventional studies of MFR are 
inconclusive. The literature are limited by lack of clear definition of MFR techniques and 
high quality primary studies. It appears that techniques are considered to be MFR if the 
intention is to target the myofasciae but whether myofasciae are biologically affected is 
unknown.  
2.2.2.1 Methodological Limitations of Massage Therapy RCTs 
There is one large RCT of massage therapy in low back pain that was included in the 
Cochrane review by Furlan et al. (2015) that is worth examining in detail because, it is 
large, has long term follow-up, and compares two different and commonly used massage 
systems—clinical massage and relaxation massage.  Furthermore, this study challenges 
the Cochrane review findings as the authors claim a benefit of massage therapy on 
functional outcomes over the short (up to six months) and long term (after six months).  
These conclusions may not bear up to critical analysis, which also illustrates the inherent 
challenges in evaluating massage therapy through the application of positivist scientific 
method (Godfrey–Smith, 2009). 
In this trial, adults (n=401) with non-specific low back pain of minimum one-year 
duration were randomised to treatment groups of relaxation massage, clinical massage, or 
control (Cherkin et al., 2011). Clinical massage, also called structural massage (Furlan et 
al., 2002), uses direct techniques to target tissues based on a biomechanical model of pain 
and relaxation massage uses holistic techniques to target general tension based on a 
neurophysiological model of pain (Fritz, 2000b; Sherman et al., 2006). The 10-week 
massage  sessions of 50–60 minutes were delivered in professional clinics, of 27 massage 
therapists, in Washington, Vermont, and Oregon in the USA.  Final follow up was at 52 
weeks, with outcomes also measured at 10 and 26 weeks after randomization.  
Physical function was measured using a modified Roland Morris Disability Questionnaire 
(M-RMDQ). At 10 weeks, when the intervention concluded, M-RMDQ scores compared to 
control showed improvements in both relaxation massage (2.9, 95% CI, 1.8 to 4.0 points) 
and structural massage (2.5, 95% CI, 1.4 to 3.5 points) groups. At 26 weeks—16 weeks 
after completion of the intervention—these improvements decreased respectively, (1.8, 
95% CI, 3.0 to 0.6) and (1.4, 95% CI, 2.6 to 0.3), with small effects of the relaxation 




Pain was measured by participants rating level of ‘bothersomeness’ of pain on a scale of 
one to ten. At 10 weeks between group differences of Pain ‘bothersomeness’ with control 
were found for both relaxation massage (1.4, 95% CI, 1.8 to 0.8 points) and clinical 
massage (1.7, 95% CI 2.2 to 1.2 points) treated groups (P > 0.001 for both adjusted 
estimates), but these effects were not maintained at 26 weeks or 52 weeks. There was no 
clinically important difference between the two types of massage at all time points for 
both measures of pain and function.  
The finding of beneficial functional effects is discordant to the Cochrane review 
conclusion, may be explained by bias, chance findings, or how data have been interpreted. 
Firstly, the intervention was not comparable to the control: The control group did not 
receive the same attention as the massage groups and both massage groups were 
prescribed home care exercises which the control group did not receive. While home 
exercises are a normal part of massage therapy, this additional intervention may have 
confused attribution of effect. The difference between the control and both massage 
groups at 26 weeks, was interpreted as improved function (1.8 for relaxation massage 
and 1.4 for structural massage), however this is questionable considering the authors 
state the minimally important between group difference is 2.0 points. 
This study’s results must also be considered through the lens of “regression to the mean” 
(Andersson, 1999; Ernst, 2001). The effects at 26 weeks may be due to the widely observed 
phenomenon of improvement over time, as the control group steadily improved for the 
entire study duration. The control group received no regular interaction or attention but 
continued with their usual care and received $50 for their participation. The differences 
(reduction in pain bothersomeness and disability) were noticeable between the groups at 
the conclusion of the intervention delivery phase but the differences tapered off by 26 
weeks and by 52 weeks, when all three groups had similar improvements from baseline. 
Any effect measured at 26 weeks needs to be cautiously interpreted because it is 
impossible to blind a control group receiving no treatment and negative cognitive bias is 
reported to negatively effect reporting of outcomes. This occurs in trials of popular 
treatments, such as massage therapy whose participants likely volunteered due to their 
positive expectations of the intervention (Power & Hopayian, 2011).  
It is reasonable to state, Cherkins et als functional change scores may not be confidently 
attributed to manual therapy techniques of the massage interventions and the functional 




a challenge to the Cochrane review findings about the benefit of massage therapy on 
functional outcomes than it initially appears. What this study does confirm is that there 
was no meaningful difference between the relaxation and clinical massage treatment 
groups. This means either the biomechanical model of assessment to identify treatment 
targets has no utility, or, the techniques used by clinical massage have no specific effect on 
the treatment targets of tissue extensibility and contracture. This study is also a clear 
illustration of the inherent challenges of designing an appropriately controlled study of 
massage intervention using the RCT approach.   
In conclusion, non-specific massage therapy appears to have potential efficacy for CLBP in 
the short term if multiple doses are used. There are no obvious differences in the effects of 
massage styles, with relaxation massage, clinical massage and various methods of MFR 
delivery all producing small effects in the short term, that is less than six months. The 
effects are potentially reliant on the practitioner–client interactions that provides socio-
emotional support in addition to the physical direct effects of massage. Some studies with 
more lasting effects may be caused by physiological processes that benefit from improved 
sleep quality and stress reduction. In-direct techniques facilitating non-volitional 
movement are not featured in massage therapy or MFR trials. In regards to the 
measurement of functional outcomes, massage research treatments should establish the 
known evidence of theoretical mechanisms and design studies to measure single-dose 
clinical effects as well as multiple dose outcomes important to clients.   
Evidence synthesis of a variety of massage therapies suggest these may be beneficial in 
management of chronic MSK pain. However current positivist approaches of RCT may 
have limitations in evaluating massage therapies and evidence synthesis has limitations 
due to heterogeneity between individual included studies. Furthermore, there are 
fundamental challenges in describing different massage therapy techniques which limit 
evidence synthesis. Before an evaluative study can be proposed a precise description of a 
proposed massage therapy must be developed, as well as underpinning hypothesis of 
mechanism of action. The following section presents the necessary background for 
description of the practitioner–researchers’ GRM intervention.   
2.3  Non-Volitional Movement in Therapeutic Contexts 
Gravity Relief Mobilisation’s primary essential ingredient is a non-volitional movement 
response to gentle application of holding (hand pressure) coupled with supporting the 




individuals. It features in other forms of complementary and alternative medicine, 
psychotherapy practices, as well as mind-body practices such as yoga and meditation 
(Schmalzl, Crane-Godreau, & Payne, 2014). 
The non-volitional movement response to GRM was discovered during observation over 
time in the clinical practice of the practitioner–researcher.  Other reports of this 
movement phenomenon were sought, first by searching using Google and Google Scholar 
applying the search strategy— 
((reflex)OR(involuntary)OR(spontaneous)AND(movement))AND(“manual therapy”). This 
search  led to identification of the literature on  “myofascial unwinding”, “ideomotor 
motion”, and “non-volitional movement” along with names of modalities “Muscle 
Repositioning” and “Simple Contact”.  
The practitioner–researcher was already aware of reports of spontaneous movement in 
the treatment “Ortho-Bionomy™” and “Trauma Releasing Process™”. The background 
literature of trauma releasing exercise (TRE) referred to neurological tremors to describe 
the spontaneous movement which was added as a search term and “Neurophysics 
Therapy” (NPT) was found. Whilst TRE and NPT are not manual therapies, they have been 
included in the background chapter because similar to GRM and Muscle Repositioning, 
they target the elicitation of non-volitional movement as a therapeutic mechanism.  
It seems likely that the non-volitional movement phenomenon reported in GRM is 
reported in other exercise, manual therapies, and mind-body therapies. This review of 
literature is limited to non-volitional movements in the somatic therapy context, meaning 
exercise or manual therapy. Psychotherapy, movement disorders and mind-body 
practices are excluded. 
Non-volitional movement responses feature in the massage and osteopathic treatments of 
Myofascial Unwinding (Chaitow, 2017; Minasny, 2009) and Muscle Repositioning 
(Bertolucci, 2008; Overmyer, 1988). It is an essential ingredient of the movement 
modalities Simple Contact (Dorko, 2003; McCarthy, Rickards, & Lucas, 2007), Trauma 
Release Exercise (Berceli, 2008b) and Neurophysics Therapy (Ross & Ware, 2013). 
Additionally, non-volitional movement sometimes occurs with another massage therapy 




In somatic-based therapies descriptions of non-volitional movement phenomenon range 
from subtle movements in the locally treated body region (Goyal, M., Goyal, Bathla, 
Kanimozhi, & Narkeesh, 2017) to movements of the entire body (Berceli, 2008b; Ross & 
Ware, 2013). In all instances some kind of induction is used to elicit the movement with 
four proposed mechanisms of action: ideomotor theory (Dorko, 2003), pandiculation 
(Bertolucci, 2011), neurogenic tremors (Berceli, 2008c) and self-organisation in response 
to chaos (Ross & Ware, 2013). The following sections describe the details of other non-
volitional movement treatment processes for comparison with the GRM treatment in 
order to justify the practitioner–researcher’s view that GRM is a distinct and novel 
therapy technique. 
2.3.1  Myofascial Unwinding 
Indirect myofascial release (MFR) is also known as, myofascial unwinding (MFU) 
(Minasny, 2009) and myofascial induction (Chaitow, 2017).  Originally a feature of 
osteopathic treatment (Ehrenfeuchter et al., 2011; Fernàndez, Cleland, & Dommerholt,  
2016), MFU is now incorporated in massage therapy practice (Sherman et al., 2006). It 
aims to cause spontaneous release of contractile elements of fascia (Chaitow, 2016a) by 
targeting mechano-receptors in the tissues (Lowe, 2015). The release is achieved by hand 
pressure, applying a gentle stretch in a direction that is changed in response to palpatory 
feedback, rather than maintaining a constant force on the tissues. Fritz’s (2000) seminal 
text Fundamentals of Therapeutic Massage, under Myofascial Methods, provides a more 
descriptive definition of “Tissue movement methods” (p. 484): A gentle downward 
pressure, enough to maintain traction on skin, is maintained as a crossfibre stretch is 
applied until a movement sensation is felt in the tissue, the movement is followed whilst 
maintaining tension on the tissues as an “undulating pattern unfolds” (Fritz, 2000a). 
Other definitions of the technique include passive movements of the joints through a path 
of least resistance until joint range of motion is improved (Ehrenfeuchter et al. 2011; 
Minasny, 2009; Tozzi, 2012).  
Gentle direct and indirect MFR (or MFU) are manually applied with the hands responding 
to palpatory feedback (Ajimsha et al., 2015; Ehrenfeuchter et al., 2011). For clarity 
definitions used here are: ‘direct’ techniques aim to cause a relaxation response in the 
tissues by applying constant force against a barrier until a “release” is felt (Ehrenfeuchter 
et al. 2011; Jacobson, 2011; Tozzi, 2012); ‘indirect’ techniques involve movement of the 
tissues or joints into the most relaxed position, then guide them through a path of least 




2011; Tozzi, 2012). Direct techniques are a straight forward concept to understand as 
they apply a type of tissue stretch in one direction (Figure 2.2). Direct techniques can also 
be applied to a joint and the direction of the force is determined by the practitioner 
(Figure 2.3).  
 
Figure 2-2. Direct Myofascial Release showing how a constant stretch is applied to the surface of the body. (This 
article was published in Mosby’s fundamentals of Therapeutic Massage, 2nd ed, Fritz, S., Myofascial methods, 
pp.484, Copyright Mosby Inc.. Reprinted with permission.) 
 
Figure 2-3. Example of a direct joint movement technique, intentional direct forces are applied by the 
practitioner to a joint. (This article was published in Mosby’s fundamentals of Therapeutic Massage, 2nd ed, Fritz, 





Indirect MFR is harder to define.  A detailed critique of the various definitions is beyond 
scope of this review.  Two key authoritative perspectives are offered.   A leading fascial 
researcher Robert Schleip considers the movement sensation that is felt by practitioners 
when applying gentle pressure to the surface of the body is generated by motor units 
cascading response to touch (Figure 2.4). The direction of the gentle stretch is then 
adjusted by the practitioner (Schleip, 2003a, 2003b; Schleip et al., 2005). Minasny’s 
(2009) narrative review of Myofascial Unwinding cites the American Association of 
Colleges of Osteopathic Medicine definition that “the practitioner is passively moving the 
body in response to a sensation of movement", but then goes on to clarify, possible 
greater magnitude non-volitional movement responses of “bending, rotating, and twisting 
of the upper or lower limbs or the whole body in either a rhythmic or a chaotic pattern” 
(Minasny, 2009). These larger movements are seen by osteopathic practitioners who may 
be crossing over into mind–body therapies that are called somato-emotional release 
(Minasny, 2009). The key point of both definitions is that indirect joint movement 
techniques do not involve the practitioner moving the joints themselves, they follow the 
non-volitional movement of the client, sometimes limiting it causing movement in a 
different direction.  
Osteopathic SomatoEmotional Release® is referred to as a type of MFR (Minasny, 2009), it 
applies gentle unwinding techniques with the client in an upright seated or standing 
position.  The Upledger method description, sees the practitioner placing the hands on the 
head and torso and following any movements, restricting a return to a previous position 
by gently resisting this movement direction (Upledger & Vredevoogd, 2000).  Strong 
emotional responses in clients may be evoked that are supported to translate into non-
volitional movements, as the practitioner retains gentle hand pressure to encourage the 





Figure 2-4. Robert Schleip’s representation of how the sensation of movement is experienced by a practitioner.  
Reprinted from, Journal of Bodywork and Movement Therapies, 7 (1), R. Schleip, Fascial plasticity – a new 
neurobiological explanation: Part  1, p.11–19, Copyright (2003), with permission from Elsevier. 
 
2.3.1.1 Evidence 
There is a paucity of evidence for MFU or indirect MFR as being effective treatments for 
MSK pain.  Furthermore, MFU techniques are sometimes confused with light pressure 
direct MFR (Mc Murray, Landis, Lininger, Baker, Nasypany & Seegmiller, 2015). MFU can 
include the practitioner applying their gentle pressure with their hands to the surface of 
the body, or lifting of a limb to apply tension to a joint. When applied to the surface of the 
body (similar to gentle direct MFR), it is likely that the techniques of MFR and MFU are 
difficult to differentiate as both use lighter pressure (Chaitow, 2017). The only difference 
here, is that direct MFR moves in the direction of stretch against tissue resistence, and in-
direct MFR /MFU moves tissues away from the direction of tension to a comfortable 
position (Minasny, 2009). Mc Murray et al. (2015) cite several studies that evaluate direct 
techniques as being evidence for indirect MFR, and indirect MFR has been included in 
reviews of MFR. Similarly, Fernández-Pérez, Peralta-Ramírez, Pilat, & Villaverde (2008) 
refer to their MFR intervention applying static pressure, as Myofascial Induction.  
Chaitow clarifies Myofascial Induction as not just a passive stretching of the fascial 
system, but involves movement facilitation (Chaitow, 2017). MFU becomes more distinct 
when joints are moved by the practitioner rather than just applying a technique to the 
surface of the body (Chaitow, 2016a; Chaitow, 2016b; Goyal et al., 2017). It is likely not all 
practitioners are sensitive to perceiving a sensation of movement and this would alter 




tissues into the most comfortable position which is then exaggerated slightly; and MFU is 
when the practitioner actively follows a sensation of movement in the joints and limbs. 
One study of the effects of the overarching MFR on tension type headaches, compared a 
control, direct, and indirect MFR applied to the cervical and cranial musculature (Ajimsha, 
2011). The control group received light stroking on the MFR treated areas. Baseline data 
were collected using headache frequency diaries for four weeks, followed by a 12 weeks 
multi-dose intervention, and four weeks of follow-up. The interventions were applied to 
the cervical and trapezius regions in multidose 60 minute treatments, twice a week, for 12 
weeks. The direct techniques used sustained pressure in the order of kilograms. The 
techniques named in-direct were applied in the order of grams. Both MFR groups had 
reduced the frequency of headaches compared to control, (-5.8, SD 7.6 to 4.0 and  5.4, SD 
7.2 to 3.7, p<0.001) but no differences were found between these direct and indirect MFR 
interventions (-0.6, SD -2.4 to 1.2, p=0.51). Even though the indirect MFR intervention 
description does involve movement of the head and neck, it is unclear how much 
movement sensation the practitioner perceived in the tissues as the results of treatment 
receipt is not discussed. What can be concluded from this study is that there was no 
difference between direct and indirect MFR when no joint movement is involved in this 
clinical population.  
A published case study of an osteopathic intervention, included an MFU technique of 
lifting the patients head to relieve gravity then movement into the direction of ease, for 
the purpose of treating somatic symptoms with comorbid depression unresponsive to 
pharmacological treatments (Goyal, et al., 2017). The symptoms included, palpitations, 
fatigue, body aches, insomnia.  Restrictions in the mobility of tissues, around the pelvis , 
thoracic, and cervical regions were assessed. The participant received three 20 minute 
treatments per week for four weeks. Treatments targeted the myofasciae of the 
presenting restricted body regions.  The exact nature of the MFU is difficult to determine 
as there is no mention of following a movement sensation and the authors considered this 
technique to be somato–emotional release. After four weeks of multi-dose MFR and MFU 
osteopathic treatment the patient reported improvements in depression, quality of life 
and reduction of medications. In this intervention they received therapeutic attention and 
human touch and when considering the findings of Moyer et al. (2004)—that massage is 
as effective as pharmacological interventions for depression—it is possible the 
mechanisms of the participants improvement were mainly psychological. Particularly if 




Whilst MFU is written about as having distinct processes compared to direct MFR it is not 
easily distinguishable in the MFR evidence literature. Therefore no conclusions can be 
drawn about its effectiveness compared to other types of massage therapeutic attention. 
2.3.1.2 Theoretical Mechanisms of Myofascial Unwinding 
Various theories exist to explain MFU: neurobiologic, ideo-motor action and 
consciousness model. These combine in a reasonable hypothesis to explain MFU, as a 
tissue response to sensory input that is mediated by the central and autonomic nervous 
systems (Minasny, 2009). It has been proposed that the perceived movement of 
myofascial unwinding is the client’s non-volitional movement (Dorko, 2003; McCarthy et 
al., 2007). This remains difficult to reconcile with either definition of myofascial 
unwinding as: 1) motor units responding to touch, or 2) the practitioner moving the tissue 
through the path of least resistance. Also unwinding is purported to be the process of 
tension reduction and movement into a position of ease (Chaitow, 2016b; Minasny, 2009). 
This, by definition, cannot be non-volitional movement as that would require muscle 
contractions generating momentary increased tension. What can be deduced from the 
descriptions of MFU is that the myofascial system is tensioned with techniques applied to 
the surface of the body, and in the hands of some practitioner’s, a sensation of tissue 
movement and relaxation is experienced. 
 Muscle Repositioning 
Muscle Repositioning (MR) is a novel technique developed by Physiatrist and manual 
bodywork therapist Dr. L.F. Bertolucci (Bertolucci, 2008; Bertolucci & Kozasa, 2010). It 
aims to improve motor function by targeting an unknown nervous systems response to 
manoeuvres that tension the myofascial tissues. The hands are pressed onto the surface of 
the body. Whilst retaining traction on the skin, muscles at various tissue depths are 
moved in relation to the harder underlying bony structures, hence the name Muscle 
Repositioning. The holding of the tissues is maintained as the body is allowed to process 
its own response. Bertolucci (2008) classifies MR treatment as a type of MFR. Muscle 
Repositioning should not be confused with Positional Release techniques that passively 
move parts of the body into their most comfortable position in order to achieve a 
relaxation of contracted tissues (Chaitow, 2016b; Jones & Ontario, 1964).  
2.3.2.1 Evidence  
A possible mechanism of Muscle Repositioning was investigated in a controlled clinical 




Myography (EMG) (Bertolucci & Kozasa, 2010). The six subjects were healthy females 
aged 22 to 32 years old. They lay supine on the treatment table during the EMG 
measurement of the cervical erector muscles. For both the control and test MR 
manoeuvres, participants started with heads resting on the table showing EMG readings 
in the cervical erector muscles of 0.  
During the control condition, the participants voluntarily raised their heads using the 
cervical flexors. Holding their heads up they maintained an isometric contraction (>20 
seconds) until returning to the resting position. The graphs of the EMG root mean value 
readings showed a co-contraction of the cervical erectors which was relatively 
symmetrical, approximately 4µV and 8µV for different participants.  
During the test manoeuvre the practitioner (Bertolucci) held up the weight of the 
subjects’ head with the hands; keeping traction of the skin with the fingers, he applied 
directed pressure into the occipital region that caused slight translation and rotation of 
the head. The practitioner adjusted the manoeuvre until he felt an increase in muscle tone 
of the cervical erectors, holding this for 10-15 minutes.  The MR manoeuvre was released 
when spontaneous softening of the tissues occurred under palpation. The EMG readings 
showed a gradual asymmetric increase in activity of the cervical erectors. EMG recordings  
varied, in magnitude, time of occurrence, and duration before spontaneous relaxation. The 
differences between the mean readings of left and right sides ranged from1.24 µV to 17.77 
µV.   This was interpreted to mean that a sustained manually applied pressure, adjusted to 
tense the myofascial system, causes tonic reactions in the muscles moderated by their 
individual characteristics. This is followed by increase in tone, which stimulates the 
central nervous system (via a cascade of afferent discharges), resulting in neurological 
reflexes observable as other coinciding involuntary movements.  
In summary, this study supports some objective physiological processes underpinning the 
practitioners’ reported treatment.  EMG showed tonic reactions sharply increased with 
application of hand pressure that coincided with a sense of firmness felt by the 
practitioner. Sometimes a strong muscle contraction occurred, pushing the head into the 
practitioner’s hands, with a sharp decrease in tone as the tissues spontaneously relaxed. 
In addition to the tonic reactions, non-volitional movements were observed: rapid eye 
movements, body tremors, tonic and clonic muscle contractions in the body’s appendages. 
Occasionally these were extreme, for example trunk flexion causing the subject to 




muscle relaxation were measured, to demonstrate the similarity between the reaction to 
the MR manoeuvre and the natural phenomenon of pandiculation. Pandiculation is 
thought to maintain neuromuscular system of animals by causing a build-up of muscle 
contractions to stretch tissues followed by relaxation.  
Another study of MR effects has been briefly reported in an extended conference abstract 
only.  Two MR manoeuvres, were applied to the thoracic region of 14 healthy adult 
subjects (mean age of 34 years) in side-lying positions. EMG readings were monitored of 
both the cervical and lumbar erectors (Bertolucci & Kozasa, 2010). Again the muscle 
activity increased gradually before dropping suddenly with spontaneous relaxation. The 
first manoeuvre lasted 14.75 minutes (SD 5.22), and the second lasted 7.63 minutes (SD 
3.35). Activity was demonstrated, in the cervical erectors for both manoeuvres in 11 of 
the subjects, and for just one of the manoeuvres in two of the subjects. Seven subjects 
displayed synchronised lumbar EMG readings. Results for the remaining subject were not 
mentioned.  
These two studies give objective demonstrations of increase in muscle activity with the 
application of a manual technique, with implications for manual therapy clinical practice 
and research. Firstly, manual therapy that gently tensioned the soft tissues elicited a 
response, perceived by the practitioner as an increase in muscle tone, and was verified by 
EMG. Secondly, this resulted in non-volitional activities. The muscles of the left and right 
sides responded individually before regaining a resting symmetry. The coinciding non-
volitional movements observed in other parts of the body, lead the author to hypothesise 
that application of MR stimulates a neurological reflex. Bertolucci (2008) suggests that the 
occurrence of reflex type activity to the tissue tensioning technique could be diagnostic 
and facilitate a therapeutic mechanism simultaneously. In other words, the application of 
the technique reveals underlying excess contraction and muscle tone asymmetry which 
self-correct as the technique is maintained.  
2.3.2.2 Theoretical Mechanism 
Bertolucci (2011) has gone on to propose that this mechanism is the same as the 
mechanism of the stretch-yawning syndrome, which is a form of pandiculation. It is 
hypothesised that pandiculation is a homeostatic mechanism, maintaining an animal’s 
ability to express controlled movement, by re-setting movement potential of the 
myofascia after periods of inactivity. The experimentally induced muscle tone of the 




to peak muscle tension before dropping suddenly, accompanied by a sense of well- being. 
The muscle tension can be in regional body parts or involve the whole body.  
What these small studies also suggest is that non-volitional movement response to the 
tension applied to the myofascial system only occurs after a period of sustained holding, 
up to 15 minutes for this technique. This is very different to the few seconds used in 
trigger point therapy or massage techniques that use no sustained holding. 
The important points Bertolucci has demonstrated is that manual stimulation of the 
neuromyofascial system produces objectively observable effects, indicating manual 
therapy can cause reflex responses that may have therapeutic value. This supports the 
theory that in-direct manual therapy stimulates a self–correcting mechanism of the 
musculoskeletal system.     
 Simple Contact 
Physiotherapist Barrett Dorko has written extensively about the use of non-volitional 
movement as a therapeutic mechanism (Dorko, 2003). In his own practice he developed a 
treatment called Simple Contact. Simple Contact is the act of the practitioner, applying a 
gentle touch to parts of the body on a seated or standing client. They then ask the client to 
become aware of any sense of movement and “allow it to unfold” (Dorko, 2003; McCarthy 
et al., 2007). The aim of Simple Contact, is to relieve chronic musculoskeletal tension by 
the expression of movement. It targets the client’s interoception of movement originating 
from subconsciously held tension. Simple Contact is first engaged in at a manual therapy 
treatment session with a practitioner who provides with their hands, a gentle resistance 
to movement, facilitating the clients interoception of it. The level of resistance offered by 
the practitioner does not halt the movement.  
2.3.3.1 Evidence 
There is only one published study assessing the effectiveness of Simple Contact and it has 
significant weaknesses in its design. A quasi-experimental single case design, used a 
three–phase protocol to evaluate the effects of Simple Contact on chronic cervical pain in 
a 40-year old female (McCarthy et al., 2007). Each phase was three weeks in duration. 
Pain was measured using the 100 mm Quadruple Visual Analogue Scale (QVAS) which 
includes a report of current pain with the recall of three pain levels: pain at best, pain at 
worst, and average pain since last clinical treatment. The known psychometric properties 




multiple item Visual Analogue Scale (VAS), matched the VAS pain ratings caused by 
experimental heat stimulus to the to the lowest, usual, and highest levels of pain 
experienced over the past week in adults with chronic MSK pain (Price, McGrath, Rafii, & 
Buckingham, 1983; Wewers & Lowe, 1990).  
Mc Carthy et al. (2007) found reduction in QVAS were demonstrated after three treatment 
sessions, with further reductions maintained to the end of the follow-up phase. Outcomes 
were measured using neck pain and disability index (NDI) which has adequate 
responsiveness and reliability if scores surpass the measurement error (Cleland, Childs, & 
Whitman, 2008).The mean absolute reduction was 32 mm in the follow-up phase lasting 
three weeks. However, the measures showed clinically significant reductions during 
baseline phase (-52%) and then remained relatively stable through both exposure phases. 
Also the follow-up phase did not withdraw the intervention as outcome data was collected 
by the researcher with the participant visiting their clinic when they encouraged to 
continue with the self management technique. The authors attribute this reduction in NDI 
to pain neuroscience education that was provided during the baseline phase, possibly 
suggesting the education was more significant than the treatment intervention.  
The only other study of Simple Contact, used single case methodology with a similar 
design and recruited five adults, with neck pain for 6 months or more (Mason, 2009).  
This study was unable to reach a conclusion due to low measurement compliance, 
resulting in not having the minimum number of data points (n=3) needed in each phase 
for statistical analysis.  
Therefore, no conclusion can be made about Simple contacts effectiveness for MSK pain. 
However, as a non-volitional movement therapy it may have biological plausibility 
although as with other manual therapies it is difficult to separate these effects from 
psychological mechanisms of therapeutic attention. 
2.3.3.2 Theoretical Mechanism 
Dorko (2003) defines the movement phenomenon expressed from Simple Contact as 
Ideomotor Motion and this term has been consequently adopted by other authors when 
referring to non-volitional movement responses to manual therapy (McCarthy et al., 2007; 
Minasny, 2009; Rickards, 2014). Dorko explains non-volitional movement in Simple 
Contact is the expression of a desired movement goal that was originally repressed. 




intentional movements occurring in a range of situations. Fundamentally the ideomotor 
principle refers to reflex motor actions caused by the brain’s perceptions (Shin, Proctor, & 
Capaldi, 2010). One example is hydrophobia, a respiratory spasm when people with 
rabies were confronted with representations of water (Stock, A., & Stock, 2004). 
Historically the term was used to explain paranormal phenomena in occult practices, and 
movement phenomenon in hypnosis and psychotherapy (Stock,A., & Stock, 2004).  
Ideomotor action theory developed to explain, in a two-step process, how motor control is 
learnt. First, by the accumulation of knowledge of the sensory effects of a movement, 
which develops action codes associated to a sensation. The second step, is the selection of 
action codes by the brain anticipating the desired sensory effects (Stock,A., & Stock, 
2004). The resulting ideomotor motion is the transformation of perception into an action, 
with no further steps involved (Shin et al., 2010). Dorkos’ theory relies on the concept that 
an additional step exists between perception and an idea (a decision to repress or not 
repress an evoked movement). Shin et al. (2010) considers this to be a weak ideomotor 
theory.   
Disregarding any discussion of ideomotor phenomenon, ideomotor action theory has 
been criticized through its history (Thorndike, 1915). It appears to have some utility but 
is incomplete in explaining non-volitional movement phenomenon (Cox & Hasselman, 
2013; Herbort & Butz, 2012). Its use in manual therapy contexts may be inappropriate as 
movements are being expressed in the absence of the ideas to activate the action codes of 
ideomotor movements. Even though Dorko (2003) argues that the movement is a reflex 
expression of a previously repressed idea, excluding simple reflexes, it does not seem 
reasonable to relegate all movements that are not made in the forefront of the mind as a 
reflex to an idea. Ideomotor motion as a mechanism in manual and exercise therapies has 
not been objectively verified and so different terminology may be more appropriate when 
referring to non-volitional movement in all of these contexts. 
 Tension and Trauma Releasing Exercises 
Tension and Trauma Releasing Exercises (TRE) is a self-help therapy designed to relieve 
the body of deep chronic tension by evoking natural physical recovery processes. It uses a 
sequence of seven bodyweight exercises to stress muscles in the body that normally 
contract in response to threats, in particular the psoas muscle. The process of performing 
these specific exercises induce tremoring is called The Trauma Release Process™. It is an 
intervention, devised by clinical social worker Dr. David Berceli after working in trauma 




The exercises involve, lower body isotonic contractions and some stretching. It concludes 
with the individual lying supine on the floor, gently holding isometric muscle contractions 
of the hip flexor muscle groups that encourage shaking and trembling to begin. This 
response is referred to as tremoring and begins in the legs and hips as the exercises are 
worked through. Over the course of a few minutes it can spread to other regions of the 
body that may be holding muscle tension. In this way the body works through its 
individualised tension patterns. Advice is given to people who learn TRE to be 
conservative in the amount of time they spend tremoring, a suggested dose is 10 minutes 
every second day. An additional a note of caution, if unpleasant intense emotions are 
experienced then it is best to practice the exercises under supervision (Berceli, 2008c; 
TRE for ALL© Inc., 2018). This style of self–lead treatment is a learned tool that can be 
used throughout one’s life, it gives back more autonomy to the client compared to 
practitioner reliant treatments (TRE for ALL©, Inc., 2018). 
2.3.4.1 Evidence 
Some evidence exists assessing efficacy of TRE as a somatic therapeutic intervention for 
stress and anxiety (Berceli, 2009; Berceli, Salmon, Bonifas, & Ndefo, 2014). A review 
article of case studies reports improvement of somatic symptoms and stress reduction in 
Ukrainian Soldiers. It also cites a report of a German study, which observed decreases in 
physical symptoms such as pain, tingling and tinnitus (Herold, 2015). Original articles are 
not in English, precluding critical evaluation. 
2.3.4.2 Theoretical mechanism 
TRE aims to induce a physiological tremor, which is hypothesised to be unresolved 
tension from previous stressors or trauma. The tremoring process, is said to be a normal 
mammalian response that returns the nervous system to a resting state (Scaer, 2014a; 
Berceli, 2008a; Levine, 1997). The return of the body to a resting state, is thought to 
resolve somatic manifestations of stress such as pain (Scaer, 2014b). 
 Neurophysics Therapy 
Neurophysics therapy is similar to TRE, in that the client performs a set series of specific 
exercises, except no stretches are included. It is presented as an exercise system that 
stimulates therapeutic adaptations (Neurotritional Sciences, n.d.). The exercises are gym 
based using equipment, and are performed at a super slow rate with very light weights. 
Their purpose is to invoke a tremor response, to the conscious perfecting of posture and 




movement tempo, symmetry of the body and contact points with the equipment, upright 
posture, distribution of tension evenly through body and, respond to instructions to pause 
and re-start. This is followed by verbal support to allow varying intensities of tremors or 
chaotic movements, and when instructed, calmly regain conscious control of the non-
volitional movement. 
Clients are progressed by adding different machines to work more body parts and ranges 
of motion. They are also coached to learn how to evoke the tremors with the exercises 
themselves and how to stop them at will. The dose and intensity of the coaching sessions 
are determined on an individual basis.  
2.3.5.1 Evidence 
Multiple case studies are cited on the founder’s website as evidence for the efficacy of 
Neurophysics Therapy (Neurotricional Sciences Pty Ltd, n.d.). Some of these cases are 
presented with EMG evidence of before and after effects of the therapy, but these do not 
meet the methodological criteria for single case experimental research. Personal 
testimonials are provided with video links and the list of conditions that NPT claims to 
help is impressive. However, none of the clinical research cited on the website study pain 
and no intervention studies could be found in scientific publications. It appears that NPT 
is aiming to establish legitimacy through complex theorisation of its mechanisms rather 
than producing scientific evidence of its effects. 
2.3.5.2 Theoretical Mechanism 
The exercises in the first phase of treatment target the front of the body, hypothetically 
the most vulnerable region, including the chest, abdomen and groin area. The exercises 
require an opening of the chest to perform a pectoral fly, extension of the shoulders and 
torso to perform a lateral pulldown, and an opening of the hips to perform a leg press. It is 
thought that the opening of these areas challenges protective behaviours that lead to 
chronic muscle tension. It is theorised, the body’s tremor response to this challenge is an 
expression of neurophysiological chaos. Executive control over this state, is learned by, 
practicing evoking and stopping tremors at will. This learning is hypothesised to be one of 
the therapeutic mechanisms. Another theory is that energy in the body may be 
misdirected causing dysponesis (disturbance of the body’s physiology and functions due 
to dysregulation of the nervous system) (Whatmore & Kohli, 1968), this is re-directed 
during the therapy, causing a correction within the complex neurophysiological system 





Ortho-Bionomy is a treatment system, which subscribes to positional release 
methodology, that aims to cause a spontaneous reduction of muscle tension (Chaitow, 
2016b). Positional Release as a documented musculoskeletal treatment originates from 
Osteopathic physician L.H. Jones. His method, aims to relax contracted tissues by moving 
parts of the body into their most comfortable position (Fritz, 2000a; Jones & Ontario, 
1964). This position is often counter–intuitive, and can be at extreme ends of joint ranges 
of motion. The reasoning is, when a trauma is experienced by contractile tissues, 
surrounding tissues will go into spasm at the end of range of the original trauma. This is to 
prevent the catastrophic movement of the joint beyond this range (Jones & Ontario, 
1964). Therefore, in order to encourage the spontaneous relaxation of the surrounding 
tissues the joint/body part requires re-positioning into the original positional end point of 
the trauma. Thus reducing tensile forces on the protective tissue contractions 
encouraging them to spontaneously relax.  
Ortho-Bionomy extends the positional release methodology by adding light compression 
or traction forces on the tissues and joints. These encourage subtle movement patterns 
that are followed by the practitioner (Overmyer, 1988). The Ortho-Bionomy treatment 
system progresses through phases, towards increasing involvement of self-corrective 
reflexes within the client (Ortho-Bionomy, 2017). Scientific evidence of Ortho-Bionomy is 
hard to find, potentially affected by trademark registration.  
2.3.6.1 Theoretical Mechanism 
The mechanism of Ortho-Bionomy is proposed as a reflex action of proprioception 
(Overmyer, 2008), registering positioning and compression or traction around a joint. The 
central nervous system is alerted to the surrounding shortened and stretched muscle 
fibers, the reflexive signal is said to reset these muscle fibres to normal resting length, 
easing tension and pain. 
 Summary of Somatic Therapies Using Non-Volitional Movement  
It appears that tensioning of the neuro–myofascial system elicits a non-volitional 
movement response. Expressed to varying degrees of freedom and intensity depending on 
contextual factors. These factors are, executive control of movement, body position, and 
degree of mechanical stimulus. The treatment processes, have similarities that fall into 
three domains, tensioning of the neuro-myofascial system, practitioner behaviours, and 




neuro–myofascial system in order to elicit a non-volitional movement, then supporting 
this movement to express. The position of the body affects the possible range of 
movement, it is limited by the recipient’s surface contact points and practitioner’s hands. 
In manual therapy the neuro–myofascial system is tensioned by the practitioner’s hands 
with application of a direct technique to the surface of the body. They may adjust the 
contact points in ways that facilitate the movement and its direction, but do not dictate 
the movement. In exercise therapy the neuro–myofascial system is tensioned with 
resistance exercises to illicit non-volitional movement, the practitioner acts as coach and 
support person during this hands–off process.  
The term myofascial is often used to describe the target of manual therapy ‘release’ 
techniques, but this appears incomplete due to the omission of a descriptor for the 
involved neurological processes. Bertolucci (2008) describes Muscle Repositioning as a 
type of MFR but uses the more comprehensive term neuro–myofascial release. It has been 
proposed that the facilitation of fascial unwinding in indirect MFR can be explained as an 
ideomotor expression (Dorko, 2003; Minasny, 2009). Other proposed mechanisms are 
pandiculation (Bertolucci, 2008, 2011) and neurogenic tremor (Berceli, 2008b, 2009; 
Berceli et al., 2014; Herold, 2015; Levine, 1997; Ross & Ware, 2013).  
Non-volitional movement may have physical and psychological therapeutic benefits. It 
appears to be facilitated by application of tensioning of the neuro–myofascial system, 
through some kind of central processing. Coaching seems to be important, and once 
executive awareness of an inhibition mechanism of the inherent non-volitional movement 
is learned, the movements can be expressed without external support. However, the role 
of the practitioner might be essential for some individual’s psychological safety, acting as 
a grounding influence to prevent dissociation or escalating into a traumatically cathartic 
experience. It is unknown if manual therapy facilitation of non-volitional movement, has 
any benefit over, elicitation through exercise or other methods. Like massage therapy, 
potentially this is simply a matter of: client preference; differences in coping strategies; 
desire for social support, comfort of touch, and psychological oversight; and tolerance of 
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2.4  Challenges in Massage Therapy Research 
Massage therapy is used by people for non-pharmacological management of intermittent 
and persistent musculoskeletal pain (Breivik, Collett, Ventafridda, Cohen, & Gallacher, 
2006; Konvicka, Meyer, McDavid, & Roberson, 2008). Multi-disciplinary care is a clinical 
management option for complex problems like chronic pain, although the best mix of 
treatments is undeterminable and likely to be highly individualised (Plsek & Greenhalgh, 
2001; Scascighini, Toma, Dober-Spielmann, & Sprott, 2008). Massage therapy is arguably 
a discipline that can contribute to multi-disciplinary rehabilitation interventions for CLBP, 
simultaneously providing comfort in both social–emotional domains and physical 
relaxation (Foltz et al., 2005; Smith, J. et al., 2009, 2011).  
Massage therapy’s popularity is notable, but this does not reconcile with the lack of 
comprehensive high–quality evidence of efficacy. One significant challenge in evaluating 
massage interventions is a lack of evidence for the theoretical mechanisms pointed out by 
many authors (Ajimsha et al., 2015; Cherkin et al., 2011). Further complexity is added by 
the different clinical reasoning processes of massage styles used to select techniques and 
the body regions they are applied to. Massage research that demonstrates a lack of 
intervention effect, could mean either the techniques have no effect on the treatment 
targets, or the clinical reasoning process is not valid, or both.  
Research questions about intervention effectiveness are usually answered by scientifically 
designed research studies, which are the foundation of evidence–based practice (EBP). 
The gold standard of these, are randomized controlled trials (Sackett et al., 1996). The 
utility of RCT methodology in massage research is questionable, as issues of intervention 
standardisation limit efficacy by compromising massage therapy’s usual individualisation 
of treatment delivery (Baskwill, 2017). However, EBP is not totally reliant on data from 
RCTs; it incorporates reasonable clinical judgement, and when no scientific evidence is 
available the best available evidence is consulted (Sackett, et al., 1996). In the field of 
rehabilitation EBP, clinical decision making can be challenging when—due to narrow 
research priorities—no rigorous research of the topic concerned exists (Dijkers, Murphy, 
& Krellman, 2012). Additionally, a trade-off is made between the internal and external 
validity of rehabilitation research. Typically, the more rigorously a study is controlled the 
further it departs from usual clinical practice.  
Systems based thinking maybe can inform scientific method to evaluate complex 




based thinking assumes that complex interactions between components are modified in 
ways that are unpredictable, but this gestalt does produce observable patterns (Plsek & 
Greenhalgh, 2001). Therefore, systems-based thinking aligns with in-direct approaches to 
manual therapy that aims to stimulate unspecified self–correction responses.  
Practice based evidence (PBE) formalises the process of evidence collected by clinical 
observations (Green, 2008). It requires collection of detailed information at all stages of 
the research process. This could supply systems–based thinking with the information 
required to generate practice based evidence that is both externally valid and 
scientifically rigorous (Green, 2006, 2008).  
Single subject design methodology is getting increasing recognition as a valuable 
contributor to EBP (Graham, Karmarkar, & Ottenbacher, 2012). It is easily employed in 
clinical situations, its narrow subject focus (n=1) and wide contextual focus increases its 
external validity, potentially qualifying it as PBE. It is proposed here that single subject 
research methodology creates an opportunity to engage systems–based thinking so as to 
evaluate massage therapy interventions in ecological settings. It could be viewed as a 
hybridisation of EBP and PBE. 
Collection of personal and contextual information is routine in professional massage 
therapy practice. However, for research purposes clinical notes with details about 
massage therapy interventions require some level of standardisation to facilitate 
systematic reviews and treatment comparisons. One problem in massage therapy 
research when comparing the large range of manual therapy techniques and modalities is 
how to define interventions by their component ingredients. Sherman et al. (2006) 
massage treatment taxonomy, addresses this problem with a three-tiered hierarchy of 
massage treatment classification, but this has not yet been universally adopted by 
massage researchers.  
Whilst Sherman et al. (2006) mention that massage research may evaluate massage as a 
whole system of care, they have not incorporated the term Massage System in their 
terminology. They do recognise that distinct massage styles [modalities] use a standard 
combination of techniques for specified purposes.  Treatment systems then, may be an 
individual practitioner’s approach to treatment, a research intervention protocol, or a 
massage modality. Standardised treatment systems can be identified as proprietary 




includes the approach to assessment and the underpinning models of dysfunction and 
theoretical mechanisms. For example, biomechanical, biopsychosocial, direct, or in-direct 
approaches. This would achieve better descriptions of massage intervention components 
and not just a mix of techniques. Research could then be designed to examine each 
component.   
The Massage Taxonomy’s classifications of massage styles and lists of techniques, 
correspond to, rehabilitation interventions treatments and ingredients (Figure 2.5). For 
the purposes of this thesis and to be consistent with the Rehabilitation Treatment 
taxonomy, Sherman’s (2009) massage styles are called treatments and techniques are 
treatment ingredients. The exception is, Relaxation Massage renames Sherman’s (2009) 
corresponding term, Swedish Massage. 
Treatment ingredients are linked to the mechanism of action and the targets of the 
ingredient. The GRM intervention is an entire treatment system and the GRM CLBP 
intervention is a treatment protocol.  































2.5  Clinician and Researcher Dual roles 
An implicit tension exists in the dual roles of clinician–researchers and patient–
participants. It is unreasonable to expect clinicians to divorce themselves from duty of 
care when performing research roles, and the declaration of Helsinki ethically binds 
researchers to prioritising the welfare of the patient over the needs of the research 
(World Medical Association, 2013).  
In single case designs, where the clinician is also the researcher the dual roles are integral 
to the study design. SCDs are used as, clinical decision–making tools to determine the best 
intervention for a patient, in addition to intervention evaluations (Graham et al., 2012). 
But, a number of issues are identified that contribute to the stresses of dual roles for both 
researchers and participants (Hay-Smith, Brown, Anderson, & Treharne, 2016). Firstly, if 
the clinician–researcher is overseeing recruitment, a risk of bias arises if they feel 
conflicted recruiting participants that may not benefit from the intervention. Further 
concerns may be about, participant’s potential or real experience of adverse effects. 
Secondly, issues of reciprocity, expectations of benefit, or an alternate agenda, can stress 
the relationship between the two parties. The researcher, endeavours to maintain 
research rigour that in-turn limits compliance to other pressures and vice versa (Hay-
Smith et al., 2016). Many of these dual role stresses can be mitigated by the study design. 
One advantage in single case methodology, is that if variations of intervention delivery 
from protocols occur, they are recorded and considered in the final responder analysis 
(Kratochwill, Hitchcock, horner, Levin, Odom, Rindskopf, Shadish., 2010).  
2.6  Conclusion 
Therapeutic attention in the form of massage therapy seems helpful to manage CLBP in 
the short term but its effects on functional outcomes are unclear. Massage therapy 
includes a large range of techniques, which attempt to exploit different theoretical 
mechanisms for therapeutic purposes. However, it appears that psychological 
mechanisms are the most significant determinants of outcome.  In summary the 
mechanisms of massage therapy are likely to be neurophysiological. This means the 
nervous system determines the individual’s response to the manual therapy stimulus. 
Massage therapy’s mechanical effects on cells and tissues likely are not as important as 
neurobiological responses. 
Some massage techniques facilitate a non-volitional movement response of joints and 




adhesions or contractures, increasing the ability for tissues to move, 2) reduction of 
dysponesis improves nervous system function that regulates recovery processes and, 3) 
psychological effects reduce anxiety and improves recovery.  Massage therapy techniques 
that utilise non-volitional movement responses, are called in-direct techniques, and their 
procedures are very different to the direct application of sustained pressure. Subjective 
sensations of movement detected by the practitioner when applying gentle pressure to 
the surface of the body are difficult to rationalise as being non-volitional movement.  
GRM is an in-direct manual therapy technique because it targets facilitation of non-
volitional movement of joints and tissues. This classification is made reluctantly because 
of ambiguity in what constitutes an in-direct technique. GRM is generated by the client’s 
muscle activity, with the practitioner facilitating their expression. Essentially it is 
achieved by the contraction and relaxation of the client’s muscles over which they have 
executive control, but this movement is not consciously directed by them. Therefore it is 
non-volitional. The client can stop or over-ride the non-volitional movement with a 
consciously directed movement. This means that the client submits (offers no resistance) 
to the movement, so by this definition, GRM is a passive mobilisation technique and it 
does not employ bony thrust manipulations.  Therefore, the novel GRM treatment falls 
within the scope of practice of massage therapy.   
Non-volitional movement, in the absence of identified underlying pathologies, is known to 
occur during pandiculation and stress response resolution. In clinical settings, it is 
commonly viewed as a self–correcting mechanism, and is an accepted component of 
somatic psychotherapies for stress and anxiety. For this reason, it may be particularly 
appropriate as a component of chronic (persistent) low back pain treatments. Because, 
persistent LBP is associated to increased psychological co-morbidities compared to acute 
conditions.  
The utilisation of non-volitional movement in bodywork and exercise therapy is relatively 
widespread.  Unfortunately, high-quality evidence of its effectiveness for musculoskeletal 
pain syndromes is lacking, although case studies and anecdotal reports have been found. 
Various physiological mechanisms are proposed to explain the elicitation of the 
movement with some objective evidence supporting the pandiculation hypothesis. 




Massage practice within New Zealand incorporates a wide range of modalities and 
techniques beyond direct tissue manipulations. This allows, indirect manual therapies like 
GRM, which elicit non-volitional movement phenomenon. It is reasonable to conclude, 
non-volitional movement responses to manual therapy occur along a gradient. These may 
be modulated by biopsychosocial differences in the clients, the skills of the practitioner, 
and the method used to evoke the movement. GRM as a manual therapy shares 
similarities with other non-volitional movement somatic therapies, but none of these use 
amelioration of gravity to intensify the movement response.  
GRM appears to involve a complex phenomenon about which little is known. Additionally 
CLBP itself has a complex aetiology. Therefore, a systems thinking approach is applicable 
to answer the question of whether GRM is an effective ingredient of a massage therapy 
intervention for persistent musculoskeletal pain. A systems thinking approach is 
facilitated by single–subject research methodology, and in the situation of a single 





Chapter 3 Methods 
The purpose of this research project was to investigate whether GRM is an effective 
component of a massage therapy intervention for persistent musculoskeletal pain. The 
researcher has observed apparent therapeutic effects of the novel GRM in clinical practice. 
However, no objective evidence exists to justify its’ use instead of usual therapeutic 
massage techniques for the management of chronic and persistent musculoskeletal pain.    
This exploratory study used a series of single case experiments to evaluate the effects of a 
massage therapy-based intervention featuring GRM on low back pain—the most common 
problem seen by massage therapists. It was hypothesised that in people with chronic low 
back pain, the intervention would lead to a reduction of pain intensity and distribution, 
after a transient increase in pain following each treatment session. Thus the research 
strategy required the monitoring of treatment effects over time, which is a feature of 
single case methodology. 
3.1  Methodology 
Single case research methodology has three main features: the subject is a single (n=1) 
case or unit, the subject is measured repeatedly over time, and the subject serves as its 
own control with progressive exposure and no-exposure phases (Graham et al., 2012; 
Kratochwill et al., 2010; Tate et al., 2016). This methodology enables the use of rigorous 
research methods in a clinical setting, when the intervention under study may be tailored 
to the individual participant.  It also accounts for the individual’s response to the 
intervention, due to variables such as demographic and biopsychosocial contextual 
factors (Graham et al., 2012; Kratochwill et al., 2010). Single Case Experimental Design 
(SCED) includes element/s of randomisation (Tate, Perdices, Rosenkoetter, Wakim, 
Godbee, Togher, & Mac Donald., 2013).  
Originating from extensive use in the behavioural sciences, SCEDs are now used in wider 
health science research (Krasny-Pacini & Evans, 2017; Kratochwill et al., 2010; Morgan, D. 
& Morgan, 2008; Tate et al., 2016). Single case methodology encompasses: N-of-1 Clinical 
Trials, Exposure and withdrawal designs, Multiple baselines, Alternating treatments, and 
other design variations. It does not include single case descriptions or pre- and post-
intervention studies (Tate et al., 2013). N-of-1 trials involve multiple cross over phases 
and are now relatively common in medicine. This is evidenced by the development of the 




types of SCEDs have been developed by a consensus group and were published in 2016 as 
the Single Case Reporting Guideline in Behavioural Interventions (SCRIBE). This 
document covers a range of experimental and non-experimental single case methodology 
designs (Tate et al., 2016).  
 The type of single case methodology used can be determined by the nature of the 
intervention being explored. In rehabilitation research, if the intervention does not have 
enduring effects, then an N-of-1 trial design is applicable (for example evaluation of 
function when using a mobility aid). If enduring effects are anticipated, then other designs 
may be more appropriate (Krasny-Pacini & Evans, 2017; Tate et al., 2016; Vohra et al., 
2016).  
SCEDs are an appropriate methodology to study both chronic conditions, and to test novel 
interventions in a clinical rehabilitation setting (Krasny-Pacini & Evans, 2017). The no-
exposure and exposure phases can be manipulated to best suit the experimental 
conditions. The intervention may be tailored for each individual to maximise effects. The 
small number of participants allows detailed recording of these manipulations then 
incorporated in the interpretation of the results (Kratochwill et al., 2010).   
3.2  Study design 
In this research project, the GRM–massage intervention under study was hypothesised to 
have enduring effects. Therefore, a single cross over design was used consisting of a non-
exposure phase, followed by an exposure phase. The non-exposure phase (A) provided a 
baseline control, and the intervention effects were monitored during the exposure phase 
(B). Phase B contained a number of sub-phases, established a priori, to analyse effects at 
different times during and after exposure to the intervention. Even though monitoring of 
effects continued after the intervention was concluded, the enduring effects of the 
intervention could not be withdrawn. This meant that effect replication had to be 
demonstrated across multiple cases because it could not be done within a single case. 
Replication was achieved by enrolling five participants. Participants crossed to the 
exposure phase at randomly determined times by the use of random baseline lengths. 
Baseline phase (A) established the stability of the CLBP condition, exposure phase (B) 
consisted of a series of clinical treatment sessions that delivered the GRM-massage 
intervention, and a follow-up sub phase (B2) was used to evaluate enduring effects. The 




each treatment session. The intervention follow-up period (B2) is a sub-phase of B rather 
than a separate withdrawal phase, because enduring treatment effects were hypothesised. 
As it was also unknown if enduring intervention effects would wash out over time, the 
inclusion of B2 allowed exploration of this possibility.    
The maximum duration planned for each SCE study was 31 weeks, shown in Figure 3.1, 
made up of a maximum possible seven week baseline phase A, 12 weeks of intervention 
delivery, and 12 weeks of follow up phase B2. The minimum duration possible was 27 
weeks, with a minimum baseline Phase A length of three weeks. The concurrent baselines 
of phase A began as each participant was identified and enrolled. Figure 3.1 shows the 
study design, with the approximated roll out of the five Single case experiments (SCE’s). 
Each SCE was allocated a randomised baseline length, between three and seven weeks 
duration, determining the time of cross-over to treatment onset (phase B).   
The length of phase B was 24 weeks; during the first 12 weeks  participants were required 
to attend at least four, and a maximum of 12, treatment sessions. Four treatments 
sessions, was thought to be the minimum number required for the intervention to have an 
effect. A range, rather than set number of treatment sessions, was deemed most 
appropriate, because the clinical need for treatment and tolerance of treatment (tolerance 
and recovery of the GRM effects) was expected to differ between participants. 
Each post treatment monitoring sub-phase B1 was three days. The number of B1 sub-
phases, corresponded to the number of GRM-massage intervention treatment sessions, 
received by each individual participant. The follow up sub-phase B2 was also 12 weeks.  
This project was registered before recruitment began with the Australian and New 
Zealand Clinical Trials Registry. The published protocol is also available online at 
[Internet]: Sydney (NSW): NHMRC Clinical Trials Centre, University of Sydney (Australia); 
2017 - Identifier ACTRN12617001110370. Effects of Gravity Relief Mobilisation on 
Chronic Low Back Pain: a series of single-case experiments. ; 2017 Jul 28 [cited 2018 May 





 Baseline A Intervention B Follow-up B2     
Weeks of Study Duration 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 
Single Case Experiment Number 
1 E                          
2  E                         
3   E                        
4    E                       
5     E                      
Figure 3-1. Showing Roll-out of Single Case Experiments 1 to 5 with staggered Enrolment (E), Phase A Baseline 
Control consisting of a minimum 3 weeks and maximum 7 weeks before, Cross-over to Phase B Intervention 
Exposure of 12 weeks succeeded by, Sub-Phase B2 Follow-up of 12 weeks. 
Approval for this research project was obtained from the University of Otago Human 
Ethics Committee (Health). Final approval was granted (H17/063; see Appendix A), after 
the practitioner-researcher addressed the committees questions. Consultation with Ngāi 
Tahu Research Consultation Committee, returned a recommendation that self–identified 
ethnicity data be collected, which included a question of Iwi descent. This was added to 
the participant information form.  All SCEs were underway when an application for 
amendment to the outcome measurement schedule was submitted to, and accepted by, 
the Human Ethics Committee. 
 Replication 
It is commonly accepted that SCED research requires at least three attempted replications 
of an effect, although more are recommended (Kratochwill et al., 2010; Wolery, 2013). 
Within a single case, this can be achieved by repetition of exposure and withdrawal 
phases. In withdrawal designs, replication of effect may be observed in the same 
individual across multiple phases, or across multiple individuals’. Kratochwill et al. (2010) 
explains, “Multiple AB data series are compared and the introduction of the intervention 
is staggered across time. …effect replication across series is regarded as the characteristic 
with the greatest potential for enhancing internal and statistical–conclusion validity.“ 
(p.7). Direct inter subject replication across five participants was planned for this project 




 Randomisation of base line length 
The baseline length (Phase A) for each SCE determined when the participant would cross 
over to the intervention exposure (Phase B). Baseline lengths were whole numbers of 
weeks, randomly generated, before recruitment.  
Randomisation is stated to improve the internal validity of SCDs, and is a requirement of 
SCEDs (Tate et al., 2016). It reduces risk of bias similar to the purpose of randomisation in 
controlled clinical trials. However, when baseline length is randomised, it determines a 
priori when the cross over to the exposure phase will occur, rather than occurring when a 
stable baseline has been established. It is argued that this could cause phase change at a 
potentially inappropriate time (e.g. after a random event that causes an increase in pain) 
resulting in an interpretation of a treatment effect, when in fact the change is due to a 
regression to the mean for the individual (Wolery, 2013). This is partly controlled for by 
inter subject replication. In other words, a change in pain conditions across all 
participants seen at the same point in time, could be due to a widespread event that has 
caused significant psychological distress. For example, large scale change in 
environmental conditions, such as flooding of a community. Although, it is more 
reasonable to expect random events within individual circumstances to threaten the SCEs 
internal validity.  
Another approach to managing threats to internal validity is by statistical inference 
testing. Even though it is not commonly conducted in SCEDs, some types of analysis do 
allow for the generation of confidence intervals and p values. This quantified the 
likelihood of a different result if sampling occurred at a different point in time, i.e. with a 
different baseline length. This generally is possible in a SCED when the values of data 
points in the baseline and results show stable mean levels or trends. The distribution 
around these, can be ascertained from the number of data points available for analysis 
(Shadish, Rindskopf, & Hedges, 2008). In other words, the possible changes in pain levels 
attributable to random events within an individual’s circumstances can be expected to be 
within the range of known pain levels, across the exposure and no-exposure phases.  
Whilst it is debated whether this type of randomisation decreases threats to the internal 
validity of SCD research (Kratochwill et al., 2010; Wolery, 2013), randomisation was used 
in this project to determine cross over from baseline phase to intervention exposure 
phase. The project also had to fit with a Master’s thesis time frame, so limiting time 




baseline conditions were stable, meaning pain increases or decreases were predictable 
and had a stable mean. 
The ideal baseline length for this combination of condition and intervention was 
unknown. In other words, how long participants would tolerate waiting for the massage 
intervention before they dropped-out. Massage therapy is a commonly used pain 
management modality for people with low back pain, and the recruitment exclusion 
criteria stipulated no other new therapy for pain be started during the study period. 
Participants may have been incentivised to enrol in order to receive the intervention.  
Therefore, the baseline lengths were limited to what was judged as reasonable.  
The lower limit of three weeks was chosen to provide a minimum of three data points if 
scheduled measurement compliance was only 33% (only once per week of the three 
days/week scheduled). The upper limit was set at seven weeks for two reasons. Firstly, to 
what seemed a reasonable length of time for a participant to be waiting for their first 
treatment session (avoiding attrition), and secondly to fit the time frame of this Masters 
research project. 
 Outcomes 
The intervention aimed to reduce low back pain intensity, pain distribution, and the 
effects of these on physical function. Additionally, the spatial distribution of pain locations 
in the body (i.e. outside the back also), was relevant to monitoring of participant’s 
responses to each treatment session.  
Three outcomes were selected to measure (continuously over time) the effects of the 
intervention. Pain intensity is the participant’s self-reported pain level—measured by 
Visual Analogue Scales (VAS). Pain distribution is the number of discrete pain locations. 
The effects of pain on physical function was measured as pain interference (Chiarotto et 
al., 2015)—the impact of pain on quality of life—with seven questions pertaining to: 
general activity, mood, walking ability, normal work, relations with other people, sleep, 
and enjoyment of life.  Each item was scored from 1–10, with a total possible score of 70. 
The measurement of these three outcomes, was combined in one electronic data 
collection app called the Pain Quality Intensity and Location Tracker (PainQuILT).  
As this research project asked participant’s to complete multiple repeated measurements, 




designed to provide a way of efficiently mapping multiple pain sites, with associated 
intensity and quality, in a user friendly digital format (Lalloo, 2014). In a study evaluating 
the PainQuILT usability and content, it was the preferred self-measure pain report of 58% 
(29/50) of adults with chronic pain (Lalloo, Kumbhare, Stinson, & Henry., 2014). 
The PainQuILT’s convergent validity has been assessed, against the established pain 
outcome measures of Brief Pain Inventory (BPI), and Mc Gill Pain Questionnaire. A high 
correlation (r ≥0.7) was found between the BPI score and the PainQuILT mean reported 
score across all body sites (Lalloo et al., 2014).  In people with chronic low back pain, the 
BPI pain interference survey also has acceptable convergent validity. It has strong to 
moderate correlations to the back pain specific Oswestry Disability Index (ρ=0.66, 
P<0.001)(Song et al., 2016), and Roland Morris Disability Questionnaire (r=0.57, 
P<0.01)(Tan, Jensen, Thornby, & Shanti, 2004).  
The latest iteration of the PainQuILT (www.app.painquilt.com), includes the Pain 
Interference survey based on the BPI; added when the HTML5 version of the PainQuILT 
was built (C. Lalloo, personal email communication, July 17, 2018). This was prompted by 
clinician feedback, of an older (Flash) version of the tool, collected during PhD thesis 
studies when the tool was being tested and developed (C. Lalloo, personal email 
communication, July 17, 2018). The BPI Pain Interference scale is a recommended tool for 
measuring physical function in chronic pain clinical trials in the Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials (IMMPACT) (Dworkin et al., 2008).  
The minimal important change (MIC) for the numerical rating scale for outcomes of pain 
and functional status in LBP is two points or 30% change in the baseline score (Ostelo et 
al., 2008). This cut-off was reached by a synthesis of recommendations made by an expert 
panel attending “VIII International Forum on Primary Care Research on Low Back Pain” 
(Amsterdam, June 2006). A workshop discussion was facilitated, following a literature 
review assessment that identified various interpretations of common measures for LBP.  
The Pain Interference scale does not have a published MIC score for LBP. However, for use 
in non-cancer chronic pain, a change in mean score across all items (total score/7) of 
more than 1 point is considered significant (Dworkin et al., 2008).  The Pain Interference 
scale has moderate to strong correlations with LBP specific measures the Oswestry 




(RMDQ),(r=0.7–0.81) (Ostelo et al., 2008). A 30% change from baseline is considered MIC 
for both these outcome measures (Ostelo et al., 2008).  
It may have been preferable to use a low back pain specific measure of physical function 
(Dworkin et al., 2008), such as: Oswestry Disability Index (ODI), the Roland Morris 
Disability Questionnaire (RMDQ), or a PROMIS measure. But, the convenience of the 
PainQuILT’s combination of pain tracker and physical function measures in one app was a 
reasonable way to reduce the participants burden of response associated to continuous 
measurement, through several weeks of the research phases. Use of the PainQuILT, 
authored by Dr. James L. Henry and Dr. Chitra Lalloo, was made under license from 
McMaster University, Hamilton, Canada. 
3.3  Participants 
Adult participants (18 years or older) with chronic low back pain (CLBP) were recruited 
from the general population of a provincial New Zealand town (population 65 000). The 
chronic low back pain condition was selected because in clinical practice, the 
practitioner–researcher has not observed GRM to be helpful in managing acute low back 
pain. Convenience sampling was used until five study participants were enrolled.  
 
 Recruitment and Retention 
Participants were recruited by an invitation to participate, in the form of an 
advertisement (Appendix B), distributed to three community leisure facilities, two general 
medical practices, two pharmacies, one personal trainer, and posted in the practitioner–
researcher’s own clinical massage therapy practice. No active recruitment was done in the 
clinic, although the advertisement was available to clients who requested information and 
wanted to refer people they knew for the study.  
The advertisement invited interested potential participants to email a study email address 
(grm@otago.ac.nz) supplying a phone number and a time they could be contacted. An 
intermediary-person (principle or co-investigator RG or WT) called them to briefly 
describe the study and undertake a screening process to assess their eligibility to 
participate. If individuals were eligible and interested, the intermediary person asked for 
permission to pass their contact details onto the practitioner–researcher (HV).  
The participant’s details were entered into an Excel workbook that also contained sheets 
that listed the interview guide. The workbook was password protected and shared 




sharing service. HV retrieved the contact details of the potential participant from the Excel 
workbook, and emailed them participant information sheets (Appendix C) and consent 
forms (Appendix D).  
Two days later HV contacted them by phone to explain the study details (e.g. logistics), 
answer questions, and undertake process of consent. One individual declined to 
participate at this stage, due to difficulty with internet access. For the five who continued, 
an appointment was made for them to come into the clinic, view the facility where the 
intervention was to be delivered, meet HV the practitioner–researcher delivering the 
intervention, and ask further questions.  
 
 Eligibility Criteria 
The eligibility criteria were applied by the intermediary person in a phone interview with 
the potential participant. The screening process followed an interview guideline, 
(Appendix E) which incorporated the inclusion and exclusion criteria under three 
headings—general questions, clinical questions, and internet access.  
To participate individuals had to meet all of the following criteria: 
• be an adult 18 years or older, 
• experienced low back pain, located on the posterior of the body from the 
inferior margin of the 12th rib to the gluteal folds, 
• low back pain for six months or longer and, 
• low back pain at least half of the days of the past six months, 
• did not-respond to usual care as per ACC Acute Low Back Pain Guide (Accident 
Compensation Corporation, 2004) and, 
• using no pain relief medication, or using over-the-counter pain relief only.  
Accident Compensation Corporation back pain care guidelines include the process of 
proper investigation, that each potential participant should have been through with their 
general practitioner or physiotherapist. Individuals were excluded if they had not been 
evaluated according to these guidelines. 
Reasons for exclusion related to contextual factors that may have affected the CLBP 
condition, and the interpretation of the results, or impacted the practitioner-researcher’s 
ability to safely deliver the intervention. As the intervention involves the lifting and 




the intervention ingredients to obese individuals, ascertained by Body Mass Index. 
Potential participants were asked if they were overweight, if yes, then they were asked 
their height and weight in order to calculate Body Mass Index. Additionally, as the 
intervention had been observed to cause changes in pain location and/or increases in 
pain in some people, there was concern about co-morbid psychological factors. These may 
have caused individuals to be vulnerable to associated stress and anxiety. 
 It is acknowledged that biopsychosocial management of chronic musculoskeletal pain 
should include comprehensive assessment, which includes screening for substance abuse 
and mental status evaluation (Cheatle, 2016). Therefore participants were excluded, if 
they self-reported diagnosed mental health issues and/or substance use disorders due to 
possible complex interactions of these factors affecting the delivery of the intervention 
and interpretation of results. Individuals with underlying medical conditions were not 
excluded if their medical condition was stable, being managed, and did not contra-indicate 
massage therapy.  
Interested individuals who met any of the following criteria were excluded: 
• receiving treatment or using medication for low back pain (other than 
over-the-counter pain relief), 
• underlying medical condition contraindicating massage therapy, 
• body mass index (Weight/Height²) greater than 40kg/m2, 
• currently under care of a clinical psychologist or psychiatrist, 
• pregnancy or delivered birth in the last 12 months, 
• scheduled to begin a new treatment for pain relief either naturopathic 
or allopathic or other intervention within study period, 
• substance abuse and addictions,  
• unable to use an electronic device with internet access. 
 
The clinical screening included the CAGE Adapted to Include Drugs (CAGE-AID) rapid 
screening tool for substance abuse (Brown & Rounds, 1995), and the ACC Acute LBP Care 
Guide (Accident Compensation Corporation, 2004). CAGE-AID is validated for use in 
primary care settings to identify substance use disorders and takes only 60 seconds to 
deliver, making it suitable for the participant screening process. However, as it may 
identify only past behaviours, a question was inserted to precede it—“are you currently 
using drugs or alcohol regularly?”—to identify current problems. However, it is not meant 
to have any questions inserted before it, because this is known to effect the sensitivity of 




 Enrolment  
Participants were enrolled as they were identified, at staggered intervals of 
approximately one week. A  list of ten random whole number baseline lengths, with equal 
probability of being between three to seven weeks long, was computer generated (WT).  
This list was blinded to the principle–investigator RG and practitioner–researcher HV. HV 
emailed WT before the enrolment appointment, who revealed the next listed random 
number giving baseline length in weeks. The potential participant was also blind to the 
baseline length prior to enrolling, told only that their baseline phase would be from three 
to seven weeks long.  
Signed consent forms confirmed participation in a Single Case Experiment. Each 
participant, from one to five, was assigned correspondingly to an experiment labelled 
SCE-1 through SCE-5. They were then informed of their baseline length, and the first 
treatment session was scheduled to mark the start of the intervention exposure phase. 
Following this, participant information and history was collected in a hard copy form 
(Appendix F), filled in by the participant. An on-boarding process followed that included: 
personalisation of Gmail logon password, PainQuILT training, determination of their best 
days and times to complete the PainQuILT online measurement tool and, permission was 
requested to text or email a reminder if the measurement was missed.   
3.4  Research Procedures 
 The measurement tool selected measurement 
The outcome measurement tool used was an online application called the Pain Quality 
Intensity and Location Tracker (PainQuILT) which combines a visual pain tracker with 
survey questions about pain interference (a measure of physical functioning). It includes a 
pain diagram, pain descriptors and pain rating scale, and takes less than five minutes to 
complete (Lalloo et al., 2014). For demonstration purposes the PainQuILT can be accessed 
here: 
 Open the following webpage: http://app.painquilt.com  
 Works in all browsers, except Internet Explorer. Suggest using Safari if on a Mac, 
or Firefox if on a PC.  
o Click “sign in as User” 
o Use the following login for the demo: 
Email: painquilt.test@gmail.com  




In the PainQuILT app, participants “clicked” on a selection of pain locations on a 
mannequin, then assigned a standardised pain descriptor icon and intensity rating from 
0–10 (Figure 3.2).  Additional painful body sites could be added before finalising the pain 
record. They then completed the pain interference survey, answering seven compulsory 
questions which could be scored between 0 to 10 with anchors of 0 ‘does not interfere’ to 
10 ‘interferes completely’(Figure 3.3). When the data was analysed the answers were 
added together to give a total score from 0-70.  
 
Figure 3-2. Computer Screenshot of PainQuILT showing highlighted: Locations Left-Lower Back, Lower-Mid 
Spine, Left-Hip, Left-Buttock, Left Thigh, Pain Quality Descriptors of Aching and Stiffness, and Pain Intensity 
rating of 4. 
 
  
Figure 3-3. Computer Screenshots of the PainQuILT app. showing two of the Pain Interference Survey Questions 
and associated 0-10 Rating Scales. 
PainQuILT images Copyright McMaster University 2018. Reproduced with permission. 
  
 
The PainQuILT mannequin has over 100 codified body sites and eight of these represent 




back pain should have been 80. However, some user problems existed that caused 
replication of the left and right hip sites, resulting in ten low back pain sites and a total 
possible score of 100. This is explained in the data reformatting (section 3.8.3). 
Participant’s used an allocated anonymised email address (e.g. grmstudy1@gmail.com) to 
log in to the PainQuILT app for the duration of their experiment. At time of enrolment the 
generic password was reset by the participant, with the practitioner-researcher kept 
blind to new password.  The study email address (grm@otago.ac.nz) was set up as the 
practitioner–researcher’s log in (also password protected) so that the practitioner-
researcher could view each of the participants PainQuILT records. 
The PainQuILT was the chosen outcome measure because it was an electronic on-line data 
capture method, included a pain diagram and a measure of function. The pain diagram 
was needed to monitor pain locations (site and number) because the interventions 
hypothesised mechanisms necessitate treatment of the whole body.  Additionally, the 
number of pain sites in the body is thought to impact disability more than actual pain 
location in people with chronic back pain (Smith, B. et al., 2004), suggesting intervention 
studies should record multiple pain sites to be included in the intervention response 
analysis (Carnes et al., 2007). Although multiple pain sites were recorded, only low back 
sites were included in this study's  statistical analysis. Additionally, GRM is thought to 
produce short term variability in pain location as well as intensity, which meant the entire 
body locations needed to be monitored to enable tailoring of each intervention .  
Pain intensity and distribution were measured using repeated samples of Ecological 
Momentary Assessments (EMA).  Ecological Momentary Assessments are used to capture 
self-reported, real world, experiences of research participants at a moment in time. This 
reduces recall bias and improves validity of cause and effect inferences (Stone & Shiffman, 
2002). The PainQuILT app instructed participant’s to record their pain characteristics 
according to how they felt “right now” making it appropriate for EMAs. The Pain 
Interference survey measured effects pain had on physical function over the past 24 
hours, thus it was relevant for only one record per day and not the pre- and post-
treatment session records. A drawback was that participants had to skip through all these 
questions to reach the end of the online questionnaire, but this did not affect the results as 




3.4.1.1 Measurement Schedule  
The sampling frame (density and timing) of the assessments ideally would represent the 
participant’s whole pain experience, assuming that this is influenced by daily and weekly 
routines (Stone & Shiffman, 2002). No evidence existed about compliance rates to 
scheduled measurements over time using the PainQuILT on-line tool. Therefore, the 
sampling density was decided pragmatically, and the timing of the EMAs was decided by 
the participants themselves. 
The measurement schedule was set at a spread of three to four days per week, at the same 
time of the day. At enrolment and on-boarding the participants were asked to determine, 
the most convenient time of day and days of the week for them to complete the PainQuILT 
data collection. The actual measurement was permitted to occur one hour either side of 
the chosen time. The participants were also asked to adhere to these times, however, if 
they missed a day they could complete the record the following day in the correct time 
interval. This meant that the day of EMA could vary over the course of the study. 
Additional records to monitor the treatment delivery (pain intensity) were completed 
immediately before and after treatment sessions, within 30 minutes of the start and end 
of the manual therapy component. This was meant to be at the clinic, but some 
participants preferred to use their own devices and completed the record prior to their 
appointment at their own convenience. Post session records were completed in the clinic 
after the conclusion of the manual therapy treatment component. This was either on the 
clinic computer or on participants’ own devices.  
The intensity of measurement also varied across each phase of the study (Table 3.1). The 
baseline phase measurement schedule asked participants to complete the PainQuILT 
three times per week.  The intervention phase was 12 weeks for all participants, and they 
were asked to complete the PainQuILT up to six times per week (including pre- and post-
treatment records). During the follow up phase, participants were asked to complete the 
PainQuILT three times per week for one week, then every fourth week up to week twelve. 
Giving nine Phase B2 records in total for each participant. Reminder texts and emails were 
sent to participants if they missed a day of Pain Quilt recording. Permission to do this was 
obtained during on-boarding, along with confirming preference for text or email 







Table 3-1. Proposed Measurement Schedule for Single Case Experiments, with 7 weeks maximum baseline, 12 treatment sessions and 12 weeks of follow-up. Each week shows day number 
of the scheduled measurements. 
Phase Baseline A Intervention Exposure B 
Sub phase  
Intervention Delivery 
Includes B1 subphases and B between treatment session baseline phases 
Intervention follow-up 
B2 Subphase 
Week 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 … 23 … 27 … 31 
Day  
1 M M M M M M M Rx1  Rx2  Rx3  Rx4  Rx5  Rx6   M  M  M 
2        1.M1 M 2.M1 M 3.M1 M 4.M1 M 5.M1 M 6.M1        
3 M M M M M M M 1.M2  2.M2  3.M2  4.M2  5.M2  6.M2   M  M  M 
4        1.M3 M 2.M3 M 3.M3 M 4.M3 M 5.M3 M 6.M3        
5 M M M M M M M            **  M  M  M 
6        M M M M M M M M M M M M       
7                          
Scheduled PainQuILT EMA (Measurement = M); Treatment session number(Rx.n) includes immediate pre- and post-treatment PainQuILT 
measurements (these have been excluded from plots and analysis); B 1 sub phase three days of post treatment EMAs (n.M1, n.M2, n.M3) plotted but 






This research was conducted in a single setting, within a residential area of a provincial 
New Zealand town. The intervention was delivered at the home-based clinic of the 
practitioner–-researcher. The clinic room is set up as a professional space dedicated to 
massage therapy, separate to the main residence. Parking is provided under cover in front 
of the clinic waiting room entrance, making access easy for elderly or mobility-impaired 
clients. The treatment table was set in the centre of the room at a diagonal, allowing 
ample space around the table for the practitioner to work (Figure 3.4). A comfortable 
chair was provided, next to the desk in one corner (facing the treatment table) for the 
participants to sit during interview and discussions.  The practitioner sat at a distance of 
1.5 metres from the participant, at the desk adjacent to the wall. The seating was 
consciously placed to feel intimate but not imposing, intending that the participant felt 
they were considered to be an equal partner with the practitioner-researcher in the 
intervention. The table castors were dropped down to roll the table aside when using the 
space for exercises and movement education. The room was heated by radiators in the 
cold weather, and a door opened to a private courtyard for airflow expressed by a tall 
pedestal fan in hot weather. Temperature was adjusted for the comfort of each 
participant.  
  
Figure 3-4. Set-up of Clinic with Observer XT Portable Lab Recording Equipment and one Camera Angle. 
Measurement of pre-treatment pain and immediate post-treatment session effects was 
done by the participants on their mobile devices, or they logged onto the PainQuILT on 
the office personal computer, and logged off afterwards. All other measurements were 





This research project used video recordings of the treatment sessions, for subsequent 
assessment of the fidelity of the interventions implementation to the treatment manual. 
Two cameras were used, set at angles that provided views of the treatment table looking 
down its length and from the side (as viewed in Figure 3.4) 
Both these views were at the table’s height, so they did not appear to invasively be 
directed down on the client-participants. The cameras were intentionally placed like this 
to avoid identifying participant’s faces or directly view sensitive body areas.  This  
compromised the ideal camera angles for capturing from above, all the body regions in 
every possible position. Therefore occasionally the practitioner-researchers’ manual 
techniques were obstructed from the cameras view. The only participant with some 
apprehension about video recording was accepting of this once camera views were seen 
at time of enrolment. 
 Provider 
The practitioner–researcher is a massage therapist with 15 years clinical practice 
experience, is a member of Massage New Zealand, and holds a Post graduate Diploma in 
Rehabilitation, a Diploma in Therapeutic Massage and, a Diploma in Sports Science and 
Management. She has rehabilitation experience working with stroke and spinal injured 
patients, peripheral nerve and trauma injuries, persistent musculoskeletal pain, and 
palliative massage for pain. Her background, prior to massage therapy, included exercise 
programming and instruction in gym and home exercise environments. This experience 
has been working with people in private practice, wanting to improve their condition 
further, after discharge from medical and physiotherapy services. She has also worked 
multidisciplinary, overseen by primary and specialist care physicians and 
physiotherapists.  
It is argued that the processes of manual therapy interventions profoundly influence 
effectiveness, by delivering far more than just their structural ingredients (Bialosky, 
Bishop, George, & Robinson, 2011; Bialosky et al., 2009). In massage therapy these 
additional ingredients, include the effects of the behavioural interactions of the clients 
and the practitioner (Smith, J., et al., 2009, 2010). 
The intervention was viewed as an interaction between practitioner and client, rather 





that everything the practitioner–researcher said and did, was done with the knowledge 
that it is responded to by the client, rather than thinking the practitioner causes a change 
in the client. Attempts are made in the CLBP treatment manual to describe the 
biopsychosocial approach of this intervention, but the practitioner–researcher 
acknowledges this is a complex of nuances that contribute to the placebo effect of 
massage therapy practice (Bialosky et al., 2011; Smith, J., et al., 2010). 
 Materials 
This project’s processes of recruitment, on boarding, intervention delivery, and outcome 
measurement, utilised a combination of hard copy forms and web-based computer 
software. A detailed treatment manual was written to characterise the GRM intervention.  
It was developed by the practitioner–researcher prior to writing the protocol for the 
ethics application and has since been refined for clarity and brevity. In this project video 
footage of the treatment sessions was recorded for the subsequent fidelity assessment.   
Materials for massage therapy delivery are given here or in the intervention section 3.5. 
An Excel work book was used to keep track of the recruitment process, onboarding of 
participants, measurement schedule, and treatment sessions. The workbook contained 
three sheets, Recruitment Screen, Task Management, and Activity Log. It was password 
protected and shared via Dropbox between the practitioner-researcher (HV), principal 
investigator (RG), and co-investigator (WT). The task management sheet held a detailed 
checklist of all pieces of required information and permissions, as well as the 
measurement schedule. The activity log served as the research journal, where the 
practitioner-researcher kept a to-do list and notes about any problems that occurred 
during the project.  Participant information and history forms were completed at 
enrolment and clinical notes were kept in hard copy, before being transferred to a 
password protected and secure, cloud-based clinical practice management system 
(Appendix G). Hard copies were kept in a locked cabinet drawer.  
3.4.4.1  Participant on-boarding 
The first step of participant onboarding, involved set up of Gmail email addresses for all 
participants to log on to the PainQuILT app. Otago University’s webmail system hosted 
the role based email address (grm@otago.ac.nz) that was used as the practitioner–
researcher’s log-in. This also functioned as a contact point for the participants during the 





phone number. Contact was necessary to confirm or change treatment session 
appointments, as well as respond to queries about the measurement schedule or 
PainQuILT app. Treatment sessions were scheduled in the university webmail Outlook 
calendar (associated to the GRM study email address) then sent to the practitioner–
researcher’s clinic calendar. 
The next step of onboarding, trained participants how to use the PainQuILT app, following 
a demonstration guide provided by the PainQuILT developers (Appendix H). Three of the 
participants experienced some difficulty in the first three weeks remembering how to use 
PainQuILT, so HV developed the training guide into a user guide (Appendix I). The user 
guide was approved by the apps developers before it was distributed to these participants 
in printed hard copy (C. Lalloo, personal communication via email, August 20, 2017) .  
Participants used their own electronic devices to log in to the PainQuILT app. The app did 
not function well in Internet Explorer, so participant 1 and 4 had to download Firefox to 
their computers as an alternative browser. Participant 1 sought external IT support to do 
this, and participant 4 was talked through the process over the phone. The remaining 
participant logged in on mobile devices with pre-installed browsers; participant 2 used 
Safari and participant 3 and 5 used Google Chrome. Participant 3 was shown how to save 
the PainQuILT app webpage icon to their mobile phone homescreen. 
3.4.4.2  GRM Treatment Manual 
The GRM-intervention was characterised in detail as a treatment manual, retained as an 
electronic copy. The treatment manual was reviewed by massage therapist and University 
of Otago Wellington research fellow MB. However, the GRM technique described in the 
manual has not been replicated by another therapist at time of writing.  
The manual was written specifically for the purpose of this research project.  Low back 
pain is the most common problem massage therapists see (Sherman et al., 2005; Smith,J., 
Sullivan, & Baxter., 2011; Sundberg et al., 2017) and the practitioner–researcher felt that 
whilst every treatment session is tailored to individual clients, enough similarities existed 
across low back pain treatment sessions that it could be codified as an intervention. The 
intervention was developed over several years, meaning that the treatment manual is a 
detailed summary of the most common treatment session ingredients for CLBP, used over 





was more efficient, to itemise the generic intervention ingredients, and detail the 
deviations from this in clinical notes.  
An overview of GRM is given in the next section (1.5.2). The treatment manual describes 
in detail application of GRM for the entire body and how the GRM technique arose is 
provided in the prologue. Videos have been posted on a dedicated Vimeo channel to 
accompany the manuals photographs. The technique also required a name, and the term 
Gravity Relief Mobilisation was chosen, to describe how the technique was applied (taking 
the weight of a body part assisting non-volitional muscle contractions to move joints and 
tissues), rather than infer any underlying mechanism. What the manual also outlines is 
the practitioner-researcher’s approach to assessment and treatment ingredient 
prescription. This approach is holistic, biopsychosocial and values the therapeutic alliance 
between clinician and client. It is not a unique approach, being common to other massage 
and manual therapy modalities (Myers, 2004; Smith, J., et al., 2009, 2010).  
The treatment targets were body structures and body functions being addressed by 
manual therapy treatment group, and contextual factors addressed by the supplementary 
educational treatment group. Treatment targets were recorded after the session in the 
clinical notes alongside how they were addressed. 
3.4.4.3 Treatment session Videos 
For subsequent fidelity assessment, the gold standard to assess treatment adherence is 
using video or audio recordings to objectively verify the treatment delivered versus what 
was planned (Bellg et al., 2004). The videos were recorded using a Noldus portable 
observation laboratory with Observer® XT software. The Noldus equipment, loaned by 
Otago University’s Department of Medicine comprised of two cameras, a microphone, and 
dedicated laptop.  
The recording time was pre-set to run continuously for two hours and was activated 
when participants entered the clinic room. Only the treatment table was in the cameras 
field of view and participants were shown where in the room they could dress and 
undress in private. Video data was uploaded to a University High Capacity Data Storage 





3.4.4.4 Other materials  
Other materials used for intervention delivery are versions of usual items in relaxation 
massage therapy practice: 
1. Treatment table; with three sections. The head and foot boards were adjustable by 
angle, and were required for participants comfort in pain free positions. The table also 
had a face hole cut-in, and was easily height adjustable by pneumatic foot lever, so the 
table could be lowered if required for participants to get on and off the table safely (Figure 
3.4 above). 
2. Draping; warm polar fleece sheets on colder days or polycotton sheets in the summer.  
3. Bolsters; micro fibre down alternative, hypoallergenic pillows. One or two medium 
sized bolsters were used under the knees lying supine, and used under the ankles lying 
prone. One soft bolster was used under the abdomen lying prone, or used for the head and 
neck lying supine. 
3. Memory foam contour pillow. Used for head and neck support for participants with a 
head forward posture or excess thoracic kyphosis. 
4. Massage Balm; Pure Fx Deep Relief balm, Auroroa NZ Ltd, Kaiapoi, New Zealand. This 
particular balm is slightly stickier than other massage balms and oils, enabling transition 
between massage techniques and GRM without losing grip of the body part. 
5. Heater and fan. To regulate temperature. 
6. Spotify (Spotify AB, Spotify Free, 2018) relaxation Internet music stations. Used when  
participants indicated preference for music during treatment.  
 
3.5  Intervention 
The intervention consisted of relaxation massage, GRM, breathing instruction, and 
education on posture and movement. Treatment sessions always included empathic 
listening to the client and was holistic, meaning that all the major joints of the body were 
treated. An overview of the intervention ingredients is given in Table 3.2. Full details are 
characterised in the CLBP GRM Treatment Manual that covers assessment, treatments, 
follow up discussion and prescription of exercises and stretches, all integral to the 





The a priori intervention characterised in the CLBP treatment manual was divided into 
three stages. Each stage was intended to be four weeks long and designed to progress the 
client to functional, pain-free movement without overwhelming them with too much 
information in each phase.  Stage One, familiarised the client with the GRM process and 
achieved the mobilisation of the muscles using GRM. Stage two included breathing and 
postural education. Stage three progressed to include movement re-education and 
practice. 
The theoretical mechanisms of the manual therapy techniques of the intervention are 
thought to be neurophysiological (Joel E. Bialosky et al., 2009), not mechanical—these 
tissue properties are not targeted. Instead biomechanical principles were considered 
when, deciding which body areas to focus on, as well as what exercises were prescribed. 
For example, areas of chronic unconscious muscle tension were addressed with GRM, 
until the muscles’ ability to relax and contract was restored, which allowed for improved 
posture and movement efficiency. This objective was hypothesized to  make everyday 
movements easier to perform. 
 Relaxation Massage  
Relaxation massage was used across all phases of the intervention (detailed in the 
Treatment Manual, p.51). First to acclimatise the client to therapist touch, and then to 
stimulate relaxation. This was revisited throughout the session as needed, as the 
practitioner-researcher moved to different body parts. If incidents of increased pain 
occurred during the session with the application of GRM, relaxation massage techniques 
were applied to the surrounding soft tissues until the pain subsided.  
The relaxation massage techniques used were limited to gliding, kneading, and holding 
(Sherman et al., 2006). Gliding and kneading are also known as effleurage and petrissage 
in the Swedish system of massage (Fritz, 2000b). The holding technique is used in many 
different manual therapy modalities, but is differentiated from compression by the degree 
of pressure applied (Sherman et al., 2006).  
Holding involves the application of sufficient pressure to gain traction on the skin, so that 
a cross-fibre stretch can be applied to the depth that contacts the muscle and connective 
tissues being addressed. The pressure and traction is never beyond a level 6 on the pain-





participant does not tense their muscles because of pain, caused by the pressure being 
applied. Holding does not aim to compress and cause a spontaneous relaxation of muscle 
tension, nor tissue ischaemia followed by reperfusion. The technique is also a component 
of GRM but can be applied on its own. Holding is used on muscles of the trunk, that cannot 
be treated with GRM, because of limitations in body position lying on the treatment table. 
For example, muscles in the low back that flex or extend the lumbar spine.  
The theoretical mechanism of relaxation massage is described by the term 
dermoneuromodulation, meaning neuromodulatory effects of the cutaneous nerves 
stimulated from the surface of the body (Jacobs, 2016). Placebo effects also contribute, 
nuanced by positive expectations of the therapist or the therapy context, experience of 
pleasant sensation, and previous positive experience of massage therapy (Bialosky et al., 
2011; Puentedura & Flynn, 2016; Smith, J. et al., 2010). 
 Gravity Relief Mobilisation 
Gravity Relief Mobilisation (GRM) aims to relieve chronic musculoskeletal pain by 
improving the client’s ability to move. It contains ingredients of holding, amelioration of 
Gravity (AmG) and mobilisation by non-volitional movement. Its objective, is to invoke 
tonic muscle reactions by applying gentle hand pressure (<0 .1 kg/cm2) at varying angles, 
then support this reaction to express as movement. AmG is the taking up of the weight of 
the body part, and how this is done—along with the surface contact points of the body 
with both the practitioner and the treatment table—form parameters of the possible 
ranges of joint movements.  
The movement is surprising as it is generated by the client’s musculoskeletal system, 
rather than by the efforts of the practitioner. Although in cases where the movement is 
weak or non-existent the practitioner can nudge a joint in a direction to see if the 
movement seems to continue in the same direction. If there is any resistance at all, the 
practitioner does not exert additional force. The final direction of the elicited joint 
motions is not determined by the client nor the practitioner, and so it is classified as non-
volitional movement. The practitioner simply holds up the weight of the body part being 
treated, and follows the joint as it flexes, extends and rotates. They adjust the contact 
points to explore different ranges of movement. The amount of non-volitional movement 





with consecutive sessions, displaying a type of learned response. It was intended that a 
GRM response be established by the second stage of the intervention.  
An example of GRM is given, with the client lying prone and shows treatment application 
to the hip region and entire leg. The weight of the lower leg is being held by the 
practitioner, but all the motions of knee flexion, extension, rotation, and hip rotation are 
occurring due to the non-volitional muscle activity of the client. The practitioner is 
constantly relieving the weight of the limb and following the muscle contractions, which 
create joint movements. The demonstration video can be viewed at 
https://vimeo.com/224535923 (password: 2018RX4BACKPAIN) 
It may be difficult for an external observer to appreciate that these movements are not 
directed by the practitioner.  An easily appreciated, yet typical, non-volitional movement 
of knee flexion can be seen, at 1:30 when the strength and range of the GRM activity has 
increased. The practitioner reduces their level of support at 2:10, holding the lower leg 
weight with fingertips only, allowing the non-volitional movement to be observed whilst 
it is being followed by the practitioner. As the demonstration continues, a change in 
where the practitioner contacts and takes up the body regions weight, is what allows for 
the exploration of various ranges of motion: flexion, extension, abduction, adduction, 
internal, and external rotation. 
The non-volitional activity is strong in this client, so all of the movements are client non-
volitional movements. The practitioner is simply following them, but actively, holding up 
the weight of the leg. On a scale of 0–5 the GRM overall activity in this example video was 
rated as level 4, with 0 being no movement, and 5 movement occurring beyond the 





Table 3-2. GRM CLBP Intervention Treatment Session Ingredients 










Placebo (Joel E Bialosky et al., 2011). 
Therapeutic alliance (Smith, J. et al., 2009). 
 
Acclimatise client to practitioner’s 
touch, relaxation, build rapport. 
Collect palpatory feedback. 
 
Relaxation at beginning of treatment 





1) Holding technique. 
2) Amelioration of Gravity.  
3) Mobilisation by non-
volitional movements. 
 
Non-volitional isotonic contractions of fascia, 
tendons and muscles (Bertolucci, 2011; Dorko, 
2003). Improved brain-body schema (Puentedura & 
Flynn, 2016). 
Pain free joint and soft tissue 
movement.  
Holding techniques also applied to upper 
leg musculature with GRM whilst 
supporting the weight of the leg under the 
knee joint to allow the exploration of 
movement of the hip and or knee. 
Breathing 
Instruction 
1) Rhythmical nose and 
belly breathing 
instructions.  
2) Application of holding 
techniques to chronically 
stressed accessory 
breathing muscles. 
Decrease in sympathetic nervous system tone 
(Chaitow, 2004; Mehling et al., 2005). 
Relaxation. Holding techniques of taught tissues 
around solar plexus region with instructions 




1) Postural assessment & 
education. 
2) Stretching exercises. 
3) Strengthening exercises.  
4) Basic movement 
pattern assessment & 
education. 
Self-awareness and efficacy to develop movement 
confidence (Puentedura & Flynn, 2016) through 
information about biomechanical and ergonomic 
principles of the musculoskeletal system. 
Awareness of body position and 
muscles used doing everyday 
movements in order to improve 
movement efficiency and reduce 
postural stress. 
i. When moving from sit to stand: moving 
forward on the seat, placement of feet 
under the body, then standing up not 
allowing the knees to collapse together. 




The specifics of how or why GRM elicits non-volitional movement are unknown. However, 
it is reasonable to attribute therapeutic effects to the simple movement of joints and 
tissues that have been compromised for whatever reason. It may also be that the non-
volitional nature of this movement has an inherent therapeutic effect (Bertolucci, 2011; 
Bertolucci & Kozasa, 2010; Dorko, 2003; McCarthy et al., 2007). Further details about 
GRM delivery can be found in the Treatment Manual, p.57. 
 Breathing Education 
Breathing instruction is a standard part of massage practice that aims to further facilitate 
relaxation (Fritz, 2000d; Sherman et al., 2006).  It was included in stage two of this 
intervention. Chronically stressed accessory breathing muscles (Bartley & Clifton-Smith, 
2006) are targeted with the application of holding techniques, whilst breathing is verbally 
directed by the practitioner (detailed in the Treatment Manual, p.75). It is thought that 
GRM requires a decrease in sympathetic nervous system tone to be effectively applied, 
and breathing is an important tool to facilitate this physiological response. However, each 
client varies as to whether breathing instruction is needed in addition to relaxation 
massage, and so it is a non-essential ingredient.   
 Posture and Movement Education 
Supplementary activities aim to consolidate improvements in movement gained from the 
manual therapy ingredients of the treatment sessions. Recommendations for exercise and 
movement were given in stage two and three of the intervention. As part of usual practice 
many massage therapists provide instruction on exercises the client can practice at home 
(Fritz, 2000d). This intervention included some basic education on posture and 
movement which is a non-essential ingredient due to client individual variation (detailed 
in the Treatment Manual, p.81).  
 Intervention Procedure 
The intervention was delivered in the same manner as routine clinical practice. Each 
session began with 5–15 minutes of discussion and assessment, before the hands on 
treatment.  After the treatment and when the participant was dressed, the session 
concluded with discussion, and practice of, movements and prescribed exercises. 
 At the initial session, the participant’s history was reviewed. A brief standing postural 
assessment was conducted, identifying gross patterns of pelvic tilt, hemi-pelvis 




the feet. All of this information was considered when deciding how to begin the session, 
the treatment targets, and the positioning of the client. For example, participants with 
pronounced forward head posture were supported by a thicker pillow under the head 
lying supine; participants with anterior pelvic tilt observed in standing posture were 
supported with extra bolsters under their pelvis and feet lying prone. Other contextual 
factors were also considered, such as no previous experience with massage, or noticeable 
physical or verbal expression of anxiety about body work. Prompting the session to begin 
with the participant lying prone (a less vulnerable position) until they became 
accustomed to the practitioner–researcher’s touch. The plethora of contextual factors that 
influence the practice of client centred massage therapy are innumerable, attempts are 
made in the CLBP treatment manual but may be better comprehended by the 
practitioner–researcher’s background and experience as the intervention provider (see 
3.4.3). 
After assessment, the participant was given instructions how to get on the treatment 
table, arrange themselves under the draping supplied, and then left in private while the 
practitioner-researcher left the room to wash her hands. Upon returning, client comfort 
was attended to, by securing draping, adjusting bolsters and table section tilt and 
confirming verbally participants were comfortable in a pain free position. Massage was 
then applied using a skin lubricant to allow glide of the hands over skin and hair. The 
sessions could be delivered fully clothed if preferred by the participant, as the principle 
active ingredient of GRM did not require the application of massage strokes to the skin.  
If the participants were comfortable to undress for the session, their underwear remained 
on and draping was conservative with the chest, anterior and posterior pelvis covered at 
all times. When GRM was applied to the shoulder or hip regions, draping was wrapped 
around the leg or secured under the shoulder to ensure the participant’s did not feel 
exposed. A fully clothed session—could be done with the participant wearing loose 
flexible clothing. When draped or clothed areas were being addressed the techniques 
were applied over the draping/clothing.  
At consecutive treatment sessions, the targets were discussed and determined with the 
participant, before the hands on treatment began. First, the participant was asked how 
they were for the three days following the last session, and how they had been since then. 
The previous session’s clinical notes were reviewed, which included the plan for the 




work on in the current session then offered their own thoughts regarding treatment 
priorities. The practitioner–researcher also considered the client’s, current concerns, pain 
locations and severity, time available, and planned activities (immediately after the 
session and the following 72 hours). They then made the final decision about the content 
of the treatment sessions. All of the major joints of the hips, knees, ankles, shoulders, 
elbows, wrists, cervical region and lumbar region were treated with GRM if possible, 
varying in the amount of time spent with each joint.  
The goal of the hands on treatment sessions, was increased pain free joint ranges of 
motion and pain free muscle contractions. To achieve this, as much time as possible was 
spent on GRM, the interventions active ingredient. However, GRM would sometimes cause 
muscle cramping and pain, or muscle fatigue, limiting how long it could be applied. If this 
occurred, the participant was asked if they were okay or needed a rest. If they were okay, 
work continued until the pain resolved. If they needed a break, the limb was laid to rest, 
and relaxation massage techniques applied until the pain eased. The area was noted, for 
work later in the session, or the following session.  
Sessions could be delivered entirely supine or mostly prone, finishing with the head and 
neck supine. The session ingredients were combined, taking in account time available and 
the treatment session focus. The time spent on each region of the body was adapted for 
participant comfort, but ultimately determined by the practitioner–researcher.  
Features of muscles and joints that increased the time spent on the body region:  
• reduced range and shape of joint movement compared to normal movement; 
• reduced range and shape of joint movement compared to the contralateral limb; 
• high levels of neuromuscular tension that demonstrated strong GRM activity; 
• abnormal low muscle tone with absent GRM activity; 
• muscle atrophy compared to contra lateral limb; 
• fibrosis or scar tissue; 
• sensation of cold to touch;  
• detection of a ‘therapeutic pulse’; 
• feedback from the participant that a particular technique felt good; 
• increased pain (not caused by hand pressure) in any area, work continued if 





The time available in the session, also had to be considered, and divided up so that all the 
body regions could be addressed. Other limiting factors for time spent on one area, were 
features of muscles and joints that decreased time spent on a body region, such as: 
• improved range and shape of joint movement, 
• reduced levels of neuromuscular tension and GRM activity, 
• evidence of psychological distress with work on a particular area, 
• increased pain or fatigue that became intolerable. 
 
Muscles and joints associated to movements the participant found difficult, and/or areas 
with high or very low muscle tone, were identified as treatment targets. High tone is 
identified by palpation and by GRM activity levels. Low tone may be identified by atrophy 
in comparison to the to the contralateral limb, or unexpectedly low muscle tone, if a body 
region is known to have a significant trauma history (such has major injury or surgery). In 
these cases, motor nerve traction injuries are suspected. Therefore, both excess tone and 
low tone may be considered as dysfunctional states.   
Some of the muscles around the trunk and low back cannot be addressed on the treatment 
table using GRM. Thus, just relaxation massage techniques are used on these body 
regions. Areas that feel cold under palpation, are massaged until the client reports a 
warming sensation. Fibrotic areas of tissue in the lumbar region are addressed with cross-
fibre holding techniques, and a therapeutic pulse may be detected by the practitioner 
(Therapeutic pulse is explained under Holding technique in the Massage section of the 
treatment manual p. 51).  
 Scheduling/Dose 
Participants were asked to attend a minimum of four and a maximum of 12 clinical 
treatment sessions over the course of 12 weeks. The first treatment session was 
scheduled at time of enrolment. Consecutive treatments were arranged at the end of the 
sessions, and scheduled according to response and recovery from the previous session. 
Convenient times were discussed and negotiated between the practitioner and 
participant.  
After the first session, within 48 hours, participants were contacted by phone  to ascertain 
rate of recovery. If they were feeling comfortable, the next treatment session was 




Four sessions was thought to be the minimum number needed for an intervention effect. 
Due to time limitations the intervention end point selected was at 12 weeks. This allowed 
the minimum number of sessions to be delivered at three weekly intervals. Clinical 
practice observations indicated that intervals between sessions of one to three weeks is 
most acceptable to clients. 
 Intensity 
Sessions were approximately 1 ½ hours of hands on treatment with an extra half-hour for 
assessment, exercise prescription and discussion. Techniques used were selected at the 
discretion of the practitioner, after a clinical reasoning process that considered client 
treatment preferences and goals. As treatment sessions progressed it was intended that a  
higher percentage of mobilisation and movement components would be included.   
The intensity of the GRM dose for each body region was affected by the GRM activity level, 
which is the range of movement of the joints created by the non-volitional movement 
response. The greater the movement range and number of movements, the more likely 
the participant would feel muscle fatigue. During sessions, if a body region was being 
worked with using GRM for several minutes, the participant was asked if they had had 
enough, or their muscles felt tired. If the participant answered in the affirmative, work 
with this area was stopped and the body part laid to rest.  
The practitioner rated the GRM activity level (Table 3.3) and kept a record of this in the 
clinical notes. Increasing levels of GRM activity in consecutive treatment sessions, 
indicated increased levels of treatment receipt for the body region being targeted. This 
information was used in clinical reasoning and for treatment planning. In research 




Table 3-3. Gravity Relief Mobilisation Practitioner Subjective Rating of Perceived Activity Level of Non-Volitional 
Movement. 
Level Perceived activity Description 
0 No activity Limb or head feels limp and heavy, full weight of limb is in 
practitioners hands, low muscle tone felt with palpation. 
1 Small amount of 
isometric contraction, 
no movement 
Limb or head feels like client is holding it up slightly, most of the 
weight is being supported by the practitioner, slight muscle tone 
felt with palpation. Joint is moving less than 45 degrees. 
2 Small amount of 
movement of head or 
limb joints. 
Limb or head feels like client is holding it up slightly, most of 
weight being supported by the practitioner, slight to moderate 
muscle tone felt with palpation. Joint is moving through 45 
degrees. 
3 Definite movement of 
head or limb joints.  
Limb or head feels like client is holding it up slightly, most of 
weight being supported by practitioner, moderate muscle tone 
felt with palpation. Joint is moving through 45 degrees. 
4 Strong movement of 
head or limb joints 
Limb or head feels like client is holding it up slightly, most of 
weight being supported by the practitioner, high muscle tone felt 
under palpation. Joint is moving 45 degrees or more. 
5 Independent movement 
of head or limb joints, 
may include torso 
Limb or head not being held by practitioner, movement is in body 
region where AmG is not applied. Practitioner may still be 
applying a holding technique to region or hands may be 
contacting a region different to where the movement is 
occurring. 
 
3.6  Adverse Effects 
In New Zealand massage therapy is accepted by the public as low risk for adverse effects 
(Smith,H., 2018), although adverse events do occur (Posadzki & Ernst, 2013).  An Adverse 
Event is defined as an unintended reaction that causes, or potentially causes harm, to the 
individual receiving treatment (Health Quality and Safety Commission New Zealand, 
2017).  As the GRM intervention is gentle and does not force the tissue in any way, serious 
Adverse Events related to the intervention were highly unlikely, therefore advice was to 
use the term Adverse Effects rather than Adverse Events (Dr. B. Smith, Chair of Lakes DHB 
Research and Ethics Committee, personal communication, April 28, 2017).  The 
practitioner–researcher believes adverse effects of massage therapy interventions should 
be acknowledged.  Acknowledging  Adverse Effects accounts these as indirect costs to 
clients, which can be balanced against benefits of particular massage styles and 





Even though no forces to cause tissue damage are used in GRM, the practitioner-
researcher had observed in clinical practice the treatment could cause transient increases 
in pain and pain distribution in the days following a treatment session. This increase can 
appear to cause psychological distress. In practice clients tolerated this (as evidence many 
returning for further treatments), provided it did not last longer than three days. When 
GRM treatment doses were reduced, adverse effects were also reduced, meaning the 
treatment could be titrated to tolerable levels. Psychological distress, is proposed to also 
arise from trauma memories, being relived in the process of body work (Levine, 1997; 
Van der Kolk, 2006). This has been observed by the practitioner-researcher in her clinical 
practice. The handling of these situations, by directing client attention away from the 
unpleasant memory, is covered in the treatment manual. 
Adverse effects in massage therapy studies may be to be under reported, in part due to a 
lack of defining criteria, meaning they pass unidentified. Additionally, adverse effects in 
clinical practice may go unnoticed, as people simply don’t return for further treatment. It 
should be noted that some unpleasant experiences are not necessarily harmful, possibly 
being part of recovery processes (Fosha, 2006; Gunnarsdottir & Jonsdottir, 2010). 
Delayed onset muscle soreness after intense exercise is a common example (Cheung, 
Hume, & Maxwell, 2003). Even so, some of these effects could be indicators of harm, 
whether it is physiological or psychological, and should be acknowledged to stimulate 
further enquiry on the topic. In this intervention, if it was delivered as intended, increases 
in pain and distribution would not exceed tolerable levels. Therefore, for this project, 
adverse effects were precisely defined a priori by what were considered unpredicted or 
intolerable effects. 
Potential adverse effect was considered as: 
1. intolerable psychological distress that the individual receiving treatment 
attributed to research participation, 
2. general symptoms with a temporal  association to treatment sessions,  
 
or had all of the following criteria; 
1. Development of a new pain site or increase in pain compared to highest baseline 
measurement on VAS scale, 
2. pain beyond 72 hours post treatment, 
3. pain interferes with activities that causes distress, 




The principles of these criteria were written into the research protocol but only 2, 3, and 4 
were stipulated a priori. The definition of adverse effect was refined during the course of 
intervention delivery when this issue was confronted.  
To deal with adverse effects, principal- (RG) or co-investigator (WT) (both medical 
practitioners) were alerted of any occurrence of abnormal pain or if participants 
developed new pain that persisted beyond 72 hours, or if any significant adverse effects 
or emergent medical illness occurred during or after treatment sessions. Participants 
were re-assured they could withdraw at any time. If they wanted to continue, they were to 
be asked to contact RG to assess continued participation. Decisions to terminate a study 
prioritised the participant’s wellbeing and was made on medical grounds, or if massage 
therapy was contra-indicated. This was followed up with appropriate communication 
with the participant’s general practitioner. Reasons for withdrawal or termination were 
noted in the Research Activity Log and assessed whether they were related to the study 
procedures. 
3.7  Ethics 
Informed consent was obtained from the participants in writing, after they had the 
opportunity to meet the practitioner–researcher and view the clinic where the 
intervention was delivered. This proved to be an appropriate strategy, as some questions 
about the practitioner–researcher and the research–setting were best answered in 
person. For example, participant 5 was concerned about camera angles showing the face, 
participant 4 wanted to know if the practitioner–researcher whom they met at the 
enrolment appointment, was going to be the massage therapist delivering the 
intervention.  
Consent for the collection of video data was addressed by a specific clause on the consent 
form. Other ethical issues pertained to intervention delivery and preservation of 
participant’s anonymity, whilst collecting detailed identifying information typical of SCED 
research. Therefore basic demographic characteristics have been reported, but details 
about occupation and other specific activities have not been. These details were only 
relevant to the individualisation of the interventions delivery. The intervention was 
delivered within the scope of practice of the practitioner–researcher, outlined by the 
Massage New Zealand (2018) Code of Ethics. This study was conducted in full 
conformance with principles of the “Declaration of Helsinki”, and within the laws and 




Participants received the intervention at no cost to them, and were not compensated for 
their participation in this study. However, they all accepted a complimentary 1 ½ hour 
massage at the end of data collection and this may have provided some incentive to 
complete the follow up phase. The intervention has been made available to the study 
participants as a private practice service, initiated only by enquiry from the participants. 
The intervention under study was developed by practitioner-researcher (HV). Therefore,  
intervention evaluation will inform HVs private practice which stood to gain promotion 
from favourable study outcomes. Thus it was considered important to conduct the 
research as rigorously as possible, which would include a fidelity assessment. However, 
this was beyond the scope of this Master’s thesis and the video data has been retained for 
future analysis.  
Accident and injury of the participant, or damage to any personal property, during the 
course of visits to the practitioner–researcher’s clinic, was covered by Health Professional 
Indemnity Insurance and Public Liability Insurance provided by Aon New Zealand, policy 
number 80 0015915 PLI. Approval for this research project was obtained from the 
University of Otago Human Ethics Committee (Health) H17/063; see Appendix A). 
3.8  Data Analysis 
Data analysis of SCEDs has evolved, from traditional visual inspection of longitudinally 
plotted repeated measures, to include various analytical techniques. Each of these 
techniques have strengths and limitations depending on the nature of the data being 
analysed (Manolov & Solanas, 2018; Ottenbacher, 1992). Visual analysis involves 
comparison of phase—levels (means), trends (slope), and variability (standard 
deviations) of the data points (Kratochwill et al., 2010). It also includes assessment of the 
immediacy of effect, overlap, and data consistency. Immediacy of effect analyses how soon 
the consequences of phase change is demonstrated in the data point series, relative to, the 
predicted immediacy of effect (Kratochwill et al.). Data overlap between phases, 
expressed as non-overlap, is quantified by various techniques, providing plausible effect 
sizes.  However, these have inherent weaknesses that should be evaluated on a case by 
case basis (Parker, Vannest, & Davis, 2011; Shadish et al., 2008). Consistency of the data, 
ascertains whether data in phases under the same conditions have similar characteristics 
(Kratochwill et al.). Better phase consistency increases the confidence in the results of the 




The planned data analysis submitted to ANZCTR included: visual analysis, statistical 
comparison of phase means, slope and level change, and meta-analysis. The ANZCTR data 
analysis protocol was comprehensive, as might be required if results of this intervention 
are published in peer-reviewed literature.  The results presented here have been 
simplified for the purpose of this Master’s thesis. The principles of SCED analysis were 
honoured, without application of the more complex analytical techniques. Assessment of 
whether enough B1 data was collected to enable analysis is not included. This was because 
comparison of baseline A and follow-up data B2 (with abundant data points) was 
sufficient to test the main hypothesis.  
Differences between baseline phase A and follow-up phase B2, for individual subjects, and 
each outcome variable (mean LBP pain intensity, number of low back painful sites, and 
pain interference score), were assessed longitudinally, using visual analysis of plotted 
data and a measure of data overlap. Comments are made about visual inspection of the 
data slope and variability, which have implications for interpretation of the results. Also 
calculation of the phase mean level differences, provides a descriptive indication of level 
change. Before it was analysed, the data required conversion from the PainQuILT website, 
cleaning, and reformatting. 
 Data conversion  
The outcome measurement data for each SCE was downloaded as a CSV file, weekly or 
fortnightly, from the practitioner–researcher’s log on the PainQuILT website. Each saved 
PainQuILT entry contained: a time stamp, list of pain locations, the corresponding pain 
descriptors and intensity, comments if added, and pain interference survey answers.   
 Data Cleaning 
The downloaded PainQuILT data needed to be cleaned of outliers to the measurement 
schedule. Some records were not completed during the EMA time frames, and a few user 
problems occurred that required some data lines to be combined. In reporting of EMAs, it 
is recommended that criteria of timely response and how outliers will be handled, are 
determined a priori (Stone & Shiffman, 2002).  
A timely response to the participant’s outcome measurement EMA time was, reasonably 
determined, one hour either side of their elected time. Also records, immediately pre- and 
post- treatment sessions, served the stated purpose of monitoring the immediate effects 




analysis. However, neither the definition of ‘immediately pre-and post- session’ or how 
outliers would be handled were explicitly defined in the study protocol. Therefore, some 
minor post hoc decisions were made regarding exclusion of some data points.   
The data during the intervention delivery phase were plotted but not analysed for this 
thesis. However, the data in this phase was cleaned so that the plots showed continuous 
data that were consistently collected. Most immediately pre- and post- treatment session 
records were excluded.  These recordings were not within the EMA time frames and this 
is how they were identified, then checked against the treatment session dates. Pre-
treatment session records within the EMA time frame were not excluded. Any post–
treatment session records within EMA time frames were excluded because the treatment 
session likely affected their normal daily pain levels.  
During data collection, it became evident that some timely PainQuILT records would not 
be valid. Even though SCED research does not usually exclude data points that are 
extreme outliers (Kratochwill et al., 2010) it was decided to exclude data collected outside 
of the experimental conditions, reducing data variability caused by unusual events like 
international travel. However, some data outliers remained. The experimental conditions 
measured outcomes within a repeated time interval that was relative to time of rising in 
the morning. Measurements that occurred due to transit of participants during 
international travel, or were completed for reasons other than an EMA (for example when 
participants were practising using the PainQuILT) were excluded. These were identified 
in the records, from the participants comments written in the PainQuILT. 
 Data Reformatting 
After the data was cleaned it needed reformatting for plotting and analyses. The 
participants cleaned CSV data files were saved as Excel workbooks. The raw PainQuILT 
data, when downloaded, contained several lines of data delimited by carriage returns, as 
well as comma delimited items within a line. Data reformatting, separated out this 
information into single cells. Once this was completed, the site specific, low back pain data 
needed to be identified and extracted.  All of the steps of the data reformatting process is 
explained in Appendix I. 
When the data was being reformatted, it was noticed that the Left- and Right-Hip sites 
were sometimes replicated. It was discovered, this occurred because the left and right 




posterior views of the mannequin. There was no way to distinguish between the anterior 
and posterior selected hip regions. Therefore, the total number of low back pain sites had 
to be increased to 10.  Conceptually this made anatomical sense because the lateral aspect 
of the hip corresponds to the gluteus medius and minimus muscles, they have anterior 
and posterior origins and are continuous with the other low back musculature. The sites 
were:  
1. Left-Low Back,  
2. Lower Mid-Spine,   
3. Right-Low Back,  
4. Left-hip (anterior),  
5. Right-Hip (anterior),  
6. Left-Hip (posterior),  
7. Right-Hip (posterior),  
8. Left-Buttock,  
9. Tail Bone, 
10. Right-Buttock. 
 Statistical techniques 
The statistical techniques used to compare Baseline Phase A with Follow-up Phase B2 
were a modified version of Percentage of All Non-Overlapping Data (PAND). The mean 
level shift and visual inspections of slope and variability were not statistically tested. The 
auto-correlated nature of the data rendered appropriate analysis too complex for the 
scope of this thesis.  
3.8.4.1 Percentage of All Non-Overlapping Points (PAND) 
Overlap indices are useful to quantify the change in level between phases, elucidating an 
effect size. They are usually less affected by extreme outliers, which can overweight 
means affecting their comparison (Parker et al., 2011). This is because overlap indices 
compare the relative position of the points. In other words, it is a binary value of whether 
the phase A point is above/below the highest/lowest phase B point. They are not 
calculated from the values of points, and do not require parametric assumptions. 
However, for some data sets, calculation of confidence intervals and p values is reasonable 
but only if the phases are not greatly affected by trends (in time), such as, regression to 




overlap indices is that they do not account for baseline trends (Parker et al., 2011), thus 
are best suited to stable conditions. 
PAND is a conceptually straight forward overlap index. It has been demonstrated to 
correlate well (0.93) to the similar but more complex, Non Overlap of All Pairs (NAP). NAP 
may have greater external validity than PAND, as it utilises more comparisons of data 
points across the phases, but PAND has been demonstrated to be more accurate— 
producing narrower confidence intervals (Parker & Vannest, 2009). Another distinct 
disadvantage of overlap indices, is their inability to show effect sizes for very successful 
interventions because of ceiling effects, when phase differences reach complete 
separation of data overlap (Parker et al., 2011). 
PAND is defined as the “percent of all data remaining after removing minimum number of 
data points which would eliminate all data overlap between phases A and B.”(Parker, 
Hagan-Burke, & Vannest, 2007). The number of non-overlapping points can be counted 
from plotted data. A horizontal line (non-overlap line) is drawn across the phases, in the 
position that allows removal of—from above and/or below the line—the least number of 
overlapping points, to leave only non-overlapping points (Parker et al., 2007). Identifying 
the least number of overlapping points can be challenging as this may require the removal 
of points across the two phases being compared. The more data points and variability in 
the data, the more difficult it becomes to sort where the non-overlap line should be 
drawn, and which points should be removed. 
For example, in Figure 3.5 to eliminate all overlap of data points: 
 for PAND line 1—13 points would be removed from below the line in phase A and 
0 points would be removed from above the line in phase B; 
 for PAND line 2—four points would be removed from below the line in phase A 
and three points would be removed from above the line in phase B; 
 for PAND line 3—two points would be removed from below the line in phase A 
and six points would be removed from above the line in phase B.  
 for PAND line 4—one point would be removed from below the line in phase a and 
ten points would be removed from above the line in phase B. 
PAND line 2 is in the best position as it delineates the minimum number of points that 





Figure 3-5. Showing three potential PAND lines. The minimum number of points removed from the plot to create 
no overlap of data can come from either phase A or phase B. 
 
PAND can be hand calculated from a graph as described above. The a priori data analysis 
protocol was based on the original recommended spreadsheet sorting method for 
calculating PAND (Parker et al., 2007). However, this analysis was found to produce 
inconsistent results when applied to the data of SCE-1. SCE-1 has a large number of points 
of equal value across the phases making it particularly vulnerable to the randomised 
element of sorting method described by Parker et al (2007). The problem of inconsistent 
results with this method is confirmed in other literature (Shadish et al., 2008), which has 
been recognised by the authors of the oringnal analysis technique (Parker et al.,2011). 
They now recommend only applying the hand calculation method, even though one of 
their original criticisms of this method is its vulnerability to human error (Parker et al., 
2007). A call has been made for development of a computational algorithm to achieve the 
sorting of ‘least number of overlapping points’ (Shadish et al., 2008).  No more recent 
literature addressing this was identified. It now appears that PAND has fallen out of 
favour, being replaced by Non-overlap of All Pairs (NAP) (Manolov & Solanas, 2018; 
Parker et al., 2011). However if it is accurately calculated, PAND has been shown to yield 
results with narrower confidence intervals than NAP (Parker & Vannest, 2009).  
The plotted data in these SCEs is complex enough to present a challenge confidently 
identify the non-overlap line manually. Therefore, rather than counting from the plotted 
data, Excel formulas were used to identify overlapping data points. This required  a re-
stating of the definition of overlapping data, expressed in the first two points of our data 
analysis process outlined below. Effectively, the least percentage of overlapping data in A 









problems exist with this method. The number of overlapping points identified can only 
belong to either phase A or phase B2, when it is possible the least number of overlapping 
points could be found distributed across phase A and B2 (as shown in Figure 3.5).  The 
percentage of overlap is calculated from the most extreme data point, which is the most 
unreliable. This second problem is also a weakness of the similar overlap index, 
Percentage of Non-overlapping Data (PND) (Parker et al., 2009). For example, PND selects 
the single highest point in phase A and calculates the percentage of all phase B data points 
that are above this.  
For the purposes of this Master’s level thesis the method we have used to identify data 
overlap was considered adequate to demonstrate; the concept of analysing non-
overlapping data across phases, and a method of calculating effect size with confidence 
intervals. Thus producing a quantified indication of the interventions effectiveness and 
accuracy of the result. In addition to, introducing the student (practitioner–researcher 
HV) to the various protocols and challenges of analysing SCED research studies.   
The effect size is directly interpreted from the Phi statistic, obtained from the cross-
tabulation of high/low data characteristic with phase A/B (see Table 3.4). This is a 
significant advantage to the PAND approach. Phi may range from 0 to 1, with values closer 
to 1 indicating nearer and nearer complete separation of the data between phases. 
Co-investigator WT determined the new data sorting steps required to apply the PAND 
concept to each of the SCEs data sets. The entire process that was used to calculate PAND 
is detailed (HV) here: 
1. First it was defined that A-phase data should be higher than B2-phase data for all 
of the outcomes, if the intervention produced an effect. This is because the 
intervention was expected to: reduce the Mean Pain Intensity of the Low Back 





2. For every outcome, Excel formulas were entered into each SCEs spreadsheet to 
identify overlapping points that produced the count of low A-phase scores that 
overlap (i.e. were lower than) the highest B2-phase score, and the count of high B2-
phase scores that overlap (i.e. were higher than) the lowest A-phase score. The 
overlapping scores were assigned the value of “1”, non-overlapping scores were 
assigned the value of “0”. For example, =IF(B2<=MAX($B$13:$B$45),"1","0") and 
=IF(B13>=MIN($B$2:$B$11),"1","0"). The count of overlapping scores was then 
totalled for each phase. Figure 3.6 shows how the overlapping points are sorted. 
3. The PAND 2 x 2 contingency table (Table 3-4) was completed for each outcome 
across all the SCEs. Note that variables b and c are equal to half of the minimum 
count of the overlapping scores of the phases. Variables a and d are equal to the 
total number of data points in the respective phase (n) minus half the minimum 
count of overlapping points out of Phase A or Phase B2. 
4. Proportion of overlapping points (POP) was calculated by dividing the minimum 
count (of phase A and phase B) of overlapping points by the total number of data 
points.  
POP= min{count of overlapping low As, count of overlapping high B’s}/nA + nB 
5. Percentage of All Non-Overlapping Data (PAND) was calculated. PAND=1-POP 
6. Effect size is indicated by the Phi statistic. Phi is the correlation between the data’s 
characteristic (high or low) and location (phase A or B2). This was calculated from 
each PAND table. 





Table 3-4. Construction of the Modified PAND 2x2 Contingency Table 
Outcome: 
Expected result:     High A /Low B2 
Data 
Characteristic 
Phase A (n=nA) Phase B2 (n=nB) 
High a=Non-overlapping low scores in A. 
  =nA - c 
 
b=Overlapping high scores in B2 
  =min{count of overlapping low A’s, 
             Count of overlapping high B2’s}/2 
Low c=Overlapping low scores in A 
  =min{count of overlapping low A’s,                 
         count of overlapping high B’s}/2 
d=Non-overlapping low scores in B2 
  =nB - b 
Total nA=a+c nB=b+d 
   
 
 
Figure 3-6. Modified PAND Data Overlap Sorting Method 
3.8.4.2 Mean level shift 
One of PANDs weaknesses is the inability to produce an indication of effect size in very 
successful interventions (Parker et al., 2007). This is because the value of the data points 
are not considered in calculating PAND, which means when no data overlaps across the 
phases, the quantification of the effect size is not possible—100% of non-overlapping data 
is the ceiling. Therefore a simple comparison of phase means can give an indication of 
effect size magnitude when the ceiling effects occur in the overlap methods. Mean level 
shift was calculated by the difference between the Phase A mean and Phase B2 mean but 
this has not been statistically tested, although the statistical significance of the difference 
Overlapping high B’s 
Overlapping low A’s 
Lowest A point that 
high B’s overlap 
Highest B point that 





in phase means can be somewhat inferred from the p-value associated with the phi 
estimate.  
3.8.4.3 Data slope and variability 
Comparison of phase data slope and variability are used to describe the patterns of data 
over time, and deviations from the extrapolated patterns can indicate intervention effects 
(Kratochwill et al., 2010; Manolov & Moeyaert, 2017). Impressions from the visual data 
should correlate to the analytical results.  
3.9  Procedural Changes 
Several procedural changes were made when problems were either encountered or 
foreseen. Detail about these changes, is discussed in the appropriate method and results 
sections, and are highlighted below. 
• Adaptations to the intervention delivery were made due to adverse events. The 
characteristics of adverse effects was determined a priori. However, this was 
found to be inadequate, so a comprehensive operational definition and 
management plan for adverse effects was developed during phase B. This is 
elaborated on in the adverse effects chapter sections 4.8 and 5.3. 
• Timing of Phase B2 follow-up measurements was changed. This was because the 
original schedule, once per week for 12 weeks, poorly mirrored the data collection 
conditions of the baseline phase A. See 3.4.1.1 for the new schedule and for the 
Ethics Committee application to change the protocol (Appendix A) 
• Aspects of the intervention delivery were changed, due to individualisation of the 
treatment plan that prioritised participant’s wellbeing. This applied to P1 and P4, 
and details are recorded in chapter sections 5.4. 
• Intervention stages, were also difficult to adhere to when attending to the 
individual needs of each participant, and this effected the intended Breathing 
Education treatment of the intervention, mentioned in chapter section 3.6.5. The a 
priori three stage intervention is detailed in the treatment manual section (p. 15). 
• The secondary hypothesis was dropped from the final analysis. This was because 
the practitioner–researcher did not foresee, when writing the research protocol, 
the complexity of this task, beyond the scope of a Master’s thesis project. The B1 
sub phase and intervention phase baseline data collected, has been retained for 




• The planned data analysis that was submitted to ANZCTR was simplified, also to 
remain within the scope of Masters level project. A summary of the changes are 
given in section 4.9. 
• The statistical technique PAND was discovered to have flaws in its data sorting 
method. The data sorting method was modified, but the issue was resolved only 





Chapter 4 Results 
The purpose of this research project was to investigate whether GRM is an effective 
ingredient of a massage therapy intervention for persistent musculoskeletal pain. The 
treatment is very different to usual massage therapy so evidence of benefit is needed to 
justify its inclusion in treatment sessions. Pain and functional outcomes of participants 
that received a GRM CLBP intervention were measured over a baseline phase, 
intervention delivery, and post intervention follow-up phase. The characteristics of the 
participants and the intervention they received identify particular features that may have 
influenced the data points. Adverse effects and how they were handled were also 
recorded, with judgments on whether these were attributable to the intervention.  
4.1  Participant Recruitment and Overview 
Figure 4.1 shows the flow of participants through the single case experiments. Nine 
people responded to the study advertisements, and were contacted by the intermediary 
person, in the order that their emails were received. Of the nine respondents, seven were 
screened for eligibility, one was ineligible, another declined, five met the inclusion 
criteria, and two were wait–listed for inclusion, if anyone withdrew before completion of 
their baseline phase. All five included participants were enrolled in an experiment, 
however participant three withdrew after week three of the intervention phase, meaning 







Figure 4-1. Flow of Participants Through Single Case Experiments 
 
Individual adults with CLBP screened 
from the general population  
(n=9) 
 
Assessed for eligibility  
(n=7) 
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• Did not meet inclusion 
criteria (n=1) 
• Refused participation due to 
inconsistent internet access 
(n=1) 
Wait listed (n=2) 






Single Case Experiments that 
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analysis of primary hypothesis 
(n=4) 
Discontinued Intervention (n=1) 
 Received 25% of 
Intervention 








4.2  Participant Characteristics 
Table 4.1 presents demographics, work and insurance status, smoking, and activity levels, 
for all five participants. Additional information was collected with the participant’s 
history (ethics approved), which is part of standard massage therapy assessment, for the 
purpose of treatment planning. Some of this information is reported here, as it provides 
both biomedical and psychosocial variables recommended in minimum data sets for CLBP 
research as well as other background information required for a responder analysis (Deyo 
et al., 2014). Table 4.2 contains the participant’s self-reported conditions, and treatment 
history, for both back pain and co-morbidities. 
Table 4.3 summarises subjective LBP characteristics reported by each participant, 
including information about pain variability in answer to the questions: “What makes it 
[LBP] worse?” and “What makes it [LBP] better?” This information was needed for 
treatment planning. Body regions known to be affected by certain postural positions or 
movements were targeted in the intervention delivery. Participants activities informed 
which body regions were prioritised. This evolved over the course of the intervention, as 
some participants increased and diversified their activities. Table 4.4 highlights the basic 
postural and movement characteristics, observed in participants, at initial assessment. 
Identifying details have been omitted in this report, but were collected to enable tailoring 
of each intervention. 
Positive expectations of a therapy may lead to placebo effects. Reported in the baseline 
characteristics, were the participants previous experience of massage therapy (Table 4.2), 
collected in the participant information and history sheet (Appendix F). In this research 
P1, and-4 had positive experiences of massage for LBP delivered by a physiotherapist. P2 
had previous negative experience massage for LBP finding it painful. P5 found 











Table 4-1. Participant Demographic Characteristics and Self-Reported Contextual Factors. 
No. Gender Age (years) Weight (kg) Ethnic group Work Status 
Compensation 
(Insurance or ACC) 
Education Exercise , recreation, hobbies Smoker Stress 
P1 Male 75–89 60 European (NZ) Retired Nil Secondary Active No No 
P2 Male 45–59 83 European (NZ) Working Nil Tertiary Active No Low 
P3 Male 60–74 108 
 
European Semi-retired Nil Declined to answer Active No No 
P4 Female 75–89 102 European Retired Nil Secondary Active No Low 
P5 Female 45–59 53 Maori 
 








Table 4-2. Participants Self-Reported Co-morbid Conditions and Treatment History. 
No. Conditions and diagnoses Current treatments Previous treatments Effective treatment 
P1 Co-morbid medical condition. Statins, Losec Massage, physiotherapy. Medical management of co-morbid 
conditions. Physiotherapy partly 
helped back pain. 
P2 Headaches, sleep disturbance, inflammation 
and pain. 
None, stopped using 
pain medications as 
wants to understand 
what is influencing it. 
Over the counter pain relief 
medications when needed, 
Massage. 
Pain medications. 
Massage not helpful as was painful. 
P3 Headaches, sleep disturbance, co-morbid 
medical conditions. 
Over the counter pain 
relief for low back pain, 
medication for high 
blood pressure. 
Spinal surgery. 
Acupuncture for low back pain. 
 
Medical management of co-morbid 
conditions.  
Pain medications. 
Acupuncture helped low back pain 
for a few months.  
P4 Sleep disturbance, co-morbid medical 
conditions, leg length discrepancy-right leg 
shorter after total hip arthroplasty. 
Dietary management  
Over the counter pain 
medications when low 
back pain flares up, 
(stomach unable to 
tolerate continuous 
dose). 
Abdominal surgery, right total hip 
arthroplasty, Orthopaedic specialist 
follow-up care for back pain. 
Physiotherapy and massage for low 
back pain. 
 
Medical management of co-morbid 
conditions.  
Pain medications for flare-ups. 
Physiotherapy massage helped low 
back pain for a few months. 
P5 Sleep disturbance, co-morbid medical 
conditions. 
Insulin Abdominal Surgery 
Acupuncture. 
Medical management of co-morbid 
conditions. Acupuncture helps ease 





Table 4-3. Participants Subjective Low Back Pain Characteristics. 
No. Location of Pain When did it start What makes it 
better 
What makes it worse Difficulty lying  
P1 Left low back and 
buttock, extends down 
left leg and sometimes 
catches and jumps 
down to calf. 
Since working in a labour intensive job. Don’t know but sometimes it is aggravated. None. 
P2 Entire back, low back, 
left anterior and lateral 
upper leg. 
Low back pain started over 20 years ago, 
worse over past two years. 
Activity and using 
back muscles. 
Inactivity and golf None. 
P3 Lower back, right 
shoulder, right hand 
and fingers. 
Spinal trauma 50 years ago, another two 
incidents of serious trauma 21 years ago, 
and one year ago.  
Warmth and bed 
rest. 
Cold weather worsens low back and 
right ankle pain. 
Walking more than 300 metres 
limited by low back pain. 
Right shoulder aggravated by 
painting house. 
On front. 
P4 Lower back, right knee, 
left groin, left ankle, left 
hip. 
Low back pain started after right hip 
replacement five years ago. 
Sitting and rest. Physiotherapy spinal extension 
exercises, 
Long periods of standing up straight, 
lying on left side at night. 
On front and left 
side. 
P5 Lower back Started suddenly one day when out 
walking in the middle of course of 
radiation therapy.  
Activity, ergonomic 
kneeling chair 
better than normal 
chair as it relieves 
pressure pain on 
low back. 
Long periods of sitting. Pain worse at 
end of work day from a combination 
of job stress and sitting/driving. 






Table 4-4. Practitioner Observations of Participants Basic Posture and Movement Characteristics. 
No. Standing Posture Movement Breathing 
mechanics 
P1 Left shoulder elevated, mild bilateral shoulder 
protraction, right patella elevated, bilateral pes planus. 
General stiffness in active hip ranges of motion, bilateral 
plantar flexion weakness, limited bilateral ankle passive 
and active mobility with limited plantar flexion strength, 
bilateral rigid mid and forefoot. 
Thoracic pattern 
though nose. 
P2 Forward flexion of thoracic spine and head-forward 
position culminating in weight forward of centre of 
gravity, mild bilateral shoulder protraction, dropped 
longitudinal arch of right foot. 
General stiffness in active hip ranges of motion, 




P3 Head tilt to the right, right shoulder protraction and 
internal rotation, right shoulder and pelvis lower than left, 
anterior pelvic tilt. 
General stiffness in active hip ranges of motion, very 
limited active range of motion of entire spine and no 
forward flexion, bony apposition of right ankle plantar 
and dorsi flexion. 
Apical pattern 
though nose. 
P4 Forward head posture, bilateral shoulder protraction and 
internal rotation, excess thoracic kyphosis, right shoulder 
and pelvis lower than left, anterior pelvic tilt, bilateral 
dropped longitudinal arches of feet. 
Slow and cautious ambulation, difficulty with sit to stand. 
Limited left hip extension, limited bilateral passive and 




P5 Head forward posture, bilateral shoulder protraction and 
internal rotation, right shoulder elevated. 
Slow ambulation due to low back pain, good strength sit 
to stand movement with control of hip-knee alignment. 






 Participant 1 
P1 is a 65-79 year old male, NZ European, has secondary school education, is a non-
smoker and weighs 68 kgs. He has previously experienced massage therapy and had 
physiotherapy treatment for his back pain which was somewhat helpful. P1 is retired and 
his LBP started years ago whilst he was working in a labour intensive trade, initially 
located higher up around the lumbar spine. A year prior to recruitment the pain shifted 
caudally being felt around the hips and pelvis. The pain was mostly on the left side and 
occasionally extended down into the posterior lower leg. The pain was unpredictable as 
the participant did not know what aggravated it or what made it feel better. P1 walks for 
exercise every morning. 
At initial assessment, in standing posture, P1 had an elevated left shoulder, mild bilateral 
shoulder protraction, the right patella was elevated and had bilateral pes planus. He 
demonstrated weak plantar flexion when walking and limited range of motion in both 
plantar- and dorsi-flexion. The mid and forefoot regions were rigid on palpation. 
Application of GRM revealed general stiffness of the hip joints with limited external and 
internal rotation. When lying supine, P1 was observed to breathe with a thoracic pattern 
and through the nose.  
 Participant 2 
P2 is a 45–59 year old male, NZ European, has tertiary education, is a non-smoker and 
weighs 83 kgs. He is employed and reported a low level of stress. Unrelated to a recent 
illness, P2 had been experiencing headaches, sleep disturbance, inflammation, numbness 
and tingling in legs. He had used over the counter pain medications when needed which 
helped, but was no longer using them because he wanted to understand what affected his 
back pain. His previous experience of massage therapy was painful and was not helpful. 
The low back pain started over 20 years prior, and it had been worse for the past two 
years. The current pain was located in the upper and lower back regions, left anterior and 
lateral upper leg. P2 predicted pain increases after playing golf, and periods of inactivity 
also made it worse. Moving about and using the muscles of the back decreased the pain. 
P2 is active daily, exercising during recreational activities. 
At initial assessment, in standing posture, P2 had head forward position with flexion of 
the thoracic spine that culminated in the upper body being forward of the centre of 
gravity plum line. He showed mild bilateral shoulder protraction and dropped 




mobility compared to the right. Application of GRM revealed general stiffness of the hip 
joints with limited external and internal rotation. When lying supine P2 was observed to 
breathe with a diaphragmatic pattern through the nose. 
 Participant 3 
P3 withdrew after having received 25% of the intervention.  His characteristics are 
reported because his withdrawal indicates that some people may not tolerate the GRM 
treatment. P3 is a 60–74 year old male, European, non-smoker and weighed 108 kgs. He is 
semi-retired. He reported no life stress. P3 experienced headaches, and pain in the right 
anterior shoulder. His conditions were medically managed and he used over the counter 
medications for pain relief.  Years earlier he had spinal surgery, and received a course of 
acupuncture for back pain which did help reduce back pain for a few months.  The low 
back pain started over 50 years prior, after spinal trauma, and was  further aggravated by 
two more serious trauma events. The pain was located in the lower back region, right 
shoulder, hands and fingers. P3 predicted back pain and ankle pain increases with cold 
weather, the right shoulder pain was aggravated with use. Low back pain limited how far 
he could walk. P3 recently started gentle exercise. 
At initial assessment, in standing posture, P3 had a right tilt of the head, the right shoulder 
was protracted and internally rotated, the right shoulder and right iliac crest were lower 
than the left side. The entire pelvis was anteriorly rotated (for men exceeding 5 degrees 
difference from level between the PSIS and ASIS). The right ankle had bony apposition to 
movements of dorsi- and plantar-flexion. P3 had very limited active flexion/extension 
movement of his entire spine and with application of GRM revealed general stiffness of 
the hip joints with limited external and internal rotation. When lying supine P3 was 
observed to breathe with an apical pattern through the nose. 
 Participant 4 
P4 is a 75–89 year old female, European, non-smoker and weighed 102 kgs. She had 
secondary education, was retired and reported low levels of stress. She experienced sleep 
disturbance, and had medically managed co-morbid conditions.  Total hip arthroplasty hip 
5 years prior, had shortened her right leg, after which her low back pain started. She 
continued to get follow-up orthopaedic care, but this was not helpful. Sitting and rest 
eased her back pain, and long periods of sitting predictably made it worse. Physiotherapy 
spinal extension exercises also aggravated it as did long periods of standing up straight or 




medications for flare ups was limited by gastrointestinal side effects. Physiotherapy 
massage did help ease the back pain for a few months. At time of enrolment P4 was active 
and returning to gentle exercise. 
At initial assessment, in standing posture, P4 had head forward position, bilateral 
shoulder protraction and internal rotation, and excess thoracic kyphosis. The right 
shoulder and iliac crest was lower than the left, which was consistent with the appearance 
of a shorter right leg when lying supine. The entire pelvis was anteriorly tilted (for women 
exceeding 15 degrees difference from level between the PSIS and ASIS). She had bilateral 
dropped longitudinal arches of the feet, limited ankle mobility and weak plantar flexion. 
P4s ambulation was slow and cautious with a dip on the right side, she also had difficulty 
with the sit to stand movement.  With application of GRM the left hip was painful and had 
limited flexion compared to the right. n the left ankle had decreased mobility compared to 
the right. When lying supine P2 was observed to breathe with an apical pattern through 
the nose. 
During the intervention delivery phase P4 received two other external interventions 
which contributed to increased confidence to move about which were also likely to have 
contributed to reductions of both LBP and Pain Interference. She was assessed by 
Community Physiotherapy Services and was prescribed a walking frame which she first 
used just before treatment 7,  and a podiatrist prescribed a 9 mm heel lift for her 
measured leg length discrepancy just before treatment 8, which she reported made 
walking much easier. She reported only using the walker first thing in the morning after 
rising. Towards the end of the intervention she strained her low back in the sacroiliac 
region with increased pain but then recovered.  
 Participant 5 
P5 is a 45–59 year old female, NZ Maori, non-smoker and weighed 56 kgs. She had tertiary 
level education, was employed, reported no life stress, but did report work related stress 
that contributed to tension and back pain. She had medically managed co-morbid 
conditions. She also experienced sleep disturbance due to back pain. Her low back pain 
started suddenly when out walking one day, two years ago during her course of radiation 
therapy. P5 could predict increases in pain at the end of a work day after long periods of 
sitting. She used an ergonomic kneeling chair in the office which reduced the pain caused 
by pressure on her low back. Acupuncture treatment sessions helped to ease back pain for 




over, but it eased overnight as her body relaxed. Pain was the lowest in the mornings. P5 
enjoyed walking for exercise. 
At initial assessment, in standing posture, P5 had head forward position, bilateral 
shoulder protraction and internal rotation, with an elevated right shoulder. She also had 
limited ankle mobility. P5s ambulation was slow and cautious but she was not deficient in 
plantar flexion strength or sit to stand movements. When lying supine P5 was observed to 
breathe with an apical pattern through the mouth. 
4.3  Overview of SCE Phases and Durations 
Figure 4.2 depicts the roll-out of baselines, intervention treatment sessions, and follow-up 
phases for all the SCEs. Advertising began in July 2017, recruitment took place August-
September 2017, and follow-up was completed in April 2018. SCE-1 and SCE-2 had 
baselines of six weeks, SCE-3 had a four-week baseline, SCE-4 and SCE-5 had seven-week 
baselines.  
The exposure phase was planned for 12 weeks, but some variation occurred across the 
experiments, due to adverse effects of increased pain and additional treatment sessions. 
An exposure wash out period, of three days, was added after the last treatment session. 
SCE-1 and SCE-4 had approximately 14 weeks of exposure. SCE-2 and SCE-5 had 
approximately 13 weeks of exposure, whilst SCE-3 terminated after three weeks of 
exposure. The follow-up phase was 12 weeks, except for SCE-2 which was 13 weeks, as 
Participant 2 continued their EMAs an extra week. These data points were included in the 
analysis.  
The method of this research project, involved various levels of researcher–participant 
contacts across the phases, beginning at the enrolment appointment (Table 4.5). 
Researcher–participant contacts, are the number of occurrences that the practitioner–
researcher had contact with each participant, from the day of enrolment until the last day 
of follow-up phase data collection. The contacts included: treatment sessions, study 
administrative tasks, technical support for PainQuILT user problems, rescheduling of 
treatment sessions, and review of adverse effects. All of these practitioner–researcher 
with participant–client contacts, can be considered to involve psychosocial interactions,  
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Figure 4-2. Showing Roll-out of Single Case Experiments (SCE) 1 to 5 with actual week of Enrolment (E), Phase A 
Baseline Control consisting of random number of weeks before, Cross-over to Phase B Intervention Exposure of 12 
or 13 weeks succeeded by, Sub-phase B2 Follow-up of 12 weeks. SCE-2 continued follow-up measurements for an 
extra week and SCE-3 terminated after three weeks of intervention exposure. Number of Treatment sessions (Rx) 
shown for each SCE in the week they were delivered. Approximate months of study occurrence indicated 
underneath diagram. 
Psychosocial aspects contribute to massage therapy interventions as non-specific effects, 
(Borrelli et al., 2005; Smith, J. et al., 2009) and measures of non-specific effects should be 
included in the fidelity assessment of intervention research (Borrelli et al., 2005). Whilst 
these are not accurately measured in this project, the number of contacts across the 
phases was recorded in the activity log. Post hoc, this can serve fidelity assessment 
requirements of number of contacts in control and intervention conditions.  
Contacts initiated by the practitioner–researcher, were regarding PainQuILT website 
status or reminders to complete EMAs, if two days in a row were missed. Communications 
from participants, were replied to via the mode they were received, and counted as one 
contact. These contacts were mostly about the rescheduling of treatment sessions, or 
problems with using the PainQuILT. Some phone calls were regarding adverse effects 
participants experienced. On one occasion, a participant approached the practitioner–
researcher in a public space to discuss current clinical status. This incident highlighted the 
conflicts the practitioner–researcher experienced in dual roles, because it was not 
possible to ignore a participant making social contact, occurring in the setting of a small 




Across the phases participants 1, 2, 4, and 5 all had a similar number (1–2) of contacts per 
week. Participant 3 had higher number (2–6) contacts per week until they withdrew in 
week three of the intervention.   
Table 4-5. Number of In-Person, Email, Text Message, and Phone Call Contacts with Participants for 
All Study Phases. 
Participant 1 2 3 4 5 
Baseline A 
Duration weeks 7 6 4 7 7 
No. of in person contacts 2 1 1 1 1 
No. of Email contacts 2 2 2 1 3 
No. of Text messages 0 1 6 0 3 
No. of Phone calls 0 0 1 2 1 
Total contacts 4 4 10 4 8 
Average per week   1   1   2   1   1 
Treatment delivery phase B 
Duration weeks 14 13 3 14 13 
No. of in person contacts 11 10 3 14 13 
No. of email contacts 2 3 1 3 1 
No. of text messages 0 0 13 0 1 
No. of phone calls 2 0 2 6 0 
Total contacts 15 13 19 23 15 
Average per week   1   1   6   2   1 
Follow Up phase B2 
Duration weeks 12 13 - 12 12 
No. of in person contacts 0 0 - 0 0 
No. of email contacts 0 0 - 0 0 
No. of text message contacts 0 2 - 0 1 
No. of phone calls 0 0 - 2 0 
Total contacts 0 2 - 2 1 





4.4  Individual Participants and SCE Results 
The following section presents each participants information, and graphs of their EMA 
outcome data. Visual inspection of plotted data for trend, variability, and level was done to 
assess the reliability of potential effects (Kratochwill et al., 2010; Tate et al., 2016). 
However, these were not analysed for this Master’s thesis. Instead comments are made, 
on the simple visual impressions of the data alongside implications for the interpretation 
of the results.  
The outcome data extracted from each PainQuILT EMA was: Mean Pain Intensity of the 
LBP Locations, Number of LBP locations, and Pain Interference Scores. Each outcome, for 
each participant, was plotted and inspected separately. To quantify the interventions’ 
effect, a comparison of baseline and follow-up phases was done, using an estimation of 
data overlap. This method is useful only when baseline data shows no meaningful trend 
(White, 1987). Therefore, in narrating these results, the baselines are first visually 
inspected for evidence of a trend. EMAs in baseline phase were expected to be stable, 
because of the research participant eligibility criteria of CLBP. Next, effect sizes are 
estimated from the modified PAND calculation, along with their statistical significance 
(Appendix L). The desired effect direction, was a lowering of all three outcomes—mean 
pain of LBP locations, number of LBP locations, and Pain Interference score, all 
represented as positive PAND and Phi values. The simple difference (non-standardised 
and not statistically tested) of phase means, has been calculated to indicate an effect size, 
when ceiling effects of the overlap method (PAND=1) limited representation of the 
magnitude of the effect. The statistical significance of the simple mean level shift, is 
inferred by the p value of the Phi estimate, when calculation was possible. Finally, any 
obvious trends in the follow-up phase data, are commented on, giving an indication of 
how stable the intervention effects are. 
Outcome measurements (EMAs) of the sub phases, three days post treatment sessions, 




 SCE-1 Visual Inspection of Plotted Outcomes and Analysis 
Visual inspection of Figure 4.3 shows no desired intervention effect in SCE-1. The 
statistical tests, for all three outcomes in SCE-1, show small or no effect.  
Mean Pain Intensity of LBP Locations, visual inspection of the baseline phase A shows no 
obvious trend, and ranges between 0–4 points. The simple mean level increased 0.5 
points. The follow-up phase B2 appears similar, with no obvious trend, also ranging 
between 0–4 points. The data give an impression of no change in Mean Pain of LBP 
Locations, and modified PAND is 0.645 associated with a small effect, Phi=0.21 (95% CI -
0.13 to 0.55), p=0.22. However this is not statistically significant. 
For Number of LBP Locations, visual inspection of Phase A clearly shows a stable and 
constant baseline at 1, with no variability or trend in the data. The mean level increased 
0.7 points. The modified PAND is 0.645 associated with a small effect of Phi=0.21(95% CI -
0.13 to 0.55), p=0.22. The data give an impression of a possible small increase of number 
of LBP locations, also indicated by a negative lower limit of the effect size, but this is not 
statistically significant. The follow-up phase B2 impression is a possible trend of increased 
back pain locations, and ranges between 1–4 points. 
For Pain Interference Score, visual inspection of the baseline phase A shows no obvious 
trend, and ranges between 0–8 points. The simple mean level decreased 0.5 points. The 
data give an impression of no change in Pain Interference, and modified PAND is 0.645 
associated with no statistically significant effect, Phi=0.21 (95% CI -0.13 to 0.55), p=0.22. 
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Figure 4-3.  Single Case Experiment-1 Outcome Measurement Data derived from PainQuILT by Day of Ecological Momentary assessment. Mean level (- - - -), PainQuILT 



























 SCE-2 Visual Inspection of Plotted Outcomes and Analysis 
Visual inspection of Figure 4.4 shows an intervention effect, in the desired direction (a 
reduction), for all three outcomes in SCE-2. Mean LBP Intensity and Pain Interference 
Score, show large effects that appear stable. Number of LBP Locations also reduced, but 
the effect is not as strong or stable during follow-up. 
For Mean Pain Intensity of LBP Locations visual inspection of the baseline Phase A data, 
give an impression of no obvious trend, and little variability, ranging between 7–9 points. 
With no data overlap between the phases, the effects size is indicated by the simple mean 
level shift, a 3.7 point reduction.  The follow-up phase B2 data, give an impression of  no 
obvious trend, and little variability, ranging between 3–5 points. The ceiling effect of the 
PAND analysis, meant no statistical test on data phase overlap could be performed. 
For Number of LBP Locations, visual inspection of baseline Phase A data give an 
impression of no obvious trend, and ranges from 5–8 locations. There was a simple mean 
level reduction of 2.2 points. The follow-up phase B2 data give an impression of a possible 
trend of increased back pain locations. Modified PAND was  0.907, associated with a  
moderate effect with Phi= 0.74 (95% CI 0.47 to 0.95), p<0.001. 
For Pain Interference Score visual inspection of the baseline phase A data give an 
impression of no obvious trend. Most of the data points showing little variability, ranging 
between 19–20 points, although there is one score of 14.  There is no data overlap 
between the phases, so effects size is indicated by the simple mean level shift of a 15.7 
point reduction.  The follow-up phase B2 data also give an impression of no obvious trend. 
Most of the data points showing little variability, ranging between 3–7 points, there is one 
score of 12. The ceiling effect of the PAND analysis meant no statistical test on data phase 
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Figure 4-4. Single Case Experiment-2 Outcome Measurement Data derived from PainQuILT by Day of Ecological Momentary Assessment. Mean level (- - - -), PainQuILT 





























 SCE-4 Visual Inspection of Plotted Outcomes and Analysis 
Visual inspection of Figure 4.5 shows an intervention effect in SCE-4, in the desired 
direction, for Pain Interference Score, and a possible effect for Mean Pain Intensity of LBP 
Locations. Number of LBP Locations appears to have increased, which was in the opposite 
direction to the intervention’s hypothesised effect.  
For Mean Pain Intensity of LBP Locations the baseline Phase A data, give an impression of 
a possible increasing trend, and ranges between 0–7 points. An interruption of dramatic 
decrease, is followed by sudden increase. The simple mean level decreased 1.5 points and 
Modified PAND was 0.655, associated with no statistically significant effect of Phi=0.24 
(95% CI 0.16 to 0.58), p= 0.20. The follow-up phase B2 data give an impression of no 
obvious trend and ranges between 2–6 points.  
For Number of LBP Locations the baseline Phase A data give an impression of a possible 
increasing trend, and ranges between 0–5 locations: An interruption of dramatic decrease, 
is followed by sudden increase. The simple mean level increased 1.7 points and the 
modified PAND is 0.655, associated with no statistically significant effect of Phi=0.24 
(95% CI -0.17  to 0.57), p=0.20. The follow-up phase B2 data give an impression of no 
obvious trend and little variability in most of the data, ranging between 4–5 locations. The 
one count of two locations, may have been residual effects of the last treatment session. 
For Pain Interference Score the baseline phase A data, give an impression of a possible 
increasing trend,  appearing to have variability ranging between 6–42 points. The simple 
mean level decreased 15.2 points, and Modified PAND was 0.862 associated with a 
moderate effect size, Phi= 0.74 (95% CI 0.36 to 0.93), p<0.001. The follow-up phase B2 
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Figure 4-5. Single Case Experiment-4 Outcome Measurement Data derived from PainQuILT by Day of Ecological Momentary Assessment. Hard copy when PainQuILT 





























 SCE-5 Visual Inspection of Plotted Outcomes and Analysis 
Visual inspection of Figure 4.6 shows an intervention effect in the desired direction, for all 
three outcomes in SCE-5. Mean LBP Intensity, and Pain Interference Score show large 
effects that appear stable. Number of LBP Locations also reduced, but the effect is not as 
strong or stable during follow-up. 
For Mean Pain Intensity of LBP Locations, baseline Phase A data, give an impression of no 
obvious trend, and most of the data shows little variability, ranging between 3–5 points.  
There is one data point of 7. With no data overlap between the phases, the effect size is 
indicated by the simple mean level shift, a 3.3 point reduction. The follow-up phase B2 
data, also give an impression of no obvious trend, and little variability, ranging between 
0–2 points. The ceiling effect of the PAND analysis meant no statistical test on data phase 
overlap could be performed. 
For Number of LBP Locations visual inspection of baseline Phase A data, give an 
impression of no obvious trend, and ranges from 1–4 locations. The simple mean level 
decreased 0.9 points and Modified PAND was 0.621, which was associated with no 
statistically significant effect Phi= 0.21 (95% CI -0.16 to 0.55), p=0.25. The follow-up 
phase B2 data, also give an impression of no obvious trend, and ranges from 0–4 
locations.  
For Pain Interference Score visual impression of the baseline phase A data, give an 
impression of a possible decreasing trend, with some variability, ranging between 6–25 
points. With no data overlap between the phases, the effects size is indicated by the 
simple mean level shift, a 9.1 point reduction. The follow-up phase B2, shows no obvious 
trend, and little variability, ranging between 0–3 points. The ceiling effect of the PAND 
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Figure 4-6. Single Case Experiment-5 Outcome Measurement Data derived from PainQuILT by Day of Ecological Momentary Assessment. Mean level (- - - -), PainQuILT 




























    
4.5  Overview of Results   
This section presents the results of each of the three outcomes, across the four SCEs 
(Table 4.6). The entire data collection period, for all SCEs combined, is 240 days. The 
graphs are stacked to show the relative timing, of each beginning Baseline phase A, the 
cross-over to Intervention Exposure phase B, and when the phases end. With visual 
inspection and vertical comparison of the data points, no evidence of threats to internal 
validity were found. This would be in the form of external uncontrolled events, appearing 
as an increase or decrease in the data values, across all participants, on the same day. 
Following are summaries of the interventions effect on each outcome, comments are 
made on the similarity or differences in response, across all SCEs. 
Figure 4.7 shows that for Mean Pain Intensity of LBP Locations there is a change in level, 
consistent with the desired intervention effect, for three of the SCEs. SCE-2 and SCE-5 
show clear effects, with Modified PAND reaching 1 . SCE-4 shows a possible small effect, 
Phi=0.24 (0.16 to 0.58), p=0.2, and SCE-1 shows no effect, Phi=0.21 (-0.13 to 0.55), 
p=0.22. 
Figure 4.8 shows that for Number of Back Pain Locations, effects are varied. An effect in 
the desired direction is only seen for SCE-2, Phi=0.74 (0.47 to 0.95), p<0.001. For SCE-1 
and SCE-4, possible increases of number of pain locations, is in the opposite direction to 
the hypothesised effect. Their respective effect sizes were Phi=0.21 (-0.13 to 0.55), p=0.22 
and Phi=0.24 (-0.17 to 0.57), p=0.20. 
Figure 4.9 shows that for Pain Interference Score, there is a change in level consistent 
with the desired intervention effect for three of the SCEs. SCE-2 and SCE-5 show clear 
effects, with Modified PAND reaching 1. SCE-4 shows a moderate effect Phi=0.7 (0.36 to 
0.93), p<0.001, and SCE-1 shows no effect, Phi=0.21 (-0.13 to 0.55), p=0.22. The Pain 
Interference score is often calculated as a mean score in situations when at least four, but 
not all of the survey questions have been answered. This was not necessary with this data, 
because the PainQuILT app requires all questions to be answered before it allows the user 
to move to the next question, meaning all participants always answered every question. 
For the purposes of an interpretable Y-axis scale, the raw Pain Interference score was 
used for the plots. To interpret the change according to the Pain Interference literature, 




    
Looking across all three outcomes (Table 4.6), no negative effects have been 
demonstrated in the participants that completed the intervention. The intervention had 
positive responses in six instances. Three of the participants improved on Pain 
Interference, and two participants had improvement in Mean Pain Intensity of LBP 
Locations, and one participant improved  in number of LBP Locations. 
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Table 4-6. Summary of Results Assessing Level Change Using Modified PAND Between Phase A and Phase B2 for Single Case Experiments 1, 2, 4, and 5. 
 SCE-1 (n=31 observations) SCE-2 (n=43 observations) SCE-4 (n=29 observations) SCE-5 (n=29 observations) 






































0.645 0.21 (-0.13 
to 0.55) 
0.22 0.907 0.74 (0.47 
to 0.95) 
<0.001 0.655 0.24 (-0.17 
to 0.57) 







0.645 0.21 (-0.13 
to 0.55) 
0.22 1.000 1.00 (NA) NA 0.862 0.70 (0.36 
to 0.93) 
<0.001 1.000 1.00 (NA) NA 
* when Phi=1, p-value and associated confidence intervals are not able to be calculated 
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Figure 4-7. Pain Intensity Comparison across Single Case Experiment 1, 2, 4 and 5 by day of Ecological Momentary Assessment from start of Baseline Data Collection. 
Hard copy when PainQuILT was off line  ( .), Mean level (- - - -), PainQuILT outcome measurements were done at the same time of day +/- 1.5 hours, PAND data 
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Figure 4-8. Number of Back Pain Locations Comparison across Single Case Experiment 1, 2, 4 and 5 by day of Ecological Momentary Assessment from start of Baseline 
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Figure 4-9. Pain Interference Score Comparison across Single Case Experiment 1, 2, 4 and 5 by day of Ecological Momentary Assessment from start of Baseline Data 
Collection. Hard copy when PainQuILT was off line (  ), Mean level (- - - -), PainQuILT outcome measurements were done at the same time of day +/- 1.5 hours, PAND 




















4.6  Overview of Interventions 
The intervention was individualised for each participant by number of treatment sessions, 
session duration, and time spent on the various treatment ingredients. Table 4.7 gives 
summarised quantities of the intervention ingredients for participants that completed the 
intervention. The GRM treatment was standardised by the essential delivery of AmG to all 
13 body regions, at every treatment session. Although, occasionally this did not occur. 
GRM treatment receipt, also may not, always have been received by every region in the 
body. The other ingredients are listed in the table alongside the participants self-reports 
of their enacted, exercise and movement ingredients. In addition, non-study related 
interventions, and new or increased physical activities have been included, because they 
likely affected outcomes. 
Due to time constrictions, occasionally body regions involving peripheral joints (elbows, 
knees, hands and feet), were left out of a treatment session. Priority focus regions (Table 
4.7), were recorded in clinical notes because they required more time than other regions 
to achieve increases in joint range of motion, or softening under palpation, or reduction of 
pain. The record of focus regions does not mean all other regions were not treated. For 
example, the overall priority regions for P2 were the right pelvis and hip, and the left 
thoracic and shoulder (Table 4.7). Occasionally P2’s peripheral regions, were treatment 
priorities as the intervention progressed. The omission of peripheral region/s from a 
treatment session was not noted. However, this would be informed by a subsequent 
assessment of adherence to the treatment manual, which is a part of fidelity assessment. 
Fidelity assessment would also inform GRM treatment receipt, by recording when 
application of AmG (joint weight support), resulted in GRM (joint movements). Validating 
the practitioner–researcher’s record of GRM activity levels in the clinical notes. 
The actual delivery of the intervention only loosely followed the three stage plan of the 
treatment manual.  The practitioner–researcher found that it was difficult to conform the 
individualised treatment plans to an a priori structure. Whilst the planned progression 
was appropriate, the four-week time frames for the stages was not. In real life clinical 
practice, this progression happens at the most appropriate time, when the previous 
treatment goals have been achieved. The pressure to progress the participant to the next 
stage, increased the intensity and dose of the treatment sessions. The previous sessions 
effects of pain levels, may not have fully washed out before the next session. This reduced 
the number of data points between sessions, which meant that often, not enough data 




needed is at least three data points before each treatment session and associated B1 sub-
phase. For this, treatment sessions should have been at least two weeks apart.  
When the protocol was designed, it was envisioned that fortnightly treatments would be 
sufficient for the clinical population enrolled in the research, and it allowed for the 
occasional weekly session. Tension existed between limiting treatment dose and intensity 
so that the effects washed out within 72 hours and needing to progress the participant 
onto the next phase of the intervention, in addition to getting results within 12 weeks. 
Details of the intervention, including time spent on each treatment, body region and the 
rationale for dose adjustments, were recorded in the clinical notes. 
Participants experience of an intervention contributes to its social validity. Manalov 
(2017) states, it must be reported if the effects are important to participants, and their 
satisfaction with the treatments. All participants that completed the intervention liked it. 
P-2 and -5, expressed that it worked for them compared to usual massage therapy. P2 
increased the days he played golf with better recovery the following day. P5 mowed her 
lawns for the first time in two years and had significantly reduced pain when rolling over 
in bed, improving sleep. P4 felt that the combination of all the interventions helped her 
walking ability and speed. P1 enjoyed the massages, saying they were the best he had ever 
had. These details were recorded in clinical notes and are included as physical activities 
that were additions to the intervention they received (Table 4.6).
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Table 4-7. Characteristics of Intervention for Participants who Completed Entire Intervention. 
Participant 1 2 4 5 
Weeks 14 13 14 13 
No. of Rx sessions 11 10 13 12 
Number of sessions containing ingredient 
AmG 11 10 11 12 
GRM 11 10 11 12 
Relaxation massage 11 10 13 12 
Directed Breathing 1 1 1 0 
Exercise/Movement  5 5 2 4 
Contact duration* (mins) 
Total 990 910 890 1055 
Upper body: Supine 180 270 265 290 
Lower body: Supine 445 240 470 265 
Upper body: Prone  120 245 40 190 
Lower body: Prone 245 155 65 295 
Occurrences of body regions as treatment session focus 
Pelvis, hip: L 11 4 11 10 
Pelvis, hip: R 5 8 8 10 
Knee: L 5 0 6 6 
Knee: R 1 3 11 4 
Foot, ankle: L 9 2 9 9 
Foot, ankle: R 6 2 8 8 
Shoulder, thoracic: L 7 9 5 6 
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Participant 1 2 4 5 
Occurrences of Body Regions as Treatment Session Focus continued 
Shoulder, thoracic: R 3 8 5 8 
Elbow, wrist, hand: L 3 5 0 2 
Elbow, wrist, hand: R 1 4 3 3 
Lumbar 7 6 6 5 
Head and neck 4 4 2  5 
Essential ingredient: GRM 
Treatment receipt level 1–4 1-3 1-3 3-5 
Other ingredients: Exercise and movement 




Quadriceps and hamstring 
stretch. 
Ankle circles. 
Barefoot beach walking. 
Shoulder extension and 
circumduction stretch. 
Shoulder retraction. 
Trunk rotation and side bend. 
Knee extension. 




Increased activities around 
home before resting. 
 
Hip flexor stretch. 
Pectoral stretch. 
Posterior shoulder rolls. 
Increased duration of 
walking. 
Other interventions, and physical activities additional to Activities of Daily Living 
 Walking daily. Increased Golf. 
Motor bike ride (700km). 
 
Codeine, Paracetamol. 
Walking frame around home. 
Heel lift, 9mm.  
Aqua jogging. 
Started doing own lawns and 
weeding garden. 





 Number of Treatment Sessions 
The participants all received similar number of active treatment sessions, ranging from 
10–13 treatment sessions over 13–14 weeks. All treatment sessions contained relaxation 
massage, a non-essential ingredient. The essential active ingredient GRM, was omitted 
from two of P4s treatment sessions, due to adverse effects that needed more time to 
recover.  
 Contact Duration 
The contact duration is the approximate time of the manual therapy component of 
treatment sessions, including Directed Breathing, excluding Posture and Movement 
education and exercises. The proportion of time spent on AmG/GRM stipulated by the 
Treatment Manual was more than 50%. This would be verified by a subsequent 
assessment of treatment adherence. 
The approximate total contact time (Table 4.7) received by the participants was recorded 
in the clinical notes. Also listed is the approximate time spent on the upper and lower 
body. It shows how each participants clinical need was different: whilst they all had low 
back pain, the amount of time spent on the upper and lower body’s, in prone and supine 
position, varied for each of them. P4 did not tolerate lying prone, and so most treatment 
was applied in the supine position. 
 Essential Ingredients: AmG to all Body Regions 
The essential active ingredient of this intervention is GRM, it is also an aspect of treatment 
receipt. GRM is achieved by the essential application of AmG to all body regions at all 
treatment sessions. In practice this is not always achieved, due to time limitations, and the 
clinical need of treatment session targets, identified by the practitioner. Each target may 
require, more or less time spent on GRM, to achieve an improvement in range of motion 
or pain reduction. The clinical notes template, contains a list of body regions alongside a 
tick box, which was used to record when body regions were a treatment session target. 
This is not a list of all the body regions treated at each session, only the regions to which 
more time was allocated, compared to other ingredients at that session. Thus the number 
of treatment targets varied for each session.  The tally of the occurrences of body regions, 
shown in Table 4.7, also could provide information for Intervention Fidelity Assessment, 
by checking the targets identified in the initial and ongoing assessments, against actual 




The level of GRM activity was subjectively rated by the practitioner on scale of 0–5. GRM 
activity corresponds to Treatment Receipt component of Intervention Fidelity. This was 
not objectively confirmed in this research. Levels 0–1 were considered AmG with no 
mobilisation, above this mobilisation occurs. Level 2–4 was considered GRM (mobilisation 
by non-volitional movement). Level 5 was non-volitional movement occurring in body 
parts the practitioner was not applying AmG (possibly evidence of neurogenic tremors 
described in the Background chapter). The levels of GRM varied across the participants, 
within body regions, and at each treatment session. The range of GRM activity across all 
sessions was between 1–4 for P1, 1–3 for P2 and P4, and 3–5 for P5.  
  Exercise and Movement 
Exercise and movement instruction was included when indicated, to consolidate 
treatment session effects, or if exercises were requested by the participants. 
Individualised exercises were prescribed for all participants. P2 and P5 had requested 
exercises to do at home. All participants reported back whether they found them 
beneficial. They also, adapted them in ways they felt worked better, as well as how to in-
corporate them into their normal routines. This was encouraged and discussed at the 
treatment sessions. Most of the exercises delivered as treatment ingredients, were 
enacted by the participants, and have been included in the intervention characteristics 
Table 4.6. Exercises that participants did not feel were productive, were not enacted, and 
excluded from the intervention description because they were unlikely to have effected 
outcomes. 
 Breathing Education 
Directed Breathing was delivered once for P1, P2, and P4, but not for P5. It was difficult to 
deliver directed breathing, as outlined in the protocol, because the clinical need of each 
participant was better served by the other treatments. 
 Other Interventions and Physical Activities During Intervention  
Physical activities were recorded in the clinical notes, for the purposes of treatment 
planning and monitoring. As, this is an intervention that targets increased movement of 
muscles and joints, other movement participants engaged in, could have had either a 
positive or a negative effect on the outcomes. Participants 2, 4, and 5 increased and 
diversified, their physical activities over the course of the intervention, and needed 
consideration in the ongoing treatment planning. P1s activity remained constant. P4 




interpretation of the results. Use of pain medications were also recorded in clinical notes, 
but have not been considered in the results.  
4.7  Outcome Measurement 
This section explains what happened during the process of PainQuILT data collection, and 
why some records were excluded from the analysis.  
 Compliance with Ecological Momentary Assessment Schedule 
The measurement schedule was set at a three to four days per week, at the same time of 
the day. At enrolment and on-boarding, the participants were asked to determine the 
most convenient time of day, and days of the week for them to complete the PainQuILT 
data collection. The actual measurement was permitted to occur one hour either side of 
the chosen time. The participants were asked to adhere to these times. However, if they 
missed a day, they could complete the record the following day, in the correct time 
interval. This meant that the day of EMA could vary, over the course of the study. 
Participants 1-5 completed 99%, 88%, 86%, 100% and, 77% of planned EMA records 
(excluding the before and after treatment sessions) respectively, time stamped within the 
stipulated time. 
Reminder texts and emails were sent to participants if they missed a day. Permission to 
do this was obtained during onboarding, as well as confirming preferred method of 
communication. Participant -1 and -4 preferred a phone call, -2 a text message, and -4 
either text or email. P2 also requested times scheduled for EMA to be sent to their 
Microsoft Outlook calendar . Participants -1 and -4 said that they entered their 
measurement schedule into their own paper calendars. The practitioner–researcher 
regularly reviewed the PainQuILT log, and entered the time-stamps of each completed 
record, into a spreadsheet containing the measurement schedule. A reminder was sent if 
the participant had missed two days in a row. After the baseline phase began, P3 
requested text reminders on the actual day that he needed to complete the PainQuILT. 
Apart from this, only five reminders were sent out across the other participants for the 
duration of the entire data collection.   
The baseline phase measurement schedule, asked participants to complete the PainQuILT 
three times per week.  The randomly assigned baseline lengths were 6, 6, 4, 7, and 7 
weeks duration. During this phase, participants 1-5, each respectively completed 100%, 




The intervention phase was planned to be 12 weeks for all participants, and they were 
asked to complete the PainQuILT up to six times per week. They each completed 84%, 
93%, 77%, 98%, and 82% of these measurements. Participant three withdrew after week 
three, for reasons unrelated to the PainQuILT, or measurement schedule.  
During the follow up phase, participants were asked to complete the PainQuILT three 
times per week for one week, then every fourth week up to week twelve. This meant 12 
records in total. Participants 1,4, and 5 all completed 100% of these records on the 
scheduled days.  P2 completed 59% of the scheduled measures but completed the 
PainQuILT on other days to make up for those missed. 
The measurement compliance rates exceeded the data analysis requirements of this 
research project. The researcher kept a diary to note problems participants experienced 
with the PainQuILT or measurement schedule. Even though participant 2 and 5 missed 
days, they completed extra records on other days. Reasons given for having missed days 
were international travel, or forgetting, due to other commitments out of their normal 
routine. P3 said they had trouble remembering because of head trauma history. It was 
recorded in the clinical notes that P1 reported extra records on days when pain was 
worse, and P5 sometimes forgot because they had no pain. The rates, did not did not drop 
over time, once the participants became confident in using the PainQuILT and the 
associated electronic device.  
The intervention was massage based, and participants received a complimentary 1 ½ 
hour massage after the follow-up phase. This was to thank them for their participation, 
and potentially to provide incentive to complete the base–line phase. Also, at this 
appointment, participants completed the PainQuILT Acceptability e-scale questionnaire.  
In conclusion, the compliance to the measurement schedule using the PainQuILT was high 
for these adult participants with CLBP, and a low number of reminder messages were 
sent.  The compliance rates were reported back to the PainQuILT developer at their 
request, and the developer considered compliance with measurement exceptionally high 
(C. Lalloo, personal communication via email, May 19, 2018).  It is possible, the 
compliance rates were influenced by the practitioner–researcher’s ongoing relationship 
with the client-participants, for the duration of the experiments. In other words, the 
practitioner–researcher efforts to deliver the massage therapy intervention, may have 




However, compliance rates during the base-line phase were also high before the 
intervention delivery began, demonstrating the acceptability of the app for tracking 
chronic pain over time, further confirming the PainQuILT’s user acceptability (Lalloo et 
al., 2014). 
 PainQuILT Data Collection Process Report 
The Task Management worksheet contained all completed PainQuILT records, alongside 
the original EMA schedule. The Activity log was used to note user and technical problems 
that occurred during data collection. User problems were resolved over a phone call,  
between the participant and researcher, and notes were kept. A few records were 
completed outside of the time frame stipulated in the protocol, these were identified and 
also noted as the data collection was being monitored.  
A few records were recorded on hard copy during the project study period, when the 
PainQuILT was off line. This occurred during the intervention phase for all participants, 
and lasted three days. A make-shift back up, pain location, intensity, and interference form 
was devised for each participant by the researcher, and emailed to them on the second 
day the site was down. This involved a complete list of all the pain sites and descriptors 
they had previously recorded, space to write the pain intensity next to each circled pain 
site, and the seven pain interference questions. Only participant 4’s measurement 
schedule was disrupted for more than one day. Participant 4, also, used this method of 
recording one other time, when she did not have access to a computer. Whilst it was not 
ideal, the hard copy records appeared to have face validity, and so were included in the 
final data set.  
P1 also preferred to complete the session records at home, on his own computer that he 
was familiar with. This meant that these records were not completed immediately before 
or immediately after treatment sessions, but were within an hour of the session, 
sufficiently timed for the purposes of monitoring the treatment delivery. All other 
treatment session records were completed by participants in the clinic immediately pre- 
and post–treatment.  
An issue that arose during data collection was that P-2 and-5 did not know when to 
complete EMAs whilst travelling internationally. To clarify, the participants were 
instructed to complete the record, at the same time of day relative to their normal daily 




points were excluded that were recorded before this issue was dealt with. A record was 
kept in the activity log of when participants were travelling and which country they were 
in. To identify invalid records, the international time zone was checked against the 
PainQuILT time stamp, on world time buddy https://www.worldtimebuddy.com/.  
 Data Cleaning 
A log of the Pacific Standard Time (PST) and date stamps that each participant completed 
the records, was kept in the Task Management worksheet of the research Excel workbook, 
along with notes about user and technical problems. The data was cleaned, after it was 
downloaded from the PainQuILT web site to a CSV file. A duplicate copy was made 
(retaining the original data) before it was re-formatted. The time stamps downloaded as 
Universal Time Co-ordinated (UTC), and so each participants EMA response interval (in 
PST) had to be converted to the equivalent UTC sampling frame. The records that needed 
deleting or cleaning—were identified in the Task Management worksheet, highlighted, 
then the corresponding record in the CSV file was highlighted, cross checked, then deleted 
or adjusted. Excluded or adjusted, as well as invalid records, are listed in Appendix K.  
Most of the immediately before treatment session records were excluded, except P1’s 
records that were within his sampling frame. All immediately post treatment session 
records were excluded. 
Some of the PainQuILT records, not associated with treatment monitoring, were outside 
of their sampling frames. The criteria for valid and invalid records should have been set a 
priori. Instead, it was decided posteriori that if the EMA time stamp was close to the 
correct time, the record would still be valid. It seemed reasonable to expand the sampling 
frame, from two hours to four hours (two hours either side of the elected time). On 
inspection, this data did not vary from the records of the original EMA interval.  
A few records were several hours outside of the EMA interval, and these were excluded. A 
few other anomalies occurred that had to be assessed. P4 had some user difficulty, leading 
to one entire duplicate record, that was deleted. Other records had to be combined, these 
were, when each pain site was saved as a new record, for the same EMA. These records 
along with the hard copy records, were recreated in PainQuILT, then downloaded, copied, 
then pasted as a new line in the correct date order of P4s CSV file. This was the simplest 




4.8  Adverse Effects 
The study protocol required monitoring and recording of unexpected discomfort and 
unusual or new pain, with an assessment of whether these were attributable to the 
intervention. Unusual pain and new pain was loosely defined in the protocol, except for an 
“increase in baseline pain that persisted beyond 72 hrs post treatment session.”  
The a priori, plan of action for adverse effects of increased pain (compared to baseline, 
beyond 72 hrs):  
1) Notify supervisors; 
2) Then participants would be asked to contact principal–investigator RG, who 
would have assessed ongoing eligibility for participation in the study. However, 
this did not preclude any decision of the participant to withdraw at any time.  
Other types of adverse effects did occur during the intervention delivery phase. The 
practitioner–researcher felt these should be noted as adverse effects because the 
participants reported them, as being significant to them. Therefore, the need arose for a 
more comprehensive action plan to deal with these occurrences. The other types of 
adverse effects that arose were: 
1) not usual sudden pain increases, not associated  to treatment sessions (not within 
72 hours) but at a level no greater than baseline maximum; 
2) unusual symptoms or; 
3) new pain sites. 
All adverse effects, were logged, and assessed for whether they were attributable to the 
intervention (Table 4.8). Incidences of other adverse effects were also logged. They were 
reported to Supervisors, if they did not resolve within approximately 72 hours. The 
supervisors were able to oversee the plan of action, only if adverse effects were of a 
medical nature, or if a participant chose to withdraw. To deal with other adverse effects,  
the practitioner–researcher consulted a colleague, who is a physiotherapist and familiar 
with the GRM intervention, for guidance on whether any further action needed to be 
taken to prioritise the participants wellbeing. PainQuILT records were monitored by the 
practitioner–researcher, to see if pain returned to usual levels. If not, the GRM active 
ingredient, was reduced in the next treatment session, and titrated at consecutive 
sessions according to tolerance. Participants were asked if they were happy to continue, 




During intervention delivery, P3 experienced an increase in low back pain levels and 
number of sites, which caused him psychological distress. This was reported to RG and 
WT, the research supervisors, and the participant was reassured he could withdraw at 
any time, which he did. A letter was sent to the participants GP, outlining the situation 
(Appendix M). Participant 1 and 2 experienced an increase in pain (compared to baseline) 
during exposure to the intervention, but this resolved within 72 hours. P1 also developed 
a new pain site, that persisted for more than 72 hours, and this was reported to the 
supervisors. The practitioner–researcher consulted the overseeing physiotherapist, 
whose prognosis was acute pain that would resolve within a few days, which it did. P4 
experienced periods of lowered pain levels after some treatment sessions, then had 
incidents of increased pain that persisted beyond 72 hours, but this was not above 
baseline levels. P5 also had an incident of increased pain after lower LBP levels, but again 
this was not above baseline levels. Three of the adverse effects logged resulted in 
withdrawal of the GRM active ingredient, from either the following treatment session or 





Table 4-8. Adverse Effects Report 
Date         No. Effect Action taken Result Attribution 
04/10/17 3 Low back pain increased 
and new pain site. Spread 
across left and right sides 
lumbar and hips, normally 
only on right. 
Supervisors informed. 
Treatment session on 6/10/17 
cancelled, reassurance that no 
tissue injury has occurred as 
tissue barriers have not been 
pushed and may withdraw from 
research at any stage.  
Pain eased by follow up on 
9/10/17 but distribution still 
across left and right sides. 
Participant withdrew. 
Supervisor WT approved 
actions taken and advised 
letter informing GP. 
10/10/17 Letter sent to 
participants GP. 
GRM mobilisation treatment 
has been observed to cause 
change in pain distribution 
and transient increase in 
pain levels.  
9/10/17 2 Unusual symptoms, 
sweating and feverish. 
None Occurred again Unknown 
16/10/17 2 Unusual symptoms, 
sweating and feverish. 
Increased pain afternoon of 
previous session. New pain, 
tingling and aching front of 
thighs. 
Participant saw GP Participant reported GP was 
not concerned, advised it 






Date         No. Effect Action taken Result Attribution 
20/10/17 4 Low back pain increased 
beyond 72 hours post 
treatment session. But had 
this type of pain before and 
evident in baseline. Was 
not reported by P4 until 
next treatment session. 
Pain records monitored. 
Relaxation massage, omitted 
GRM treatment to allow more 
recovery time. Titrate GRM 
treatment. 
Pain reduced.  Possibly due to GRM 
treatment. Pain increase 
following day after 
treatment session which fits 
the observed pattern. 
24/10/17 2 Sweating and feverish, but 
less than before.  
None Symptoms decreasing. Possibly related to treatment 
sessions as each time 
occurred after treatment 
sessions.   
17/11/17 4 Increased pain, not above 
baseline, new pain site, 
down entire left leg which 
caused distress. 
Pain records monitored. 
Relaxation massage, omitted 
GRM treatment to allow more 
recovery. 
Pain eased within 72 hours 
with movement, used walker.  
New pain site, possibly due 
to new lift in right shoe 
prescribed by podiatrist.  
Not related to treatment 
session. 
21/12/17 1 New sharp/achy pain left 
lower buttock, okay 
walking at start but then 
stiffened up.  
Advised ice on location of pain 
and heat into hamstring muscle 
belly. Contacted overseeing 
physiotherapist. Booked an 




Pain or stiffness that comes 
on after walking for a while 
indicates acute problem that 
most likely will resolve itself 
within a few days. This did 
occur. 
Physiotherapist verbal 
assessment: Mobilisation of 
the feet and ankles has 
increased posterior chain 
activation and hamstring 
contraction, good result of 





Date         No. Effect Action taken Result Attribution 
21/12/17 4 Strained sacroiliac joint 
yesterday, has done it 
before but it was years ago. 
Participant took codeine and 
paracetamol. Continued with 
GRM treatment. 
Pain eased, weight bearing 
improved after treatment 
session. Booked extra 
treatment session.  
Participant thinks it 
happened because was 
moving too quickly getting 
out of shower as more 
confident moving.  
28/12/17 5 Whole back tightened up 
suddenly. 
Participant took diclofenac and 
gently stretched lying prone 
over a swiss ball.  
Recovered following day. Happened at Christmas, 
when was sitting on 
trampoline and kids jumped 
on it. 
18/01/18 5 New pain following day, 
whole body ache—Flu like. 
None Recovered on fourth day. Possibly related to treatment 




Chapter 5 Discussion 
This research project used a series of five SCEs, with multiple baseline design to 
investigate the effects of a novel manual therapy treatment called Gravity Relief 
Mobilisation. The treatment was included in a massage therapy intervention for CLBP.  
The primary objective of the research was to evaluate effects of the intervention over a 
period of 12 weeks follow up from the intervention conclusion.  
The outcome measurement data collected using the PainQuILT online tool was plotted for 
the purpose of visual analysis consistent with SCE data analysis protocols (Kratochwill et 
al., 2010). The primary objective was tested by comparing the baseline phase (A) outcome 
data with the follow-up (sub-phase B2) outcome data.  
The intervention was successfully delivered to the four participants that completed all 
three phases. While there was the occasional omission of treatment of a peripheral body 
region in treatment sessions, this is not considered to have affected the response to the 
intervention.  
Three of the five participants demonstrated desirable reductions in Pain Interference. 
Two showed large reductions of Mean Pain Intensity of LBP locations. One participant 
showed reduction in number of LBP Locations, and another showed no change. One 
participant (P3) withdrew during intervention delivery, due to adverse effects 
attributable to the intervention. The intervention delivered to participant 4 contained 
other components unrelated to the GRM CLBP intervention being evaluated and the 
contribution of the characterised intervention to the results is unknown. Therefore, only 
two positive results of reduced pain intensity are attributable to the GRM CLBP 
intervention. This means the accepted evidence standard of three demonstrations of 
effect for SCD research (Kratochwill et al., 2010) was reached only for effects on Pain 
Interference.  
There is a large body of low-quality evidence that suggests multi-dose massage therapy is 
effective in reducing CLBP in the short term, that is, less than six months (Furlan et al., 
2015; Moyer et al., 2004). The type of treatment applied seems to be irrelevant (Cherkin 
et al., 2011) although it is possible that interventions involving in person hand contact is 
more effective due to the practitioner–client psychological interactions (Moyer et al. 




therapeutic attention in the form of massage is effective for short term management of 
CLBP. 
The findings suggest improvement in functional outcomes, but no firm conclusions can be 
drawn about GRMs contribution.  Three of the five participants in this study experienced 
important levels of change in decreased pain interference in daily activities. Whether this 
is reflected in increased measurable function is unknown. Although, anecdotally, 
participants P2, -4, and -5 reported during intervention delivery, the intervention had 
effects that improved their participation in activities important to them. This aligns with 
Cherkin et al’s (2011) finding of improvements in functional outcomes at the 
intervention’s conclusion, but these effects were not sustained at 16 weeks (26 weeks 
after start of the intervention). In prior research, massage therapy does not appear to 
achieve meaningful or sustained improvements in functional outcomes in CLBP (Cherkin 
et al., 2011; Furlan et al., 2015). The current study adds to this knowledge because effects 
were sustained through the follow–up phase of 12 weeks (24 weeks after start of the 
intervention). Whether functional improvements persisted beyond 12-week follow up is 
unknown however there was no impression of a trend, increasing or decreasing in the 
follow-up phases of both these participants across of LBP levels and Pain Interference 
outcomes. 
GRM is a novel manual therapy treatment that facilitates a non-volitional movement 
response with the aim of improving the recipients’ ability to move pain free. The 
elicitation of non-volitional movement in therapeutic contexts is not unique but a paucity 
of evidence exists to support is use and is mostly case reports. Thus, is it not possible to 
make comparisons between the results of this research and other non-volitional 
movement interventions. Some literature exists to objectively demonstrate that manual 
therapy can elicit a non-volitional movement response (Bertolucci, 2008, 2011; Bertolucci 
& Kozasa, 2010). The current study provides preliminary evidence for a positive effect in 
some participants of non-volitional movement being included in a CLBP massage therapy 
intervention.  
The unique ingredient of GRM is the amelioration of gravity, lifting and supporting a body 
part to express non-volitional movement. As there is no comparable evidence of the 
effects of other non-volitional movement therapies it is unknown to what extent the 
amelioration of gravity contributes to the therapeutic mechanism. Another aspect of GRM 




sometimes supporting elbow or shoulder, during application of the treatment. These 
contact points, along with the treatment table and bolsters,  provide limiting parameters 
to the movement.  Practitioner contact points  are continuously adjusted by the 
practitioner to facilitate exploration of a variety of movements.  This feature may be an 
advantage of manual therapy facilitated non-volitional movement, and has similarities to 
the therapies Simple Contact (Dorko, 2003) and Somato-Emotional Release (Upledger, 
1997). Whilst the client engages with these treatments standing or seated, the 
practitioner also uses their hands to gently resist movements in certain directions thereby 
encouraging movement in new directions. How much effect the contact point resistance 
has on the tendency to move in a new direction is unknown.  Whether ‘new’ movements 
occur, or occur as readily as in GRM, in the exercise elicited non-volitional movement 
therapies that do not involve hands-on contact by a practitioner is also unknown. 
5.1  Analysis of Response 
 Participants with overall favourable results 
Two participants (P2 and P5) demonstrated clear benefit with large effects (Phi>1) across 
two of the three outcomes, Mean Pain of LBP Locations and Pain Interference. In addition, 
P2 was the only participant to show improvements in the third outcome by a moderate 
effect Phi=0.74 (95% CI 0.47 to 0.95), p<0.001 on reduction in number of LBP Locations. 
Because the Phi statistic does not give an indication of the magnitude of the effect when 
there is no data-overlap, for the purposes of this Master’s thesis an evaluation of effect 
size was done by a simple comparison of phase means. No obvious trends appeared in the 
baseline data for either of these participants, nor in the follow up phase data. Therefore 
the simple mean differences between baseline and follow-up large effect sizes infer an 
actual improvement in the pain and pain interference scores which exceeded the cut-off 
scores for minimal important change (MIC) in LBP (Ostelo et al., 2008). The level 
reductions only give an indication of effect importance as statistical tests for auto-
correlated data were considered beyond the scope of this Master’s level thesis. For 
example, neither independent t-test nor a paired t-test were appropriate to this data. 
Specifically the minimal important change for the numerical rating scale for outcomes of 
pain and functional status in LBP is two points or 30% change in the baseline score 
(Ostelo et al., 2008). P2’s simple mean difference for mean pain intensity of LBP locations 
was 3.7 points, a 53% drop from the baseline mean; P5’s difference was 3.3, an 80% drop 




The Pain Interference scale does not have a published MIC score for LBP, however for use 
in non-cancer chronic pain a change of more than 1 point is considered significant 
(Dworkin et al., 2008).  A 30% change from baseline is considered MIC for both these 
outcome measures (Ostelo et al., 2008). If the mean of the raw plotted scores are 
converted (total score/7) to the Pain Interference mean score level the reduction for P2 
was 2.2 points a 76% improvement, and P5 1.3 points a 93% improvement, indicating 
that the effects did substantially exceed MIC. 
Whilst these scores were not statistically tested the change in pain intensity is considered 
substantial (Dworkin et al., 2008), with important decreases in pain interference (Ostelo 
et al., 2008). A comparison of phase means was a simple way to indicate how large the 
effect was these outcomes for P2 and-5 because Phi >1. Thus, in these two participants, 
the GRM containing massage intervention appears to have resulted in substantial 
reduction in pain interference.   
 Participants with mixed results 
Participant 4 showed mixed effects which may have had benefit but this is not clear nor 
demonstrable as being due to the GRM intervention. There appeared to be no effect on 
pain intensity as the results are not statistically significant with Phi=0.24 (95% CI 0.16 to 
0.58), p=0.2. The Pain Interference Scale showed a significant effect with Phi=0.7, (95% 
CI0.36 to 0.93), p<0.001. The simple mean difference showed a reduction of 2.1 points, a 
62% decrease from the baseline mean. However other factors may have contributed to 
P4’s mixed result. Firstly her baseline and follow-up phase measurements appeared 
variable. This means her pain levels fluctuated more, and she reported using pain 
medication for pain “flare-ups” which could explain some of the variability. Secondly she 
received additional interventions (section 4.6.6) that limits the conclusions able to be 
drawn from the results. The additional interventions were a walker and a heel lift 
(discussed in detail, in section 4.6), both of these improved the participant’s mobility.  
 Participants with overall non-favourable results 
P1 showed no benefit across all three outcomes and P3 withdrew due to adverse effects. 
P1 did not experience desired effects from this controlled intervention although he was 
not impervious to the GRM treatment. This is shown in the obvious increased variability 
of number of LBP locations of the intervention phase that is clearly attributable to the 




that he voluntarily entered in his post-treatment PainQuILT records (Appendix K1) 
indicate he felt the treatment sessions were beneficial.  
P3 did require more support to use the PainQuILT app, possibly attributable to history of 
traumatic brain injury. Difficulty with use of PainQuILT app seems unlikely to contribute 
to withdrawal as he completed the baseline phase data collection. A plausible explanation 
is, the practitioner–researcher felt a therapeutic alliance was not established with P3, 
therefore when changes in pain occurred, she could not reassure him that the effect was 
likely to be transient. It is possible an underlying psychological factor existed, for example 
catastrophising (Rabey et al., 2016). Other participants also experienced changes in pain 
locations and were able to complete the intervention. It follows that interacting 
psychological factors of the participants and practitioner–researcher may have 
determined tolerance of the GRM intervention. This highlights psychological variables are 
important to intervention delivery and response. 
 Factors contributing to variation in results 
There are a number of possibilities as to why variation of results occurred. This 
exploratory study using single case design is unable to determine which factors are 
important but in a clinical setting these may be further explored by a practitioner in 
collaboration with the client. 
The number of low back pain locations varied across participants and phases. It does not 
appear to be important as it seems not to be related to the outcome of Pain Interference 
for the participants that completed the intervention. However, P3 reported an increase in 
number of low back pain sites and specifically this caused him concern, leading to his 
withdrawal from SCE-3 after having received 25% of the intervention at week three. 
Transient increases in LBP locations and intensity were expected during the intervention 
delivery and were  experienced by P1 and P4.  
There is one salient participant characteristic that appeared to be associated to GRM 
response—participants’ ability to predict what made their LBP worse. All the participants 
that completed the intervention had similar levels of contact with the practitioner during 
the baseline phase and they received a comparable number of treatment sessions and 
total GRM duration. One difference was that P4 did not tolerate lying prone for long 
periods so her treatments were delivered mostly lying supine, but this is not thought to 




response. All body regions were still treated with the practitioner sliding their hand under 
the body to contact areas of the back. The interventions were individualised by body 
regions according to each participants pain (Table 4.3), posture, and movement 
characteristics (Table 4.4). This means that differences in response to the intervention are 
possibly related to predictability of LBP aggravating factors.   
The intervention delivery process did not assume to know what each participant’s  
contributing factors to CLBP were. Rather the overall ability to perform important 
activities was addressed. It happened in this research project that ambulatory 
biomechanics was targeted in all the participants; pain limited walking duration for P4 
and -5, P1 and-2 participated in walking for exercise or when playing golf.  If indicated, 
adequate foot, ankle, knee, and hip biomechanics during ambulation are important GRM 
treatment targets in CLBP and this was written into the GRM CLBP treatment manual 
before this research commenced (p.31 & 88). All the participants had limited foot/ankle 
mobility at baseline and whilst this may seem irrelevant to LBP treatment, it is relevant to 
movement and bodywork therapies like GRM that use clinical reasoning processes 
assessing the function of the body’s myofascial movement chains (Myers, 2002; Wilke et 
al., 2016). However the importance of foot posture and ankle mobility in respect to LBP is 
contested by studies that focus on muscle function around the lumbar spine and lumbar 
curvature caused by pelvic tilts (Nourbakhsh & Arab, 2002). Although the LBP locations of 
all the participants in this research included the gluteal area and pelvis indicating 
involvement of non-lumbar structures. Additionally the contribution of sacroiliac pain to 
CLBP sites increases with age up to 70 years (DePalma, Ketchum, & Saullo, 2011). An in-
depth investigation into whether these factors are significant in CLBP is beyond the scope 
of this thesis but the results of this project do raise these questions. Is pain around the 
posterior pelvis of these participants contributed to by ambulatory pathomechanics of the 
foot and ankle, if so did the GRM non-volitional movement approach actually address this? 
This highlights two factors, first relating to the GRM treatment process is the clinical 
reasoning process that uses activities and movements to define treatment targets, the 
second relates to the treatment’s mechanism which is what are the GRM non-volitional 
movement effects on the targeted body regions.  
Whole body treatment was different across the participants and no interventions focused 
on the lumbar region only. The GRM CLBP intervention treatment targets (body regions) 
and doses were planned according to which activities aggravated the participants pain 




activity. Four of the five participants could predict their pain levels by their activities and 
for these participants regions with sub optimal movement were prioritised over painful 
regions. For example P2’s pain was made worse by playing golf and so muscles of the 
body regions involved with the golf swing and rotation were targeted with the thoracic 
region, shoulders and right hip featuring most often as treatment sessions targets. P5’s 
pain was made worse by walking, therefore gait biomechanics of the entire lower body 
were targeted featuring most often the feet, ankles, pelvis and hip regions. P4 had trouble 
standing up after prolonged sitting therefore the body regions involved in sitting and 
standing were targeted featuring the right knee, left pelvis and hip regions.  P1 was 
different to the other participants in that at baseline he did not know what made his pain 
better or what made it worse. Therefore P1’s intervention was not able to be 
individualised in the same manner and the pain regions were the primary treatment 
targets which may not have been the optimal. As the practitioner-researcher plans the 
GRM intervention guided by aggravating factors it may be that lack of identification of 
aggravating factors limits the ability of GRM to gain a positive response for some 
recipients of care. This would be an important consideration for future studies and in 
practical provision of care. 
5.2  Gravity Relief Mobilisation 
The interpersonal attention of the GRM CLBP intervention is likely a significant 
contributor to the positive results of individual participants, however this is not a unique 
ingredient to GRM. The relaxation massage, and the holding techniques are also non-
unique (Cherkin et al., 2011; Jacobs, 2016). Therefore this research indicates that the 
inclusion of non-volitional movement in massage therapy intervention for CLBP is at least 
as beneficial as just relaxation massage for pain management.  
It is plausible that GRM has different mechanisms of effect when compared to relaxation 
massage. For example, it encourages the muscle functions of contraction and relaxation 
which may have beneficial neuromodulatory effects on stress related disorders (Dum, 
Levinthal, & Strick., 2016) such as CLBP. In addition, the GRM intervention aims to 
improve an individual’s ability to move their bodies in the activities they usually engage in 
and does not specifically target the low back region.  This can be compared to 
individualised exercise programmes, which are shown to be the best approach to exercise 
training for CLBP interventions, and there is no evidence to support recommendation of 
specific or sets of exercises (Hayden, Van Tulder, Malmivaara, & Koes, 2005; Van 




A systematic review of RCT’s (n=45) investigated effects of different types of exercise on 
back pain compared to another exercise type, wait list controls, usual care or manual 
therapies in non-specific CLBP (Searle, Spink, Ho, & Chuter., 2015). The participants 
(n=4462) ranged in age from 30–63 years. Sub group analysis comparing exercise types 
found that strength/resistance exercise that targeted multiple muscle groups had the 
greatest, although small effects (SMD=-0.50, CI 95%: -0.77 to -0.24) and only five of the 
trials reported statistically significant results.  The coordination/stabilisation group 
(n=12), was the only other exercise type to show small effects (SMD=-0.47, CI 95%: -0.77 
to -0.18) also with only five of the trials reporting statistically significant results.  The 
trials focusing on cardiorespiratory (n=6), and combined exercise types (n=14) showed 
no effects of these exercise interventions.  
The authors cite heterogeneity of the interventions and participants as a study weakness 
although they did employ a robust search strategy to select participants with non-specific 
CLBP. The overall heterogeneity of the interventions may have led to less favourable 
results as some intervention lengths (1.5 weeks to 18 weeks) may not have been enough 
time for the intervention to have an effect. The problem they considered with participant 
heterogeneity was that trial volunteers may have been biased toward the particular 
intervention under study which may have influenced the trial outcomes through positive 
or negative expectations of the exercise type or control group comparison.  
In conclusion Searle’s et al (2015) exploratory sub-group analysis provides an indication 
that exercise of whole-body strength and co-ordination is the most beneficial type of 
exercise for non-specific CLBP. The GRM CLBP intervention also targets the whole body 
although is different from strength training in that it aims to improve the ability for the 
body’s muscles to contract and relax rather than its ability to generate power. Whole body 
strength gains (Searle et al, 2015) as well as contract–relax muscle functions conceivably 
translate into functional improvements.  
Gravity Relief Mobilisation was named to describe the procedures of the technique rather 
than referring to theoretical mechanisms or treatment targets such as the treatments 
called dermoneuromodulation (Jacobs, 2016) and Myofascial Unwinding/Induction 
(Chaitow, 2017; Minasny, 2009). When the GRM CLBP Treatment manual was written the 
interventions unique GRM treatment ingredients were called Amelioration of Gravity 
(AmG) to describe the taking up the weight of the body part being treated; and Gravity 




utilised to mobilise joints and tissues. In hindsight this terminology can be simplified to:  
Gravity Relief (GR) replacing Amelioration of Gravity; and Mobilisation with Non-
Volitional Movement (MNVM) to replace Gravity Relief Mobilisation. This new 
terminology allows a distinction between the GRM treatment and the treatment 
ingredients of GR and MNVM.  
5.3  Handling of Adverse Effects 
This project reported adverse effects—a definition consistent with the non-serious nature 
of the occurrences. Whilst increases in pain were expected to occur, consistent with 
previous observations in clinical practice, little is known about why this occurs or what it 
means. This meant that no explanation could be formulated for what was happening other 
than pain increases are a usual occurrence with this treatment. It was likely the adverse 
effects were  attributable to the intervention. Therefore, the practitioner-researcher felt it 
was important to have a second opinion from an experienced colleague to provide an 
independent management plan in response to increased or new distressing symptoms, 
that is, adverse effects. This approach was applied for P1, with satisfactory conclusion. 
This process allowed ascertainment the adverse effect was not serious, and was 
appropriately addressed.  Adverse effect reporting to a person other than practitioner-
researcher was feasible and desirable  
From the experiences in this project the practitioner–researcher recommends all massage 
research protocols include an adverse effect log, reporting all increases in pain, and 
interruptions to daily activities. These effects should be assessed as to whether they are 
attributable to the intervention. If effects are attributable to the intervention, the 
participant should be asked if they would like to continue or withdraw, or continue with 
modification of the intervention, if this can occur while maintaining fidelity of the 
massage intervention. When possible adverse effects are known or anticipated, clinical 
management protocols should be established a priori. Adverse effects that caused 
withdrawal or modification of the intervention should be considered in the response 
analysis. 
5.4  Conflict of practitioner-researcher role  
The practitioner–researcher often experienced conflict in their dual role and it lead to 
concessions of the intervention standards. The key concession was the handling of 
adverse effects changed over the course of the intervention delivery due to the anxiety 




practitioner–researcher was concerned that participants may have felt obligated to 
continue with the intervention because it was part of a formal study.  In contrast to care 
provided in private massage practice where recipients felt overwhelmed by the treatment 
they could simply not return for an appointment. The advantage of the single case 
methodology is that it accommodates these alterations without compromising the study’s 
rigour provided detailed records are kept. The other intervention concessions  that 
occurred were an additional treatment session for P4, and an additional treatment week 
for P1 and P4.  In addition the practitioner–researcher suggested external referral to 
podiatry services for P4’s apparent leg length discrepancy (LLD), which resulted in 
provision of corrective heel raise.  This additional intervention does limit the ability to 
ascribed any outcomes to the GRM containing intervention, 
It was the practitioner–researchers concern over P4’s apparent LLD that lead to the 
inclusion of the supplementary podiatry intervention of a shoe lift. Referral to external 
services when indicated is usual practice and, in good conscience, the practitioner–
researcher was unable to reconcile restriction of this for research purposes. The 
additional treatment weeks were provided because the participants experienced adverse 
effects at the end of the planned intervention period and the practitioner–researcher was 
unwilling to not provide a follow-up session to ensure they recovered.  After experiencing 
internal conflict over these matters the alterations were upheld by referral back to the 
approved Ethics application for the project which stated the research would be conducted 
in accordance with Declaration of Helsinki. This meant that the alterations to the 
intervention standard was justified by the stipulation that participants well–being is 
prioritised over the needs of the research.  
Another issue arose during the recruitment and enrolment phase that highlighted 
conflicting roles. The practitioner–researcher experienced difficulty in the final stages of 
recruitment as she did not feel comfortable denying volunteers from participation in the 
research, particularly if massage therapy is what motivated them to volunteer. 
5.5  Strengths and limitations of the research 
 Strengths  
Strengths of this research were: the practice–based setting; use of single case experiment 
methodology; large data sets representing each participant’s base line and follow-up 
measures; and a detailed characterisation of the standardised intervention. Additionally 




Single case methodology enabled rigorous data collection of individual participant 
characteristics and tailoring of the interventions without compromising the research 
internal validity. The interventions delivered were accommodated in each participant’s 
schedule and adapted to their clinical needs by variation in dose and/or intensity of the 
active GRM ingredient applied to each body region. The added benefit is that the results 
have good external validity as they were collected  in a  real world clinical setting;  in 
practice, massage therapy is always adapted to the clinical needs of the client. 
The collection of a frequently repeated data set during the baseline and follow-up phases 
strengthens the internal validity of the final analysis. The outcome measures were 
recorded using scheduled EMAs. It was important the EMA occurred at a similar time of 
the day for each participant across all of the study phases because participant’s pain levels 
fluctuated throughout the day. Use of EMAs was enabled by the electronic data collection 
method (McKeon, McCue, Skidmore, Schein, & Kulzer, 2018).  Furthermore  data validity 
was strengthened by the built in time stamps of the PainQuILT tool (Lalloo, 2014). The 
study design allowed each participant a unique EMA time which they selected for the 
most convenient foreseeable time according to their own daily routines. This fixed 
schedule proved to be an effective strategy as the compliance rates were high and 
therefore  the data provided a good comparison between the phases.  
The resultant compliance rates were deemed high by the PainQuILT’s developers (C. 
Lalloo, personal communication via email, May 19, 2018) and a large number of data 
points were collected for each participant. The PainQuILT EMA compliance in a chronic 
pain population over a period of several has not been previously reported (Lalloo et al., 
2014). Therefore this study contributes to what is known about the feasibility of the tool’s 
repeated use over an extended period of several weeks and acceptable measurement 
frequency over one week. The  dual practitioner–researcher and client–participant roles 
may have contributed to EMA compliance. The participants possibly felt obligated to fulfil 
the research requirements because of perceived client benefits they received from the 
practitioner.  Regardless of the drivers of high compliance with EMA’s, the achievement of 
high data density is a strength of this study.  
Another strength of this study is the intervention was characterised in detail in the GRM 
CLBP Treatment Manual. Generalisability of results is hindered by inadequate reporting of 
intervention details (Whyte et al., 2014) which also limits assessment of the intervention 




replicate in other studies or to adopt in clinical settings. To the knowledge of the 
practitioner–researcher no other massage research studies of CLBP have used a detailed 
treatment manual. The manual also included descriptions of socio-emotional 
communication behaviours of the practitioner and psychosocial aspects of the treatment 
planning thought to be required for effective intervention delivery.   
The GRM CLBP Treatment Manual characterised the standard intervention in detail and 
then the individualised doses, intensity, and body regions addressed were recorded for 
each treatment session. Clinical notes provided descriptive information that captured 
relevant details available for discussion in the summation of the data sources. 
The visual inspection of the plotted data indicated that the pain levels in both the baseline 
and follow-up phases did not preclude the use of a non-overlap data analysis method 
(Parker et al., 2011). Whilst the participant inclusion criteria of CLBP would have 
predicted no trends in the baseline phase due to the duration and non-response of the 
pain condition, the relatively stable follow-up data of P2, P4, and P5 was a surprising 
result. The a priori inclusion of sub-phases in the design meant that the follow-up phase 
could be analysed after any immediate effects of the treatment sessions had washed out.  
 Limitations 
One limitation of this research is the inability to differentiate the effects of the unique 
GRM ingredient of the intervention. There are two reasons for this. Firstly, the presence of 
practitioner reported therapeutic alliance, known to have strong psychosocial effects in 
all therapist–led interventions, cannot be distinguished from the hypothesised 
psychological effects specific to the GRM ingredient of the intervention. Secondly, the 
additional intervention components of exercise and movement treatments, as well as P4s 
two externally provided interventions limited the ability to attribute outcomes 
specifically to GRM. To control for non-specific effects, an alternating treatment design 
could be used, introducing GRM and relaxation massage in different phases, and/or a 
baseline phase containing exercise and movement coaching. Internal validity would be 
further strengthened by ensuring consistency in the concentration of practitioner–client 
contact time across phases. 
Another limitation of this study is the absence of blinded outcome measurement as 
expectations of effects by the participants may have influenced their reporting of the data.  




A third limitation is lack of assessment of intervention fidelity.  Intervention fidelity was 
not presented in this work due to the limited scope of a Master’s thesis. How much of the 
planned intervention was delivered has not been objectively confirmed therefore the 
outcomes of the intervention cannot conclusively be attributed to the GRM intervention 
(Perepletchikova & Kazdin, 2005). Video data of all the treatment sessions were recorded 
to enable its operationalisation in a future study. When undertaking research evaluating 
the effect of a complex intervention, assessment of its fidelity is important to enable 
meaningful interpretation of the research results (Perepletchikova & Kazdin, 2005). There 
are five main requirements to establish the fidelity of delivery of a complex intervention. 
These are: 1) a characterisation of the intervention’s design and procedures, 2) 
assessment of the training and competence of the intervention’s providers, 3) monitoring 
of the intervention delivery, 4) monitoring of the research participants receipt of the 
intervention (Borrelli et al., 2005; Gearing, El-Bassel, Ghesquiere, Baldwin, Gillies, & 
Ngeow., 2011; Higgins & Green, 2011), and 5) monitoring of treatment enactment. These 
requirements have both structural and procedural components (Century, Rudnick, & 
Freeman, 2010). 
Detailed characterisation of an intervention’s design is a structural component and 
achieved with a treatment manual that outlines the intervention’s objectives, procedures, 
theoretical mechanisms (Borrelli et al., 2005; Dane & Schneider, 1998; Dijkers, 2015; 
Gearing et al., 2011). Intervention design includes clear description of the interventions 
unique components proposed to contribute to effect, as well as treatment differentiation, 
which is what the intervention is not. Differentiation is important when comparing 
treatments or testing a new treatment. For example the effects of inclusion or exclusion of 
component treatments may be investigated.   
The training of the intervention providers should also be a structured and documented 
process. Enabling the procedural component requires training of the intervention 
providers and establishment they acquired the requisite competencies to deliver the 
intervention as intended (Borrelli, 2011).  
A procedural component of intervention fidelity is the monitoring the intervention’s 
delivery and examines the degree to which the treatment manual was adhered to. This 
informs the integrity of the intervention delivery helping to determine whether 




intended intervention (Dane & Schneider, 1998; Higgins & Green, 2011; Perepletchikova 
& Kazdin, 2005).  
When monitoring intervention delivery, scores of treatment adherence also demonstrate 
treatment differentiation. High scores mean the treatment was adhered to and the correct 
essential intervention ingredients were delivered, low scores mean a high proportion of 
other ingredients must have been included, altering the intervention. In addition 
monitoring of treatment adherence may identify that prohibited ingredients have been 
inadvertently included.  Prohibited ingredients are practitioner behaviours that are 
incompatible or interfere with the interventions theoretical mechanism (Dijkers, 2014, 
2015; Waltz, Addis, Koerner, & Jacobson, 1993).  Prohibited ingredients and high 
proportion of non-essential ingredients differentiate one treatment from another. 
Therefore inclusion of prohibited ingredients or high proportions of non-essential 
ingredients (with low proportions of essential ingredients), changes the intervention and 
accurate conclusions about intervention effects cannot drawn from the research.  
Monitoring of receipt determines whether the participants themselves were receptive to 
and comprehended the interventions treatments (Borrelli et al., 2005). The final 
requirement, monitoring treatment enactment has to do with whether the research 
participant actually engages in activities in real world settings where the intervention can 
be applied (Borrelli, 2011; Borrelli et al., 2005). It is independent from both outcomes and 
treatment receipt. If treatment receipt is established but treatment enactment is low or 
not established, the intervention may not improve the outcomes being measured. For 
example in this research, enactment is participation in activities that require movement 
when treatment receipt of GRM demonstrated clinical gains of increased pain free 
movement. The outcomes being measured over time are pain levels and reduction of pain 
interference with the movement.  
Other limitations include enrolment of participants when response to treatment may not 
have been possible, due to floor effects of the outcome measure.  Participant one was not 
able to identify what aggravated his pain, therefore the tailoring of his intervention could 
not be optimised. Hence the intervention of GRM may not have been appropriate for P1. It 
is possible that a longer intervention with a different design may have yielded different 
results. Additionally, the low levels of pain intensity, locations and interference during 
baseline phase for participant one meant that no improvement was possible from the 




pain levels in the participant eligibility criteria. Minimal levels of pain scores during 
baseline phase should be a requirement for future SCE of massage interventions. 
Another possibile limitation is that the fixed EMA schedule caused bias in either direction. 
For example, the follow-up phase measurement schedule was allocated to three times per 
week for weeks 4, 8, and 12 and higher pain levels may have occurred during the other 
weeks. A possible solution to this would have been to randomly selected weeks but the 
main objective of the study was to evaluate whether effects persisted for up to 12 weeks 
post intervention by the participants original selected time of day. Secondly, if pain was 
worst in the morning at the participants fixed EMA time, then if the daily pain fluctuation 
pattern changed by a decrease in the time it took to stabilise at a lower level (after getting 
moving) then intervention effects would be under represented. Thirdly, the outcome 
measurement schedule permitted participants to complete EMAs the following day if they 
missed one. This may have created some bias in the data to an increased number of 
records when pain was higher for that participant as they might have been reminded to 
complete the record by their experience of pain. In support of this supposition is that in 
the clinical notes of P5 it was  reported that they forgot to complete records when they 
were experiencing low pain levels. P1 also informed that he did extra records because of a 
pain increase. These examples show how tensions between rigorous data collection and 
burden of response had to be balanced in the study design.  
Another limitation is that an objective measure of functional outcomes was not included 
as an outcome. Whilst the convenience of the PainQuILT was that it provided pain and 
functional measures in one tool, the Pain Interference survey is not an ideal functional 
measure for LBP (Chiarotto et al., 2018). An additional criticism of the pain interference 
construct is that it likely represents a psychological construct that modifies physical 
function rather than serves as a proxy measure for physical function (Karayannis, 
Sturgeon, Chih-Kao, Cooley, & Mackey, 2017). Therefore these results do not necessarily 
indicate support for the neurophysiological aspect of the GRM theoretical mechanism 
although increased levels of physical activity was reported by the participants and 
recorded in the clinical notes (this information was included in the ‘…physical activities 
additional to Activities of Daily Living’ during the intervention delivery phase of Table 
4.6).  
Future research of GRM would benefit from the provision of the validated Patient-




Worzer, Hartzell, Kishino, & Gatchel., 2017) at baseline, intervention conclusion, and  end 
of follow-up . Additionally, movement based objective performance tests, administered by 
a blinded assessor, would help differentiate if specific effects of the of GRM’s movement 
component occurred. Another option, would be to use mobile electronic data collection 
apparatus such as activity trackers (Fitbit, Inc. 2018) or wearable stretchable electronics 
(Jayaraman, 2018) that can measure movement.  
Another theoretical aspect of the GRM is that the elicitation on non-volitional movement 
impacts psychological factors of the complex CLBP disorder (O'Sullivan et al., 2016; Rabey 
et al., 2016). It would have been useful to include a specific physical function measure in 
this research (Deyo et al., 2014). The participants self–reported activity and participation 
recorded each week in the clinical notes suggest that a patient specific functional measure 
would capture physical function changes better than generic measures (Pengel, 
Refshauge, & Maher, 2004). A way to include this would be to administer an additional 
functional measure framed to ask about physical function over the past week—at 
enrolment, with the pre-treatment session PainQuILT records (completed by participants 
in clinic before their treatment session), and at a the completion of the follow-up phase. 
Ideally the baseline and follow-up phases would include one measure per week. 
Additional outcomes risk increasing the burden of response potentially compromising the 
amount  of data collected, which is important SCED studies. As this was exploratory study 
and compliance to the intensive EMA measurement schedule was unknown the time 
required for participants to complete EMAs was kept to a minimum.   
 Technical Challenges 
Some technical challenges were encountered with the electronic data collection method. 
Firstly as participants were required to have reliable internet access and an electronic 
device, this did exclude some people from participating which was potentially a source of 
bias. Secondly on two occasions the PainQuILT access was interrupted and could not be 
reinstated until after the weekend when the North American–based web provider of the 
app could be contacted.  After the first interruption, to insure against future data 
collection losses the participants were emailed a document (to be printed) individualised 
with all the pain sites they had listed in previous records with pain descriptors, all the low 
back pain sites, the Pain Interference questions, and respective numerical rating scales. It 
was not an ideal strategy because it was not a validated method and likely was a barrier to 
completing EMAs as the paper diary was only used by P4 during the second interruption 




protocols for dealing with electronic service interruptions and the need for a back-up 
system to ensure continuity of data collection. Furthermore, casual attitudes to lapses in 
data collection methods conceivably conveys a negative message to research participants 
about the importance of outcome measurements to the research. Back up methods would 
need to be validated or justifications made for why the data is used in the final analysis. 
The paper diary records for P4 were used during the intervention delivery phase so were 
not needed for the final analysis.  
Another technical issue was the complexity of downloaded PainQuILT data when it was 
converted to a CSV file. Multiple steps (23) were required in Excel to separate out the LBP 
locations and their corresponding pain values into columns used to plot the data points. 
The complexity of the data conversion process is vulnerable to errors.  
To ensure errors did not occur reformatting of all of the data sets was done at the same 
time with each step replicated for all SCE’s in the respective Excel worksheet. This meant 
the process was efficient and could be done in stages. Mistakes in the process were 
obvious because the data did not fill the columns correctly and was easily spotted for the 
bigger data sets. Also the large data workbooks of P2 and P4 were manually scanned for 
anomalies. Every data line was also assigned a day number which was used to plot the 
data. Finally once the plots were generated in Excel data points that appeared to be 
outliers were checked against the actual PainQuILT record with the practitioner’s logon 
using the day number to identify the date of record completion. The date was cross 
checked in the activity log for user problems or other events, such as medication use, 
reported by the participants. This process spotted days multiple records in P4’s log that 
needed to be combined, the repeat of anterior and posterior hip locations in P2’s 
records(explained in Method 3.8.3), and confirmed the validity of the data points at low 
and high ends. For future studies it would be worthwhile to keep a separate research 
activity log for each participant.   
5.6  Future Research 
Four additional analyses could be conducted on the existing data set from this project. 
Firstly fidelity assessment of these SCEs would contribute to the researches internal 
validity and video data of all treatment sessions was recorded for the future analysis. 
Another analysis that could be conducted would be the total number of pain sites in the 
body as this was part of the parent data set that the number of LBP locations was 




impact disability more than actual pain location in people with chronic back pain (Smith, 
B., et al., 2004) and the number of LBP locations did not appear to correspond to GRM 
response. This then would be included in the intervention response analysis (Carnes et al., 
2007). Thirdly the evaluation of post treatment effects during B1 subphases would 
provide information about the observed pain increases and how long these persist. 
Gauging if beneficial effects justified the any transient increases in pain. Finally a 
qualitative study of the lived experience of the CLBP GRM intervention could be done with 
transcription of the treatment session videos. These sessions all included biopsychosocial 
assessment and empathic listening which is the usual practice of the researcher.  
Other future research would be replication of effects, validation of the treatment manual, 
trials on other conditions, and comparison to other non-volitional movement 
interventions. This would require training of other practitioners as well as basic science 
exploration of GRMs plausible therapeutic mechanisms. 
5.7  Conclusion 
These results indicate massage therapy including GRM reduces Pain Interference of CLBP.  
The GRM massage intervention may have sustained short–term effects and reduce low 
back pain. Whilst the standard of at least three demonstrations of effect on pain was not 
met, the maintenance of large effect sizes mean it is reasonable to conclude the 
intervention was effective, in these participants, in this context. Reservations are that 
non-specific effects were not controlled and the fidelity of the intervention was not 
established.  
Movement is the basic mechanism by which GRM is thought to target symptoms of CLBP. 
This research suggests that non-volitional movement can have therapeutic effects in some 
people. Its elicitation can be facilitated in a clinical setting by manual therapy 
practitioners who possess the required skills. It is also possible that some people with 
particular underlying psychological factors are not able to tolerate the intervention but 
this likely is moderated by the practitioners’ skills in dealing with psychological co-
morbidities. In private clinical practice this is also moderated by individual preferences 
for types of treatment. Soft tissue and motor–unit, use dependant changes have the 
potential to affect dose–responses to the GRM treatment. Psychological factors may partly 




The high level of engagement from these participants in the SCEs suggests that SCE design 
is a practical approach for evaluation of complex therapeutic interventions that maximise 
the research insight. Also a fixed EMA schedule of electronic data collection using the 
PainQuILT tool is an effective method to acquire repeated outcome measurements needed 
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Dr Rebecca Grainger 
Department of Rehabilitation Teaching and Research Unit (Wtn)  
School of Medicine University of Otago 
Wellington 
 
14 June 2017 
 
 
Mr. Gary Witte 
Manager, Academic Committees 
Academic Services University of Otago 
Dunedin 
 
Dear Mr Gary Witte,  
 
RE: Ethics Application H17/063 
 
Thank you for your letter dated 22 May notifying the status of conditional approval granted by 
the Ethics Committee for the proposed research entitled “Effects of a Novel Manual Therapy on 
Chronic Low Back Pain: A series of N-of-1 trials”. 
This letter is to inform you of the changes that have been made to the protocol which address 
the issues raised by the Ethics Committee. My self and the co-investigators appreciate the 
Committees helpful feedback to improve the quality of this project. The issues are highlighted 
below, bullet points list how they have been addressed, followed by changes made to the 
protocol and ethics application. Some additional changes have been made in light of new 
information that has been received. These changes are also listed for your review.  
 
Aims and description of research  
The Committee asks to be provided with a clearer description of the aims of the 
project. For example, more information is required on how the treatment is 
considered to be “novel”.  
This study has two aims that evaluate person centred effects of an intervention for chronic low 




therapy (MT) component of the intervention is thought to be “novel”. An explanation is given 
as to why it is important to study the novel component.  
 The intervention effects includes the outcomes of “change in pain” and “pain 
interference”. This will be monitored for up to 72 hours immediately after treatment 
sessions. The data analyses of each study will examine if these responses change in 
duration and intensity with each consecutive treatment session. This change over time 
of pain is why the n-of-1 methodology was chosen to evaluate the intervention effects 
that will be relevant to the continued development of the manual therapy intervention. 
 
o Section 6.0 (p12) of the research protocol has been amended to better state that 
the research aims to firstly evaluate the efficacy and side-effects of the 
intervention across the intervention delivery period. And secondly to indicate 
whether the effects of the intervention are enduring for a period of time after 
the intervention is concluded. 
o A Treatment Manual characterising the intervention in detail has been written 
and reviewed by University of Otago Wellington research fellow Melanie 
Brown. Melanie is also a practicing massage therapist licensed with Massage 
New Zealand and has a Master’s degree in Health Science (Rehabilitation). 
 
 The novel component of the intervention is the manual therapy technique that has been 
named Gravity Relief Mobilisation (GRM). Its evolution occurred during years of the 
student investigator’s clinical practice and exploration of literature on somatic trauma 
therapy.  A search through published and grey literature has found similar techniques to 
GRM and other therapies that appear to exploit a common neurophysiological 
mechanism. This mechanism is consistently referred to as being a type of self-
correcting reflex. GRM combines the application of established MT techniques with 
the novel approach of lifting and holding the limbs or body part being treated through 
the entire expression of this reflex which manifests as non-volitional movement. 
o Section 5.2, Development of the Intervention (p9) of the research protocol has 
been expanded to name the other techniques which are similar to GRM and to 
explain how GRM is different. 
 
 As GRM is observed to induce muscle reflex activity that appears to be more intense 
than other similar in-direct manual therapy’s it is important to monitor any after effects 
of the treatments and if this results in meaningful change in pain for people.   
 
o Section 5.3.3, Relevance of the Study (p11) of the Research Protocol has been 
amended to include the above. 
 
 Throughout the protocol the term ideomotor motion has been re-defined as non-
volitional movement, this is because more precisely ideomotor motion is only one 
theory that explains non-volitional movement. 
 
o Section 5.1 Background (p7) of the Research Protocol, other theories 




o Section 5.2 Development of the Intervention (p9) of the Research Protocol, 
other manual and exercise therapies that induce non-volitional movement are 
acknowledged. 
o Table 1 in section 15.0 Intervention (p19) of the Research Protocol, has been 
amended to include other theories as potential mechanisms of action of the 




Please provide more information on the recruitment process and comment 
further on how the potential for conflict of interest will be managed given the 
participants will be recruited from the student investigator’s own practice. 
Further information has been included about the recruitment process in the research protocol 
with some changes listed below and the Research Ethics application form has been amended. 
Any conflict of interest of the student investigator during the recruitment process is being 
managed by using an intermediary person to screen potential participants before recruitment. 
 An advertisement will be placed in health care provider facilities and community 
leisure facilities will inform people of the research studies.  
 
o Section 14.0 Recruitment and Retention (p16) of the Research Protocol has 
been amended to clearly state that invitation to participate is made by way of 
an advertisement. 
 
o Figure 2: Recruitment Process (p17) in section 14.0 of the Research Protocol 
has been adjusted in accordance with the recruitment process changes. 
 
 Current clients of the student investigators practice are ineligible to participate by the 
exclusion criteria “Is receiving treatment for low back pain”. Unsolicited clients who 
have expressed interest in referring potential participants will be informed of where the 
advertisements are located. The recruitment process has been changed now asking 
participants to contact a dedicated study email address to register their interest as well 
as provide a phone number and time when they will be available to be contacted. This 
change has been made as we consider it to be a better way to manage this process. 
 
o  Section 14.0 Recruitment and Retention (p16) of the Research Protocol and 
q13.3 (p16) of the research ethics application form has been amended so that it 
clearly states people interested in participating are invited to contact a study 
email and an intermediary person, principle and co-investigator (RG or WT) 
will contact them to briefly explain the study and screen the potential 
participants. Only if they are interested in taking part after speaking with an 





o It is stated more clearly in Research protocol section 14.0 (p16) and in q13.3 of 
the ethics application (p16) that potential participants will have an opportunity 
to view the facilities where the intervention will be delivered, meet the student 
investigator delivering the intervention before deciding to participate.  
 
o The recruitment Advertisement has been changed so that includes the above 
instructions and gives the study email address. 
 
 
Peer review from Dr William Levack  
In the peer review from Dr William Levack he indicated that he expected to see 
the final protocol to be submitted with the ethics application prior to submission 
to the committee. Please provide evidence from Dr Levack that he has read 
your responses to the issues raised and that he is satisfied with the protocol 
submitted for review by the ethics committee. 
 The final protocol was given to William Levack and he has been informed of the 
revisions that have been made. He is satisfied that his questions and concerns have 
been addressed and has written a letter included with this correspondence as 
Attachment A. 
o William Levack’s final approval has been added to Question 6.2 of the Ethics 
application (p8)  
 
Randomisation process 
The Committee was of the view that the randomisation process was not clearly 
described on the Information Sheet and asks for this to be revised. 
 
 The random determination of baseline length will involve the computer generation (by 
co-investigator WT) of a random list of whole numbers from 3 to7.   
 
o Section 16.1Randomisation (p19) of the Research Protocol has been added to 
clearly stating how the randomisation is being done and that each baseline 
length has equal probability of being 3,4,5,6 or 7 weeks in length. 
 
o The Participant Information sheet has been revised see details below. 
 
 The student investigator will be blinded to the baseline length until after potential 





o Section 16.2 Study Enrolment (p20) of the Research Protocol has amended to 
stipulate that co-investigator WT will inform the student investigator HV of the 
next listed baseline length once an appointment to complete enrolment has 
been made. 
 
o Section 16.1 Randomisation (p19) of the Research Protocol has been amended 
explaining that if the person decides at this stage not to participate the base line 




Participant information sheet 
Taking note of the above comment relating to the study aims, please also 
provide more detail 
on the study aims on the Information Sheet for Participants.  
In addition, please make clear the time lines involved with the baseline 
period of monitoring, the treatment and the follow-up. The Committee suggests 
you provide a 
list of bullet points indicating what participants will be expect to do and when. 
 The Participant Information Sheet has been changed so that it clearly states the study 
aims are firstly to monitor the responses to each treatment session and secondly to 
evaluate if the intervention causes a significant lasting reduction of chronic low back 
pain and how this effects people in their daily activities.  
 
 The Participant Information Sheet under the heading: Before the research starts you 
will be asked to: has been changed to clearly explain that participants will learn of their 
baseline length after enrolment, and that it is a computer generated random number 
which may be 3,4,5,6 or 7 weeks long which cannot be adjusted. 
 
 A bullet point list has been included in the Participant Information Sheet under the 
heading: If you participate, what will you be asked to do? to outline clearly what is 
being asked of the participants in the baseline, intervention and follow up phases of the 
study.  
 
 It has been clearly stipulated in the Participant Information Sheet under the heading: 
During the follow up phase (12 weeks) you will be asked to: that the treatment session 
at the end of the follow up measurement phase is optional and provided at no cost to 
the participant. No data is further data is being collected. 
 
o This has been added to q13.8 (p17) of the Ethics Application describing 






Maori consultation resulted in a recommendation to include questions about 
ethnicity and descent on the Participant History form as per the related 
questions in the latest New Zealand(NZ) Census (Attachment B).  
The questions included are abridged versions of questions 11 and 15 from the 
NZ 2013 Census, (http://www.stats.govt.nz/Census/2013-census/info-about-
the-census/forms-guidenotes.aspx). 
o The Participant History form contained in Appendix B (p35) of the Protocol 
has been added to. It now contains a question about ethnicity with check box 
choices of New Zealand European, Maori, or Other: Please state. 
o The Participant History form in Appendix B (p35) of the Protocol has been 
added to also include the question: If you are of Maori descent, do you know 
the name of your iwi? Please state. 
 
 Acceptability e-scale Survey of Pain Assessment tool  
Since the submission of the ethics application the licensor’s of the pain 
assessment tool have stipulated they require our research participants to 
complete a PainQuILT acceptability survey at the completion of each study. 
This is presented for review in this correspondence as Attachment C. 
o The additional survey has been included in the bullet point list of the 
Participant Information sheet under the heading During the follow up phase (12 
weeks) you will be asked to:  
o The additional survey has been mentioned in the recruitment Advertisement. 
 
Inclusion Criteria 
New literature has been found that gives recommendations for chronic low back 
pain research. The definition of chronic low back pain is given as: 
 “Low back pain for six months or longer and experienced on at least half the 
days of the past 6 months.”  
(Deyo, R. A., Dworkin, S. F., Amtmann, D., Andersson, G., Borenstein, D., Carragee, E., ... & 
Goertz, C. (2015). Report of the NIH Task Force on research standards for chronic low back 




o The recruitment Advertisement has been changed to include the above 
definition of chronic low back pain. Provided with the definition is a 
mannequin diagram to clearly show the low back region.  
o The Participant Information sheet under the heading: Who are we seeking to 
participate in the project? has been changed to include the above definition of 
chronic low back pain. 
o The inclusion criteria in section 13.1 Participant Inclusion Criteria (p15) of the 
protocol has been changed from “back pain for 6 months or longer experienced 
every day” to the above definition. 
 
Participant History 
The NIH Task Force Report (Deyo et al, 2015) gives a recommended minimum 
data set to be collected in chronic low back pain research. This is lengthy and 
not all the questions are appropriate for a New Zealand based study. 
o The Participant History form contained in Appendix B (p35) of the Protocol 
has been added to. It now includes NZ appropriate questions to cover the items 
recommended in the minimum data set. This includes: receipt of ACC, 
employment status, education level, weight, and smoking status. 
o The Consent form item 6 has been added to and now includes the provision of 
demographic information. 
o “Demographic information” has been added to the Participant Information 
Sheet under the heading What data or information will be collected, and how 




Dr. Rebecca Grainger 

















UNIVERSITY OF OTAGO HUMAN ETHICS COMMITTEE   
AND  
 
UNIVERSITY OF OTAGO HUMAN ETHICS COMMITTEE 
(HEALTH) 
 
REQUEST FOR EXTENSION OR AMENDMENT TO A PREVIOUSLY 
APPROVED STUDY 
If the nature, content, location, procedure (including recruitment of participants) or 
personnel (including student investigators) of an application approved by the University of 
Otago Human Ethics Committee or University if Otago Human Ethics Committee (Health) 





H17/063 Name of University of 
Otago staff member 
responsible for the 
project: 
 
 Dr R Grainger 
 
Title of Project: 
 
Effects of a Novel manual 




Please detail the amendment(s) you would like to make to your approved proposal, the reasons 
for the change(s), and any additional ethical considerations: 
 
Dear Mr Witte,  
On behalf of my research collaborators I am applying to the Otago Human Ethics 
Committee (Health) for approval of an amendment to the outcome measurement 
schedule detailed in the protocol (p21-22)  attached to Ethics Committee reference 
number H17/063. 
The protocol outlines phase A(baseline) and phase B (exposure). Phase B consists of 12 
weeks of intervention delivery and 12 weeks follow-up monitoring possible enduring 
effects on the outcome variable. The current follow-up monitoring is scheduled for one 
day per week.  
With insight gained from the research to date it is thought that this schedule of 
measurement will not adequately represent the outcome variable. During the baseline 
(control) phase the research participants pain levels were observed to vary over the 
course of the week in response to their own particular scheduled activities. The base 




The new follow up phase measurement schedule we are proposing is: three times per 
week for one week out of every four weeks, for a total of twelve weeks. This means 
nine outcome measurement data points will be collected over the twelve weeks. It is 
thought this will represent the outcome variable as it fluctuates during the week as well 
as capture any enduring effects at weeks 4, 8, and 12 of follow-up.  The follow-up 
phase is due to begin on the 13 December 2017. 
We do not think this measurement schedule will cause a burden of response as the base 
line phase was successfully completed by the participants with few missing data points. 
The base line phase consisted of outcome measurement three days per week for up to 
seven weeks. 
I have attached the new protocol (V2.1 - 06.12.17) with this application and the 
amendments can be found on p 21-22 in section 16.3.3. 





Dr R Grainger 
Principle Investigator 
Rehabilitation Teaching and Research Unit  





Please email your completed form, together with your amended Information Sheet(s), 
Consent Form(s), Survey(s)/Questionnaires, or any other relevant documents, as 
appropriate, to : 
Gary Witte (Manager, Academic Committees) gary.witte@otago.ac.nz, or 
Jane Hinkley (Academic Committees Administrator), jane.hinkley@otago.ac.nz  or  
Jo Farron de Diaz (Research Ethics Administrator), jo.farrondediaz@otago.ac.nz . 
 













ADVERTISEMENT    
PARTICIPANTS NEEDED FOR RESEARCH STUDY OF CHRONIC 
LOW BACK PAIN 
Are you: 
 18 years or older? 
 Suffering low back pain for 6 months or more? 
 NO longer receiving or undergoing other treatments                                       
(apart from over the counter pain relief)? 
If you answered yes to all the above questions you are invited to 
volunteer in this study of the effectiveness of a massage therapy 
based novel clinical intervention for chronic low back pain.  
The treatment sessions are at no cost to you. Your participation will involve 
attendance at a minimum of 4 and maximum of 12 treatment sessions over the 
course of 12 weeks. These will be about 1 ½ hours duration and scheduled at your 
convenience. These sessions will be video recorded to monitor aspects of the 
treatment session delivery. You will be asked to complete an anonymous online 
questionnaire up to 4 x/week for up to 19 weeks, and 1x / week for 12 weeks. The 
questionnaire takes less than 5 minutes to complete. Also at the end of the research 
you will be asked to fill out a survey asking you how easy the online questionnaire 
was to complete. 
If you are interested in participating in this study please email your contact phone 
number and time when you can be contacted to: 
grm@otago.ac.nz 
Dr. Rebecca Grainger or Assoc. Prof. Will Taylor of Otago University, Wellington will 
be in touch with you in the next few days to explain what happens from there. 




The supervisors are:  
Senior Lecturer Dr Rebecca Grainger and, Associate Professor William J Taylor 








































































































































































































































































































































































































Appendix C: Participant Information Sheet 
 
 
Participant Information Sheet  
Study title: Effects of a Novel manual Therapy on Chronic Low 
Back Pain: a series of N-of-1 trials 
Principle 
investigator: 
Dr. Rebecca Grainger 
Senior Lecturer 
Department of Medicine 
Contact phone 
number: 
04 806 1031 
 
Introduction 
Thank you for showing an interest in this project.  Please read this information sheet carefully. 
Take time to consider and, if you wish, talk with relatives or friends, before deciding whether 
or not to participate.  
If you decide to participate we thank you.  If you decide not to take part there will be no 
disadvantage to you and we thank you for considering our request.   
What is the aim of this research project? 
This study aims to assess the effects of a massage therapy based intervention for chronic low 
back pain that features gentle massage therapy and a new joint mobilisation approach. The 
therapy technique applies a gentle tissue stretch and lifts the arms, legs or head a small 
amount which are then fully supported through reflex muscle contractions which mobilises 
the joints. NO painful stretching or massage is used. This technique induces and supports 
natural muscle reflexes.  
The research has two aims. Firstly to monitor the responses to each treatment session, as pain 
has been observed to change and sometimes increase for up to72 hours, it then seems to 
dramatically subside. Secondly to evaluate if the intervention causes a significant lasting 
reduction of chronic low back pain and how this effects people in their daily activities.  
The new joint mobilisation techniques may help people with chronic muscle pain learn to 




Who is funding this project? 
This project is not sponsored by any organisation. 
Who are we seeking to participate in the project? 
We are seeking adults (18 years of age or older) who have low back pain for 6 months or 
longer and have experienced low back pain at least half of the days of the past 6 months. It 
may be back pain only or back pain and other bodily pain which has not or is no longer 
responding to treatments delivered by a doctor, physiotherapist or other health professional. 
If you are only using over the counter pain relief you are still eligible.  
Otherwise you are in reasonable health and do not have any other serious unmanaged 
medical or psychological conditions that affect your day to day living. For example: heart 
conditions, diabetes, severe depression or anxiety, drug or alcohol addiction, severe multi-site 
pain in joints. However if you are under the care of a medical specialist and your condition is 
managed and stable you are still eligible to participate with permission from your medical 
provider.  
Further if you have chronic back pain and have not been seen by your GP it is important that 
you are assessed. At this stage you will not be eligible to participate in the study.  
This treatment and participation in this study is not suitable to you if are extremely 
overweight with a BMI (Weight/Height²) greater than 40. This is because there may be more 
suitable interventions for you to address back pain which are not delivered in this study. 
We are unable to include people with back pain that changes daily or every few days for 
reasons you do not understand. This is because to assess if the treatment is effective we 
require a stable baseline measurement before beginning the intervention. Otherwise we will 
have no idea why your back pain is or is not effected. 
If you participate, what will you be asked to do? 
Your participation will involve a baseline measurement phase (up to 7weeks), an intervention 
phase consisting of course of clinical treatment sessions (12 weeks), and a follow up 
measurement phase (12 weeks). 
Treatment sessions are massage based, it is either fully clothed or applied to the skin with 
underwear remaining on and draping used so that the chest and pelvis are covered at all 
times. Some of these sessions will be video recorded to monitor how well the treatment is 
delivered.  
Your participation will also involve completing anonymous online surveys as well as provide 
feedback during the clinical sessions. The anonymous online survey is a pain assessment tool 
consisting of a pain diagram and 7 questions about how your daily activities are effected, it 






Before the research starts you will be asked to: 
 Attend an appointment (at a convenient time for you) to complete the enrolment 
process involving completing written consent forms, learning how to use the pain 
assessment tool, scheduling of your first clinical treatment session after a baseline 
phase. 
 Your baseline length will be the next number on a computer generated random list. It 
has equal chance of being 3,4,5,6 or 7 weeks long. You will learn your baseline length 
after you have been enrolled as a participant. This cannot be changed. 
During the baseline measurement phase (up to 7 weeks) you will be asked to: 
 Complete the pain assessment record 3 days /week. 
During the intervention phase (12 weeks) you will be asked to: 
  Attend a minimum of 4 and a maximum of 12 clinical treatment sessions over the 
course of 12 weeks. These will be approximately 1 ½ hours duration and scheduled at 
your convenience at least one week apart. 
 Complete the pain assessment before and after your treatment sessions. 
 Complete the pain assessment survey for the next three days after your treatment 
session. 
 Complete the pain assessment survey an additional one day/week for 12 weeks of 
your intervention. 
During the follow up phase (12 weeks) you will be asked to: 
 Complete the pain assessment 1 day/week. 
 Complete a short survey of ten questions at the completion of the study on your 
experience using the on line pain assessment tool. 
 You will be offered a follow up clinical treatment session (no cost to you) at the end 
of the study which is optional. 
Your participation in this research is voluntary. The researcher is providing the clinical 
treatment sessions at no cost to you and your agreement or refusal to participate will not 
affect any aspect of care should you be seeking treatment in the future.  
Is there any risk of discomfort or harm from participation? 
The treatment is very gentle, moving stiff joints and muscles that haven’t worked for a while. 
Consequently you might experience some discomfort and increase in pain for up to 72 hours after your 
clinical treatment sessions and then is expected to disappear the following day.  
Your appointments will be scheduled at times that are convenient for you and when any after effects 
will not interfere with important events or activities. You will also be consulted on how often you have 





What data or information will be collected, and how will they 
be used?  
Your contact information will be held for the purposes of communication and scheduling for 
the duration of the study and data collection.  
You will be given a de-identified email address to log in to the on-line pain assessment tool 
(e.g. backpainPQ_1@gmail.com) where you will complete electronic pain records. 
Other information collected will be your medical history, demographic information, and 
clinical notes in the form of hard copy. Clinical notes are used to help with the process of 
treatment selection and monitoring. Video footage of every session will be recorded and will 
be used to monitor how well the practitioner delivers the treatment sessions. All electronic 
study data will be securely held on The University of Otago’s servers for at least ten years. 
 
What about anonymity and confidentiality? 
A master electronic document will be held linking your personal information to a study ID and 
email address. 
 The pain assessment tool is managed by a company called Fluid Media and will hold only your 
pain records and NO personal information. Access to this password protected record will be 
only available to you and the research team. 
Clinical notes will be de-identified when transferred to electronic copies and paper copies 
destroyed when the study ends.  After this time all information collected will be anonymised 
to and records of your personal details destroyed.  
The video recordings will be stored on an external password protected hard drive in a locked 
cabinet and on secure University of Otago servers.  
If you agree to participate, can you withdraw later? 
You may withdraw from participation in the project at any time and without any disadvantage 
to yourself. However if you decide to withdraw any time after you have received the first 
clinical treatment session  your de-identified data collected up to that point will still be 









If you have any questions now or in the future, please feel free to contact either: 
Heidi Verhagen 
Student Investigator and Massage Therapist 
Rehabilitation Teaching and Research Unit 
Contact phone number: 
021 054 5296 
Dr. Rebecca Grainger 
Senior Lecturer 
Department of Medicine 
Contact phone number: 
04 806 1031 
Will Taylor 
Associate Lecturer 
Department of Medicine 
Contact phone number: 
04 806 1801 
 
This study has been approved by the University of Otago Human Ethics Committee (Health). If 
you have any concerns about the ethical conduct of the research you may contact the 
Committee through the Human Ethics Committee Administrator (phone +64 3 479 8256 or 
email gary.witte@otago.ac.nz). Any issues you raise will be treated in confidence and 









Effects of a Novel Manual Therapy on Chronic 
Low Back Pain: Series of n-of-1 trials 
Student Investigator: Heidie Verhagen; verhe928@student.otago.ac.nz; Ph 021 054 5296 
CONSENT FORM FOR PARTICIPANTS 
Following signature and return to the research team this form will be stored in a secure place for ten 
years. 
Name of participant: ………………………………………….. 
1. I have read the Information Sheet concerning this study and understand the aims of 
this research project. 
2. I have had sufficient time to talk with other people of my choice about participating in 
the study.   
3. I confirm that I meet the criteria for participation which are explained in the 
Information Sheet. 
4. All my questions about the project have been answered to my satisfaction, and I 
understand that I am free to request further information at any stage.  
5. I know that my participation in the project is entirely voluntary, and that I am free to 
withdraw from the project at any time without disadvantage. 
6. I know that as a participant I will... 
Provide information about my medical history and demographic information; 
complete the web-based survey instruments at the agreed times or when prompted 
by a reminder email or text message; and attend the agreed upon clinical treatment 
sessions providing the necessary feedback and assessment information. 
7. I know that the treatment sessions will be visually recorded for the purposes of 
monitoring     the practitioner and assessment of the final research thesis.  
8. I agree to being filmed by the University of Otago and that any material arising from 
such filming which contains my, likeness or image may be used by the University for 
the purposes of completing this study. 
9. No compensation, monetary or otherwise, is required for use of the material. 




10. I know that the web-based survey instrument will explore the quality, intensity, and 
location of my pain as well as how it interferes with my daily activities; and that if the 
line of questioning develops in such a way that I feel hesitant or uncomfortable I may 
decline to answer any particular question(s), and /or may withdraw from the project 
without disadvantage of any kind. 
 
11. I understand the nature and size of the risks of discomfort or harm which are 
explained in the Information Sheet. 
12. I know that when the project is completed all personal identifying information will be 
removed from the paper records and electronic files which represent the data from 
the project, and that these will be placed in secure storage and kept for at least ten 
years.  
13. I understand that the results of the project may be published and be available in the 
University of Otago Library, but that either (i) I agree that any personal identifying 
information will remain confidential between myself and the researchers during the 
study, and will not appear in any spoken or written report of the study  or (ii) I 
agree to be named or identified in the study and will sign a waiver form.  
14. I know that there is no remuneration offered for this study, and that no commercial 
use will be made of the data.  
 
 
Signature of participant:  Date: 
   
   
 
Name of person taking consent  Date: 





Appendix E: Screening Interview Guide 
Screening Questions Eligible or exclude 
General 
1. Are you 18 years of age 
or older?  
              Male or Female? 
Under 18 years old, not eligible. 
Female go to question 2. / Male go to question 4. 
2. Women - are you 
pregnant, or planning a 
pregnancy in next 
year? 
If yes, not eligible 
3. Have you had a baby in 
the past year? 
If yes, not eligible 
4. Are you severely 
overweight? 
If yes go to question 5. / If no go to question 6. 
5. If yes- how much do 
you weigh and how tall 
are you? 
Calculate BMI = weight/Height² 
If greater than 40, exclude. 
6. Are you seeing a 
psychiatrist or clinical 
psychologist? 
(Counsellors okay) 
If yes, exclude. 
7. Do you use alcohol or 
recreational drugs 
regularly? 
If yes go to questions 8-11. / If no go to question 12. 
CAGE-AID Scoring: Exclude if total score of questions 8-11 
equals 2 or greater 
8. Have you ever thought 
you have to cut down 
on your drinking or 
drug use? 
If yes, score 1/ if no, score 0. 
9. Have people annoyed 
you by criticising your 
drinking or drug use? 
If yes, score 1/ if no, score 0. 
10. Have you felt bad or 
guilty about your 
drinking or drug use? 
If yes, score 1/ if no, score 0. 
11. Have you ever thought 
you had a drink or used 
drugs first thing in the 
morning to steady your 
nerves or get rid of a 
hangover (an eye-
opener)? 




Screening Questions Eligible or exclude 
Clinical 
12. Where is your back 
pain? 
Not eligible if, no pain posteriorly between the inferior 
margin of the 12th rib and the gluteal folds. 
13. How long has ongoing 
back pain been a 
problem for you? 
Not eligible if, LBP history less than 6 months. 
14. How long has back pain 
been an ongoing 
problem for you over 
the past 6 months? 
Not eligible if, LBP experienced on less than half the days of 
the past 6 months. 
15. Have you seen a health 
care professional for 
your back pain at some 
stage? 
Not eligible if, has never been seen by their general 
practitioner or a physiotherapist for LBP. 
16. What advice have you 
been given and how do 
you manage your low 
back pain? 
Not eligible if, has not received advice consistent with ACC 
Acute LBP Care guide or has ceased all activities and only 
uses bed rest. 
17. Are you using pain 
relief? 
If yes-not eligible if using prescription pain medication, over 
the counter medicines okay. 
18. Do you have any other 
pain or health 
conditions? 
Exclude if has any conditions contraindicating massage 
therapy:  
Kidney infections and infectious diseases; acute injuries 
(assess severity and exclude if possible effect on back pain); 
vomiting or diarrhoea (assess whether acute or chronic); 
severe pain at rest; history of cancer or thrombosis; other 
inflammatory conditions not under medical management. 
19. Are you receiving any 
treatment now for your 
back pain? 
Exclude if receiving treatment. Over the counter pain relief 
okay. 
20. Are you planning on 
starting any new 
treatments or therapy 
in the next 9 months? 
If yes (ineligible). General lifestyle improvements such as diet 
and exercise okay. 
Internet Access 
21. Do you have every day 
access to a computer, 
phone or tablet that 
has internet access? 
If no, exclude. 
Permissions 
"Thank you for answering these questions, may I pass on your phone number to the researcher 




Appendix F: Participant Information and History Form 
Participant Information and History 
Thank you for providing this information, it is part of the recommended data to be collected 
for chronic low back pain research. It will also be used to help plan the most effective course 
of treatment for you. Your identity will be removed from the study data and this paper record 
will be destroyed at the conclusion of the research project.  
 
Name_________________________________ DoB _____________Gender:  M/F _______ 
Preferred contact no. _________________________Best time to contact________________ 
Ethnic Group:   □New Zealand European     □Maori     □Other. Please state:____________ 
If you are of Maori descent, do you know the name of your iwi? Please state:_____________ 
___________________________________________________________________________ 
Occupation__________________________________________________________________ 
Employment Status: __________________________________________________________ 
Currently receiving ACC support:   □Yes   □ No 
Education Level: ______________________________________________________________ 
General Health:  □ Very good  □ Good  □ Fair 
□Smoker  □ Non-smoker  Weight (kg):______ 















□ Headaches □ High / Low blood pressure □ Epilepsy 
□ Sleep disturbance □ Asthma □ Arthritis / Gout 
□ Inflammation □ Varicose veins □ Hepatitis A/B/C 
□ Fatigue □Hernia / Ulcer □ Virus /Flu etc. 
□ Breathing difficulty □ Diabetes □ Allergies 
□ Fluid retention □ Heart problems /Chest pain □ Vision problems 
□ Easy bruising □ RSI / OOS □ PMT 
□ Dizziness □ Blood clots □Menopause symptoms 
□ Numbness/ tingling □ Digestive problems □Other-Sunburn, tinea etc 
□ Skin conditions □ Cancer □________________ 
 
Are you currently feeling stressed?              Low←---------------------------------------→High 
Exercise, recreation, sport, hobbies? 
_____________________________________________________________________ 
Do you have any difficulty lying on your front or back?  
____________________________________________________________________ 
Have you ever had clinical therapeutic massage?               Yes / No 
Pain or discomfort and where? ___________________________________________ 
_____________________________________________________________________ 
Loss of function or movement? ___________________________________________ 
_____________________________________________________________________ 
When and how did it start? ______________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
What makes it worse? __________________________________________________ 
_____________________________________________________________________ 
What makes it better? __________________________________________________ 
_____________________________________________________________________ 






For the purposes of treatment planning please indicate on the diagram below where 
you are feeling tension or pain. 
 







Appendix G: Clinical Notes Template 





Subjective Information  
How are you doing?   
How did you go after the last treatment 
session?  
 
Objective Intervention  
Manual therapy  [ ] Massage; [ ] GRM; [ ] Other 
Duration (mins) of treatment session   
Positioning for manual therapy  [ ] Supine; [ ] Prone; [ ] Side lying - left; 
[ ] Side lying - right; [ ] Semi recline or 
sitting; [ ] Standing 
Focus regions  
 
[ ] Pelvis and hip - left; [ ] Pelvis and 
hip - right; [ ] Knee - left; [ ] Knee - 
right; [ ] Foot and ankle - left; [ ] Foot 
and ankle - right; [ ] Lumbar spine; [ ] 
Shoulder and thoracic - left; [ ] 
shoulder and thoracic - right; [ ] Elbow, 
wrist and hand - left; [ ] Elbow, wrist 
and hand - right; [ ] Head and neck  
Notes including time spent on specific regions  
 
 
Response to treatment and GRM activity 
rating, including clients reported responses as 
well as emotional response to treatment. 
 
 




Next treatment session  
 
[ ] Massage; [ ] GRM; [ ] Other 
Notes on other and positioning to start with  
 
 
Focus regions  
 
[ ] Pelvis and hip - left; [ ] Pelvis and 
hip - right; [ ] Knee - left; [ ] Knee - 
right; [ ] Foot and ankle - left; [ ] Foot 
and ankle - right; [ ] Lumbar spine; [ ] 
Shoulder and thoracic - left; [ ] 
Shoulder and thoracic - right; [ ] 
Elbow, wrist and hand - left; [ ] Elbow, 
wrist and hand - right; [ ] Head and 
neck  
 






Appendix H: PainQuILT Demonstration Guide 
Script for Demonstrator:  
[Introduction] This tool is meant to help you to make pictures to show what your pain 
feels like. To begin, we click on ‘Create New Pain Report’ [click on this button].  
[Body map orientation] This picture shows all the different parts of the body. It is meant 
to help you to show which parts of your body have pain. It shows the front and back of the 
body. These little labels [R, L] show you which side is the left and which side is the right. 
So, for example, this [point] is the front of the left hand. When you move the mouse 
pointer over different parts of the body, the regions light up in green. [Show some 
examples]. If you click on any of these green spots, then you will zoom in for a closer look. 
For example, let’s click on the chest area. Now, we have zoomed in and can highlight 
different spots on the front of the body.  
[Example Report] Let’s try an example together. Let’s pretend that I have pain in my belly 
right now. I could click on these spots on the front of the body to show where my pain is 
located. Once I have marked the spots on the belly where it hurts, I would push the Next 
button.  
[Pain Quality] Now, this is where I would choose the small pictures (icons) to show what 
the belly pain feels like. Let’s say that the belly pain is Aching and Heavy. I could just click 
on those buttons, and they will be highlighted around edges, so I know they are chosen.  
[Pain Intensity] After showing what the pain feels like, I can pick a number between 0 and 
10 to show how much it hurts. Zero means ‘no pain’ and 10 means ‘worst pain’. Let’s say 
that the belly pain was a 4/10. Now, notice how the colour on the body map changed to 
match the lighter green of the 4. Now click on the Next button.  
 
[Adding a Note] If I want to, I can write a note to give even more details about this pain.  
For example, I might write: “Could not eat lunch because of belly pain”.  
[Adding a Second Pain Location] Now, if I also have pain in a different part of my body, 
then I will click Add Another Pain [click this]. Notice how the belly pain has been recorded 
on the body map (see how the colour has changed).  Then I can repeat all of those 




[Patient Follows Vignette to Record Pain] Now, you try one. Let’s pretend that I also have 
6/10 throbbing pain behind my right knee. What would you do first to help me record this 
pain?  
[Let the patient try to record the pain as described – if they need help, provide 
instructions below]  
 Click on the back of the right leg to zoom in.  
 Highlight the back of the right knee. Next.  
 This pain is throbbing and it’s a 6/10. Next. 
 I don’t have a note about this pain.  
 I have recorded all of my pain, so I’ll click Confirm.  
 Now, before finishing, I will answer some questions about how much my pain 
is getting in the way of different parts of my life. 
[Pain Interference] The first question is, ‘Over the past 24 hours, how much has pain 
interfered with your General Activity?” A zero means that it doesn’t interfere at all. A 10 
means that it completely interferes. This pain is getting in the way a little bit, so I’ll say it’s 
a 2/10. Click Next. 
 The pain does not impact my mood at all. So, which number should I pick? 
[User should choose zero. If they don’t, check their understanding of the scale] 
 The pain does not impact my walking ability at all. So, which number should I 
pick? [User should choose zero. If they don’t, check their understanding of the 
scale] 
 The pain has gotten in the way of some of my work, but not very much. So, 
which number should I pick? [User should choose a low number. If they don’t, 
check their understanding of the scale] 
 The pain has interfered a little with my relationships, so I’ll pick 1/10.  
 The pain got in the way A LOT with my sleep last night. So, which number 
should I pick? [Users should choose a high number.] 
 And, the pain hasn’t gotten in the way of my enjoyment of life. [User should 
choose a low number] 
 Save Pain Record. 
[Report History] If I want to see my report, I’ll click on View Pain Report History. Here, I 
can see a list of all my pain reports. Let’s look at the one we just created.  




Now, you’ll have a chance to create your first personal pain report. Let’s log-out of the test 
account, and login with your own user account. [Click Sign Out, top left corner] 
 Click Sign Up As User button [this is the hyperlink below the Sign In as User button] 
 This is your study email address [xxx@gmail.com]. Whenever you use the tool during 
the study, you will use this email address to login. Type this address into the Email 
box. 
 Now, you can set your own password. Make sure you remember it, because we (the 
study team) won’t know what it is. 
 Now, we’re at your own home screen [should see Create New Pain Report, View Pain 
History, Invite Clinician buttons] 
 The first thing that we’ll do is Invite Clinician – this will link your account to mine, so 
the study team will be able to track your reports over the course of the study. Once the 
study is over, you’ll be able to set up your own independent account, and we won’t 
have access to it anymore. 
 Click Invite Clinician. [HV–enter email address that you wish to use to access 
participant’s pain reports] Click Invite button. 
 [HV – on a separate computer, login to your email and ensure that you received the 
invitation. Accept it, and login as a clinician. Once the participant finishes their first 
report, make sure that you can see it in your clinician view.] 
 Great, now you have invited me to have read-only access to your account. Next, you 
can create your first pain report. 
 Click Create New Pain Report. 
 Think about your pain right now and use the tool to create a picture of what it feels 
like. Just like the examples we did together earlier, let’s start with where the pain is 
located on your body. 
 Please go through the steps to create your pain report and “think aloud” as you go 
through each step [location – quality – intensity – descriptive note]. 
 Great, you’re all done! 
 [Once user has finished creating their pain report, check that you can see it on the 
Clinician view]   









This tool is meant to help you to make pictures to show what your pain feels like. To 
begin, click on the button ‘Create New Pain Report’.  
 
 Body map orientation 
This picture shows all the different parts of the body. It is meant to help you to show 
which parts of your body have pain. It shows the front and back of the body. The little 
labels R and  L show you which side is the left and which side is the right. When you 
move the mouse pointer over different parts of the body, the regions light up in green. 
If you click on any of these green spots, then you will zoom in for a closer look. After 
you have zoomed in you can highlight different spots on the body.  
Open the following webpage: http://app.painquilt.com 
Works in all browsers, except Internet Explorer. Suggest using Safari if on a 
Mac, or Firefox if on a PC. 
o Click “sign in as User”  
o Use the following login: 
Email: grmstudy4@gmail.com 







 Click on the spots on of the body to show where your pain is located. Once you have 
marked one area of where it hurts, push the Next button.  
 
 Pain Quality 
Now, this is where you choose the small pictures (icons) to show what the pain feels 
like. If it is Aching and Heavy just click on those buttons, and they will be highlighted 
around edges, so you know they are chosen. You can choose more than one if you want 
to. If none of the words match how your pain feels click on the box by the question 
mark and you can enter your own word to describe your pain. 
 Pain Intensity 
After showing what the pain feels like, you can pick a number between 0 and 10 to 
show how much it hurts. Zero means ‘no pain’ and 10 means ‘worst pain’. If you pick 
that your pain was a 4/10 click on it and you will notice how the colour on the body 
map changed to match the lighter green of the 4. Then click on the Next button.  
 
 Adding a Note 
If you want to, you can write a note to give even more details about this pain. For 
example, I might write: “Could not eat lunch because of belly pain”.  
 
 Adding a Second Pain Location  
Now, if you also have pain in a different part of your body, then you will click ‘Add 
Another Pain’. Notice how the first pain has been recorded on the body map (see how 
the colour has changed). Then you can repeat all of those previous steps for a different 
type of pain.  
 
 Once you have recorded all of your pain, click ‘Confirm.’ 
 
Now, before finishing, you will answer some questions about how much my pain is 






 Pain Interference 
The first question is, ‘Over the past 24 hours, how much has pain interfered with your 
General Activity?” A zero means that it doesn’t interfere at all. A 10 means that it 
completely interferes. Chose a number that you think fits best and click on it. Then 
click ‘Next’.  
To respond to the next questions again pick a number that best fits how you feel or 
think. For example: 
o If the pain does not impact your mood at all pick zero. 
o If the pain does not impact my walking ability at all pick zero. 
o If the pain has gotten in the way of some of your work, but not very much. 
Pick a low number like 2 or 3. 
o If the pain has interfered just a little with your relationships, pick 1.  
o If the pain got in the way A LOT with your sleep last night. Pick a high 
number like 8, 9 or 10. 
o And, if the pain hasn’t gotten in the way of your enjoyment of life pick a 
low number.  
o Then click ‘Save Pain Record’.  
 
Make sure you have saved your pain report 
 
 Report History 
 If you want to see your report, click on ‘View Pain Report History’. Here, you can see 
a list of all your pain reports. Click on one to view it. You do not have to do this. 
 
 When you are finished click ‘sign out’. 
 
Great, you’re all done! 
If you have any questions or need some more help learning to use the PainQuILT 
please call ------- on 00 000 0000.  
You may want to add the PainQuILT to your home screen so that you can easily access 





Appendix J: Data Reformatting Procedure 
1. Create three tabs for the three variables: location, pain intensity and pain 
interference. The first column for each tab should be copied from the Date Created 
column. 
2. In the raw data tab, insert a blank column next to Location and create a new 
variable LOCATION =SUBSTITUTE(C2, " ", ",") and FILL DOWN. This makes 
commas appear where there were spaces. 
3. Insert another blank column and create another new variable LOCATION 
=SUBSTITUTE(D2; CHAR(10), “,”) and FILL DOWN. This makes commas appear 
where there were carriage returns (new line of text). This step is necessary 
because the location values appear to be separated by both spaces and carriage 
returns. CHAR(10) is ASCII code for a carriage return. 
4. COPY and PASTE AS VALUES this column into the Location tab. 
5. Highlight the LOCATION column, use TEXT TO COLUMN. Select DELIMITED and 
COMMA and TREAT CONSECUTIVE DELIMITERS AS ONE. Use DESTINATION 
$C$1. 




Spine")+COUNTIF(D2:S2,"Tailbone")This counts the number of instances of these 
particular locations. FILL DOWN. 
6. Go back to the raw data sheet, insert a blank column next to Intensity and create a 
new variable PAIN=SUBSTITUTE(G2,CHAR(10),","). 
7. COPY and PASTE AS VALUES this column into the Pain Intensity tab. 
8. While this column is highlighted, use TEXT TO COLUMN. Select DELIMITED and 
COMMA and TREAT CONSECUTIVE DELIMITERS AS ONE. Also select OTHER and 
enter a dash “-“ without the quotes into the dialogue box. This is necessary to 
isolate the number from the text into their own cells. Use DESTINATION $C$1. 
9. Create a new variable at column R, MAX PAIN = =MAX(C2:Q2). 
10. Go back to the raw data sheet, insert a blank column next to How has it affected 
your... and create a new variable INTERFERENCE= =SUBSTITUTE(J2, 
CHAR(10),","). 




12. While this column is highlighted, use TEXT TO COLUMN. Select DELIMITED and 
COMMA and TREAT CONSECUTIVE DELIMITERS AS ONE. Also select OTHER and 
enter a colon “:“ without the quotes into the dialogue box. Use DESTINATION 
$C$1. 
13. Insert another blank column D and create another new variable LOCATION 
=SUBSTITUTE(C2,CHAR(10), “,”) and FILL DOWN. This makes commas appear 
where there were carriage returns (new line of text) and separates out only the 
groups of sites. 
14. COPY and PASTE AS VALUES this column into a new tabbed sheet ‘location-group 
x pain-intensity’. 
15. While this column is highlighted, use TEXT TO COLUMN. Select DELIMITED and 
COMMA. Use DESTINATION $C$2. 
16. Label columns C through L as Group1 through 10. 
17. Go back to the raw data sheet and COPY and PASTE AS VALUES the column with 
the pain intensity values separated by commas (column I) into column M of the 
location by pain tabbed sheet. 
18. Use TEXT to COLUMN on this column. Select DELIMITED and COMMA, and OTHER 
(-). Also highlight the columns that are not needed (those with ‘intensity’ and 
select DO NOT IMPORT COLUMN (SKIP)). Use DESTINATION N$2$. 
19. Create labels for columns N through W as Pain1 through Pain10 (corresponding to 
each location group). 





Hip",C2)),ISNUMBER(SEARCH("Tail-Bone",C2))),N2,"")This inserts the value of N2 
(Pain score for Group1) into the cell, if any of the text in C2 consists of low back 
sites. 
21. FILL RIGHT  to copy the formula for each Group and FILL DOWN to copy the 
formula for each observation. 
22. Finally create the back pain intensity values (max, min, average) using the excel 
functions across the Back 1 through 10 cells.   
23. In Location TAB, Add new column (R of Count LBP sites) headed All Location 




total number of pain locations. [ All Location Count Data not used for Masters 
Thesis]. 
24. Add new column headed Observation no. Start at 1 and fill down series to assign 
reference number to each observation. 
25. Calculate mean, of actual pain locations, not mean across all possible LBP 
locations, i.e. =sum(Pain score of LBP locations)/Count (LBP locations). 
e.g. =IF(V2<19.5,"A",IF(V2>71,"B2","B")) 
26. Categorise Observations into phases. Baseline phase=A, Intervention Exposure 
phase =B, Follow-up phase =B2. Identify the start and end of each phase using 
dates recorded in the Task Management worksheet . Insert a blank column in 
front of date created and create new variable PHASE=IF(X2< observation no. day 
of first treatment,"A",IF(X2>observation no. day last treatment,"C","B")) and FILL 
DOWN. 
Phase A:  
Start: First PQ record at participants stipulated time, omit practice record at 
enrolment. 
End: Last PQ record at participants stipulated time before first treatment session. 
 
Phase B 
Start: First PQ record at participants stipulated time after first treatment session. 
End: Last PQ record at participants stipulated time within three days post last 
treatment session. 
 
Sub Phase B2 
Start: First PQ record at the participants stipulated time, after the three days post 
last treatment session. 
End: Last PQ record. 
 
27. For each participant (1,2,4, and 5) construct plots showing: Number of Low Back 
Pain Locations, Mean Pain Intensity of Low Back Pain Locations, and Pain 






Appendix K: Excluded Data Points 
Table K1 Reasons for Exclusion of Data Points for SCE-1 and Corresponding Participants comments 
in PainQuILT Log. 
SCE 1 
























-Groin on L only, not upper leg 
electric shock like an electric fence on front of 
































L buttock pinching l shin like electric fence shock. 
After excellent massage /manipulation I feel quite 
















barely a niggle, feel at ease with the world after 
another superb session with Heidie. 
 
 23/11/17, 




another excellent session with Heidie, L buttock 















feel very relaxed after another superb session with 








no pain, another excellent session with Heidie, just 







Table K2 Reasons for Exclusion of Data Points for SCE-2 and Corresponding Participants comments in 
PainQuILT Log. 
SCE-2 
Reason PST UTC PainQuILT comments 
Excluded 














































































-Played golf on Wednesday so 
back is sore 
Shooting pain going down 
both legs 
 
  28/08/2017, 
21.55 UTC 
Travelling 
Played golf yesterday very 
sore 
  2017-08-30 
03:34:16 UTC 
 
In Finland  
-Still the same pain in the 
same areas, 24 hours of sitting 
in planes get shooting pains 
down my right hand lower 




Table K2 Reasons for Exclusion of Data Points for SCE-2 and Corresponding Participants comments in 
PainQuILT Log. 
SCE-2 
Reason PST UTC PainQuILT comments 
 
Excluded continued 





-Lower back pain is better this 
morning, just upper back 





-Very sore all week, I have the 







in a different 
time zone.  
PST irrelevant. Time in 
Finland equal to UTC time, 
therefore EMA time 
parameter aligned with 
rising time in the morning. 
1/09/2017, 
6.23 a.m. UTC 
 
In Finland  
-Riding motorcycles in Iceland, 
my back is better than if I was 
playing golf. Still sore around 
my lower back causing 
shooting pains down my left 
and right thighs. 




in time zone. 
PST irrelevant. Time in 
Finland equal to UTC time, 
therefore EMA time 
parameter aligned with 
rising time in the morning. 
4/09/2017, 
7.10 a.m. UTC 
 
In Finland  
-Been riding off road 
motorcycles for three days so 
body is a bit sore all over, feels 
a different type of sore more 
muscular than my general  
-lower back pain 








Table K3 Reasons for Exclusion of Data Points for SCE-4 and Corresponding Participants comments 
in PainQuILT Log. 
SCE4 















2017-10-06 01:02:43 UTC -worse on Fridays as 
moving about more on 
Thursdays when 
cleaning lady comes to 
help. 
-Groin only [not whole 
thigh is painful] 
 
 13/10/17, 9.57 
a.m. 
2017-10-12 20:57:35 UTC -Level 5 around the 
top of the leg, 
thigh less painful 
 20/10/17, 10.00 
a.m. 
2017-10-19 21:00:20 UTC -not the lower leg- PQ 
error 
-R hip always worse 
 27/10/17, 10.08 
a.m. 
2017-10-26 21:08:46 UTC  
 03/11/17, 10.44 
a.m. 
2017-11-02 21:44:03 UTC -groin and upper part 
of thigh 
-Not lower buttock 
 10/11/17, 2.23 
p.m. 
2017-11-10 01:23:04 UTC -upper thigh and groin 
-not lower buttocks 
 17/11/17, 10.41 
a.m. 
2017-11-16 21:41:20 UTC -groin and upper thigh 
only 
-Not lower buttocks 
-R low back not stiff , 
but is throbbing 
 1/12/17, 10.16 
a.m. 
2017-11-30 21:16:34 UTC -quite painful and stiff 
middle finger 
-not lower leg 
-groin and thigh 
-not lower buttock 
 08/12/17, 10.15 
a.m. 
2017-12-07 21:15:19 UTC -groin only, not thigh 
-Not buttock, hip only 
 15/12/17, 10.10 
a.m. 
2017-12-14 21:10:43 UTC -very sharp pain in 
thigh during the night 
 21/12/17, 1.56 
p.m. 
2017-12-21 00:56:50 UTC  
 29/12/17, 10.08 
a.m. 
2017-12-28 21:08:30 UTC -not lower buttock 
 05/01/18, 10.13 
a.m. 
2018-01-04 21:13:58 UTC {Technical problem 
with website]-other 
records have had to 
put 1 because 0 
doesn't work 





2017-10-06 02:07:17 UTC -no groin pain 




Table K3 Reasons for Exclusion of Data Points for SCE-4 and Corresponding Participants comments 
in PainQuILT Log. 
SCE4 








2017-10-12 22:21:04 UTC 
 
-No pain in upper 
back, system error 
 20/10/17, 11.14 
a.m. 
2017-10-19 22:14:04 UTC -No pain in knee  
-lower leg PQ error, no 
pain 
    
 27/10/17, 11.19 
a.m. 
2017-10-26 22:19:04 UTC  
 03/11/17, 12.09 
p.m. 
2017-11-02 23:09:10 UTC -Nothing in thigh just 
in groin, weight 
bearing more easily 
-Not lower buttock 
 10/11/17, 3.48 
p.m. 
2017-11-10 02:48:44 UTC -Not lower buttocks 
 17/11/17, 12.20 
p.m. 
2017-11-16 23:20:48 UTC -Groin only 
-not lower buttocks 
 01/12/17, 11.41 
a.m. 
2017-11-30 22:41:45 UTC -thigh and groin 
-not lower buttock 
 08/12/17, 11.48 
a.m. 
2017-12-07 22:48:52 UTC -groin only , not thigh 
 15/12/17, 11.55 
a.m. 
2017-12-14 22:55:20 UTC  
 21/12/17, 3.10 
p.m. 
2017-12-21 02:10:23 UTC -Sacroiliac region 
 29/12/17, 11.58 
a.m. 
2017-12-28 22:58:03 UTC -Feels a lot stronger 
when standing 
-not [pain] lower 
buttock 
 05/01/18, 12.05 
p.m. 
2018-01-04 23:05:46 UTC -nothing there at all 
-Not left buttock 
Adjusted 
  2018-04-01 04:47:36 UTC 
Noted in activity log, phone call 
from  participant alerting that she 
had made an error and to 
disregard the last PQ entry rated 










2017-09-17 04:24:44 UTC 





Table K3 Reasons for Exclusion of Data Points for SCE-4 and Corresponding Participants comments 
in PainQuILT Log. 
SCE4 
Reason PST UTC PainQuILT 
comments 
 24/09/17,4.22 
p.m.; 4.29 p.m.; 
4.31 p.m.; 4.34 p.m. 
 
2017-09-24 03:22:01 UTC 
2017-09-24 03:29:33 UTC 
2017-09-24 03:31:42 UTC 
2017-09-24 03:34:35 UTC 
started knitting again 
after a long break (15 
months)  this could be 




 26/09/17, 5.05 
p.m., 5.07 p.m., 5.11 
p.m., 5.14 p.m. 
 
2017-09-26 04:05:33 UTC 
2017-09-26 04:07:55 UTC 
2017-09-26 04:11:07 UTC 
2017-09-26 04:14:00 UTC 
 
 28/09/17, 4.45 
p.m., 4.50 p.m. 
2017-09-28 03:45:47 UTC 





22/10/17,4.30 p.m.   
 23/10/17, 4.45 
p.m. 
  







Table K4 Reasons for Exclusion of Data Points for SCE-5 and Corresponding Participants comments in 
PainQuILT Log. 
SCE 5 
Reason PST UTC PainQuILT comments 
Excluded 





Pre treatment 3/11/17, 8.16 a.m. 2017-11-02 19:16:31 UTC  
 11/11/17, 10.27 a.m. 2017-11-10 21:27:11 UTC  
 18/11/17, 9.46 a.m. 2017-11-17 20:46:21 UTC  
 24/11/17, 7.49 a.m. 2017-11-23 18:49:16 UTC  
 01/12/17, 6.46 a.m. 2017-11-30 18:46:38 UTC  
 07/12/17, 7.04 a.m. 2017-12-06 18:04:33 UTC  
 15/12/17, 7.17 a.m. 2017-12-14 18:17:38 UTC  
 22/12/17, 6.25 a.m. 2017-12-21 17:25:12 UTC  
 28/12/17, 8.40 a.m. 2017-12-27 19:40:19 UTC  
 11/01/18, 6.43 a.m. 2018-01-10 17:43:19 UTC  
Post 
treatment 
25/10/17, 5.29 p.m. 
 
2017-10-25 04:29:37 UTC  
 03/11/17, 10.14 a.m. 2017-11-02 21:14:57 UTC  
 11/11/17, 12.23 p.m. 2017-11-10 23:23:13 UTC 
 
 
 18/11/17, 11.44 a.m. 2017-11-17 22:44:32 UTC  
 24/11/17, 9.40 a.m. 2017-11-23 20:40:16 UTC  
 01/12/17, 9.46 a.m. 2017-11-30 20:46:18 UTC  
 07/12/17, 9.18 a.m. 2017-12-06 20:18:14 UTC  
 15/12/17, 9.10 a.m. 2017-12-14 20:10:57 UTC  
 22/12/17, 8.46 a.m. 2017-12-21 19:46:47 UTC  
 28/12/17, 10.59 a.m. 2017-12-27 21:59:33 UTC  




7/10/17, 8.08 a.m.; 
7/10/17, 5.40 p.m.; 
9/10/17, 4.49 p.m.; 
11/10/17, 4.16 p.m. 
Records in-correctly 
completed within NZ 
time parameters but 
is in Australia Eastern 
Time zone. 
2017-10-06 19:08:13 UTC 
2017-10-07 04:40:04 UTC 
2017-10-09 03:49:30 UTC 
2017-10-11 03:16:29 UTC 
-Morning I'm on holiday in Brisbane, 
what times do you want me to sign 
in at? There 3 hours behind NZ?  I 
don't have your number 
 14/12/17, 7.09 a.m. 
Miscommunication of 
treatment date. 























Appendix L: Modified PAND Cross Tabulation 
Table L1. PAND and Phi Calculations SCE-1  
Outcome: Mean Pain Intensity of LBP Locations 
Expected result:     High A /Low B2 
Data 
Characteristic 
Phase A (n=20) Phase B2 (n=11) 
High a=20-5.5 
  =14.5 
b=min{20, 11}/2 
  =11/2 
  = 5.5 
Low c=min{20, 11}/2 
=11/2 
=5.5         
d=11-5.5 
=5.5 






Phi =14.5/20 – 
5.5/11 
=0.725 – 0.5 
=0.225 
Outcome: Number of LBP Locations 
Expected result:     High A /Low B2 
Data 
Characteristic 






Low c=min{20, 11}/2 
=11/2 
=5.5         
d=11-5.5 
=5.5 






Phi =14.5/20 – 
5.5/11 





Outcome: Pain Interference 
Expected result:     High A /Low B2 
Data 
Characteristic 






Low c=min{20, 11}/2 
=11/2 
=5.5                     
d=11-5.5 
=5.5 






Phi =14.5/20 – 5.5/11 
=0.725 – 0.5 
=0.225 






Table L2. PAND and Phi Calculations SCE-2  
Outcome: Mean Pain Intensity of LBP Locations 
Expected result:     High A /Low B2 
Data 
Characteristic 












Total a+c=10 b+d=33 




Outcome: Number of LBP Locations 
Expected result:     High A /Low B2 
Data 
Characteristic 

















Phi =8/10 – 2/33 
=0.8-0.061 
=0.739 
Outcome: Pain Interference 
Expected result:     High A /Low B2 
Data 
Characteristic 












Total a+c=10 b+d=33 







   
Table L3. PAND and Phi Calculations SCE-4  
Outcome: Mean Pain Intensity of LBP Locations 
Expected result:     High A /Low B2 
Data 
Characteristic 
















Phi =14/19 – 5/10 
=0.737-0.5 
=0.237 
Outcome: Number of LBP Locations 
Expected result:     High A /Low B2 
Data 
Characteristic 
















Phi =14/19 – 5/10 
=0.737-0.5 
=0.237 
Outcome: Pain Interference 
Expected result:     High A /Low B2 
Data 
Characteristic 
Phase A (n=19) Phase B2 (n=10) 















=1– 0.138  
=0.862 
Phi =17/19 – 2/10 





Table L4. PAND and Phi Calculations SCE-5  
Outcome: Mean Pain Intensity of LBP Locations 
Expected result:     High A /Low B2 
Data 
Characteristic 
Phase A (n=17) Phase B2 (n=12) 





Low c= min{0, 0}/2 
=0/2 
=0 
d=12 – 0 
=12 
Total a+c=17 b+d=12 




Outcome: Number of LBP Locations 
Expected result:     High A /Low B2 
Data 
Characteristic 
Phase A (n=17) Phase B2 (n=12) 





Low c= min{17, 11}/2 
=11/2 
=5.5 
d=12 – 5.5 
=6.5 





Phi =11.5/17 – 5.5/12 
=0.676 – 0.458 
=0.218 
Outcome: Pain Interference 
Expected result:     High A /Low B2 
Data 
Characteristic 
Phase A (n=17) Phase B2 (n=12) 






Low c= min{0, 0}/2 
=0/2 
=0 
d=12 – 0 
=12 
Total a+c=17 b+d=12 








Appendix M: Letter to GP Reporting Adverse Effects 
Heidie Verhagen  
19A Grey Street 
Glenholme  
Rotorua 
Ph. 07 350 3373 
 
Dr Kingsley 
Ngongotaha Medical Centre 
17 Taui St 
Ngongotaha 
10 October, 2017 
Dear Dr. Kingsley, , 
Re: David Badcock, DOB. 29 Mar 1945 
David has experienced adverse effects on the 04/10/10 with his participation in a 
registered clinical trial studying the effects of a gentle manual therapy on chronic low 
back pain. He reported these effects on the 06/10/17 and similar but not as severe pain 
occurring the previous week were reported on the 29/09/17.These changes in pain were 
expected transient effects of a muscle and joint mobilisation technique called Gravity 
Relief Mobilisation (GRM).  
Action taken on the 06/10/17 was to cancel his treatment session that day, reassurance 
was given that no injury had been caused and that he may withdraw from the research 
participation at any stage. David followed up on the 09/10/17 to indicate that he wished 
to withdraw and that his pain had eased and now was an ache across his low back on both 
sides. 
GRM induces muscle contraction and relaxation to gently mobilise tissues and joints. This 
is achieved indirectly by the amelioration of gravity, activating the mobilisation of nerves, 
muscles, connective tissues, and joints. The mechanism at work induces reflex like non-




and angular cross stretches that are applied with the hands gently to the soft tissues. No 
external forces against tissue resistance have been applied at any stage of this treatment. 
David received treatments of relaxation massage and GRM on the 15/09/17, 22/09/17, 
and 29/09/17. These were of between 60 and 90 mins duration whilst he was lying 
supine and supported with pillows so that he was comfortable and able to relax. David’s 
immediate response to the treatment was also usual. He, was able to relax, his hips felt 
better but he did have some stiffness across the low back on both sides. 
David has expressed concern about the unfamiliar occurrence of left side low back pain. 
This transient pain is likely associated to the intervention as change in pain sites and 
unusual pain has been observed in other cases.  
I sincerely thank David for his participation in this project and appreciate all his efforts to 
provide accurate and full pain records. His experience with the treatment technique 
contributes significantly to our knowledge of how a clinical population with chronic 






CC David Badcock 
 
